



An assessment of fractures , bone mineral density and 
habitual bone metabolism in female distance runners   
 
 
Jennifer A. Higgins 
A thesis submitted to the University of Limerick in fulfilment of the requirement for the 





Supervised by Dr Brian Carson & Professor Philip Jakeman  
 










Title: An assessment of fractures, bone mineral density and habitual bone 
metabolism in female distance runners  
Author:  Jennifer Higgins 
Background 
Exercise is generally considered osteogenic, promoting the accrual of bone during growth and 
preventing its loss during ageing. However female distance runners (FDR) present a paradox 
to this consensus. Despite regular engagement in weight bearing activity, reports of low bone 
mineral density (BMD) are evident amongst up to 45% of FDR. Up to 60% of FDR report at 
least one previous stress fracture; an injury that occurs in response to repetitive sub-maximal 
loading. There is variation in the prevalence of low BMD and/ or fracture history within the 
extant literature. Understanding whether poor bone health poses a significant problem 
amongst FDR, through evaluation of its magnitude was an aim of this thesis.  
BMD is the recommended measure of bone health. But due to its static nature, it does not 
enable understanding of the mechanisms of exercise induced adaptation or maladaptation. 
BMD represents the net effect of formation and resorption processes over a period of time. 
Changes in BMD take time. These changes represent the net effect of bone metabolism, 
constituted of the formation and resorption processes, over that time period. Bone metabolism 
itself has been proposed as an independent risk factor for fracture. Elevated bone metabolic 
activity is associated with elevated fracture risk. Assessment of bone metabolism, using bone 
turnover markers (BTMs) may therefore provide a more appropriate index of current fracture 
risk. Bone metabolism, notably resorption, has been shown to increase in response to 
endurance exercise. This response is maintained for a number of hours. The effect of habitual 
exercise is less clear. In this thesis altered bone metabolism was proposed as a measure of 
current fracture risk amongst FDR. The central aim of the thesis was to examine whether FDR 
display altered bone metabolism relative to a non-athletic reference control (CON) population.  
Approach: 
Two study designs were used to address the central research questions. Females 18-35 y were 
recruited in both.  
The first assessed fracture history amongst 119 FDR using an online survey. Stress fracture 
and fragility fractures that occurred at any time up to the time of data collection were included. 
Fractures were deemed confirmed if they had been diagnosed by x-ray or magnetic resonance 
imaging (MRI). Of the 119 respondents 39 FDR also had BMD evaluated at the spine and hip 
using dual energy x-ray absorptiometry (DXA).  
 
ii 
A 7 day study was used to assess habitual bone metabolism in a cohort of FDR (n=7) who 
were compared to CON (n=11). Homeostatic bone metabolism was assessed using fasted, 
early morning blood samples collected at a standard within participant time. CTX and P1NP 
were measured. Total daily resorption was assessed from 24 h urine samples. uNTX, fDPD 
and fPYD were measured. Concurrently training was captured using training logs. Energy 
expenditure was assessed by Sensewear Pro3™ (SWP3). Menstrual status was assessed by 
self-report questionnaire. Body composition and BMD were assessed by DXA. A sub-group 
of FDR (n=5) also had energy expenditure assessed by double labelled water (DLW). In order 
to understand whether any observed effect was attributable to exercise, or was compounded 
or due to nutrient intake, dietary intake was also evaluated. The energy requirements of FDR 
were compared to those of CON. The validity of SWP3 was assessed through comparison of 
energy expenditure measured by DLW, assessed in 24 h epochs. The energy and nutrient 
adequacy of FDR was then compared based on dietary intake recorded using estimated food 
intake records (eFIR).  
Findings: 
Amongst 119 FDR 35% had a history of fracture. The sub-group (n=39) who had BMD 
assessed had a similar fracture history (36%). Prevalence of low BMD was 31%. However 
sensitivity of BMD to identify those with fracture history was only 14% suggesting that 
fracture risk is not adequately explained by BMD alone. Resorption (assessed by CTX) was 
31% lower and formation (assessed by P1NP) 15% lower in FDR relative to CON. 24 h bone 
resorption (assessed by uNTX) was 37% greater in FDR. Menstrual dysfunction was evident 
amongst 86% (6/7) FDR and 0% of CON, indicative of low EA (LEA). However measured 
EA amongst FDR (45 ± 9 kcal.kgFFM-1), indicated that the FDR in this study addressed their 
10% elevated energy requirements, incurred through a threefold greater exercise energy 
expenditure. FDR also consumed adequate (1474 ± 287 mg) calcium but only consumed 57% 
of the vitamin D recommendation.  
Conclusion: 
The greater total resorption displayed by FDR is indicative of an exercise induced response. 
However the lower homeostatic resorption and formation suggests the response is transient. 
Whether transient increases in resorption are necessary for osteogenesis or are harmful to bone 
is currently unclear. The lower homeostatic bone metabolism may be indicative of an adaptive 
response. But in the absence of an FDR cohort without menstrual dysfunction this finding 
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“One of the lessons from Beijing was that there was a difference between being fit 
and being healthy. I was one, not the other” – Deena Kastor, USA marathon record 
holder on fracturing her foot during the Beijing Olympic marathon.  
 
Athletes are often lauded for their physical capabilities. Their exercise-centric lifestyle 
often considered synonymous with health. Yet, for some, this pursuit of peak 
performance, of embodying the Olympic axiom citius, altius, fortius, instead plunges 
their health into a deep ravine with long lasting, perhaps lifetime, consequences.  
 
Instead of capitalising on the benefits of physical activity, including decreased fracture 
risk (Stattin et al., 2017) and increased acquisition of bone mineral content (BMC) 
(Baxter-Jones et al., 2008), as many as 60% of female distance runners (FDR) present 
with stress fracture history (Heikura et al., 2017b).  Low bone mineral density (BMD) 
has been observed in up to 45% of FDR (Hind et al., 2006).  Though it should be noted 
that prevalence data has ranged widely in the literature.  
 
The development of low BMD poses a particular challenge. Peak bone mass (PBM) 
develops within the first three decades of life (Matkovic et al., 1994), the same period 
that athletic development and potential is emphasised. Optimisation of PBM has been 
suggested to delay the onset of osteoporosis later in life. A 10% increase in PBM can 
delay the onset of osteoporosis by 13 years (Hernandez et al., 2003). By contrast 
failure to attain potential PBM is unlikely to be recoverable later in life. Therefore 
early identification of young adults who are not gaining, and perhaps are even losing 
bone is critical in the prevention of a widespread, debilitating disease.  
 
Both genetics and environment influence bone health. Exercise, particularly 
modalities that induce rapid rates of loading of relatively high magnitude (through 
jumps, changes in direction, or sprinting), and adequate intake of calcium and vitamin 
D are beneficial for the development of PBM (Weaver et al., 2016). By contrast 
menstrual dysfunction, and inadequate dietary intake arising with or without 
disordered eating are detrimental to bone health (Weaver et al., 2016, Nattiv et al., 
2007). The presence of such factors can make adolescence and young adulthood a time 
3 
 
of vulnerability (Heaney et al., 2000). These are key elements within two paradigms 
that aim to explain poor bone health in athletes – the female athlete triad (TRIAD) and 
Relative Energy Deficiency in Sport (RED-S) (Nattiv et al., 2007, Mountjoy et al., 
2014). FDR with menstrual dysfunction have been reported to have 5-6% lower BMD 
(at the spine and hip respectively) than eumenorrheic (EUMEN) counterparts. 
EUMEN FDR with elevated eating disorder inventory (EDI) scores (linked to low 
energy availability (LEA)) have 11% (spine) and 5% (hip) lower BMD than EUMEN 
FDR with normal EDI scores (Cobb et al., 2003). Bone metabolic responses, which 
regulate changes in bone mass, provide evidence to explain the lower BMD in the 
presence of TRIAD components. Southmayd et al. (2019) reported suppressed bone 
formation in oestrogen and energy deficient active women. This supports early 
research from Anne Loucks (Loucks and Thuma, 2003, Ihle and Loucks, 2004), 
showing altered bone metabolism and reproductive hormone release with LEA 
induction for 5 days.  
 
However the mechanisms through which exercise itself could contribute to poor bone 
health in FDR have not been adequately considered. Evidence of acute (hours) 
perturbations of bone metabolism (elevated resorption) in response to endurance 
exercise have been observed (Kohrt et al., 2018). But whether regular exposure to 
endurance exercise alters the basal rhythm of bone metabolism (referred to as 
homeostatic bone metabolism within this thesis) is currently unclear. Should the rate 
of bone metabolic activity be altered, any uncoupling from other influences (e.g. 
menstrual dysfunction, inadequate nutrient intake) would be magnified (with 
increased rate of metabolism or turnover) or suppressed (with decreased rate of 
metabolism or turnover).  
 
BMD is the marker of bone health recommended by the World Health Organisation 
(WHO) due to its strong gradient of risk. There is a twofold increase in fracture risk 
with each 1 SD decrease in BMD (Marshall et al., 1996). However it has limitations, 
particularly in young populations who are still accruing bone. During bone mineral 
accrual early detection of arrested accrual, or even bone loss enables early 
implementation of interventions. Early intervention enables the remaining growth and 
development window to be optimised. The 2019 position stand from the International 
Society of Clinical Densitometry (ISCD) outlines that typically one year intervals 
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between BMD assessments is appropriate when assessing changes in mass (ISCD, 
2019). Changes in bone mass, of which BMD is an indicator, represents the net effect 
of bone resorption and formation. Therefore measurement of bone metabolism itself 
may be an innovative approach enabling early detection of maladaptive bone 
responses. Furthermore in Robert Heaney’s 2003 narrative he outlines that bone mass 
fails to adequately explain changes in fracture risk across the lifespan and in response 
to treatments. He proposed bone metabolic activity as a more relevant explanation 
with changes in fracture risk occurring earlier than changes in BMD (BMD is the 
outcome of the metabolic process). Ivaska et al. (2010) reported increased fracture risk 
with elevated bone resorption markers (hazard risks of 1.13-1.32 per SD increase in 
concentration); although the association reported was not significant when adjusted 
for baseline BMD.  
 
Measurement of bone metabolism offers the opportunity for early identification of 
maladaptive physiological activity rather than waiting for a manifestation of a clinical 
condition. To effectively interpret any marker of health (or performance) knowledge 
of the population norms is required. Understanding the effect of lifestyle influence on 
such markers is also imperative; particularly in athletes, where exercise is part of their 
daily activity. Bone metabolism also enables development of an understanding of the 
adaptive or maladaptive responses that may occur in response to exercise, helping to 
explain the paradoxical finding of poor bone health amongst FDR, as indicated by 
fracture and low BMD.  
 
1.2 Thesis Rationale and Aims 
Within the existing literature, presented in Chapter 2, FDR are identified as a 
population at risk of poor bone health. To date this has been largely attributed to 
menstrual disturbances and/ or LEA (Gibbs et al., 2014). In parallel, acute 
perturbations to bone metabolism in response to exercise, particularly an increase in 
resorption,  have been reported (Scott et al., 2011). The effect of habitual exercise (i.e. 
training) on bone metabolism is less clear. This thesis has focused on the role of 
exercise in bone health of FDR, examining whether a shift in bone metabolism could 
independently alter risk, or exacerbate sub-optimal environmental influences (e.g. 
LEA). It aimed to examine whether habitual bone metabolism differs from a non-
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athletic control. In support of the main thesis aim, to examine whether FDR have 
altered bone metabolism compared to a non-athletic control, information on the burden 
of poor bone health amongst FDR was required. Fracture history (stress fractures and 
fragility fracture) and prevalence of low BMD were examined for this purpose. Further 
to the observed difference in bone metabolism between FDR and controls (CON) 
adequacy of dietary intake needed to be considered. A validation study of energy 
expenditure assessed by Sensewear Pro3™ (SWP3) and examination of differences in 
energy expenditure between FDR and CON was undertaken. This supported further 
examination of the adequacy of dietary intake with regard to energy and nutrients 
known to support bone health in FDR. Energy availability (EA) was the main dietary 
variable of interest. Macronutrient, calcium and vitamin D intakes were also examined 
and discussed relative to existing guidelines.  
 
1.3 Thesis Structure 
The thesis comprises of an introductory chapter (Chapter1) prefacing the research 
topic and aims. Chapter 2 presents a review of the existing literature. This review 
addresses the determinants of bone health with a focus on lifestyle (exercise and 
dietary) influence, the underpinning biology that regulates the acquisition, 
maintenance or loss of bone, the methods of assessing bone health and fracture risk, 
and the implications of each of these in the bone health of FDR.  
 
The study designs, participant details and common methods used in this thesis are 
detailed in Chapter 3. 
 
Chapter 4 reports the history of fracture (self-reported collected using an on-line 
survey), and prevalence of low BMD (assessed by DXA) amongst FDR.  
 
The effect of habitual exercise on bone metabolism is reported in Chapter 5 through 
comparison of habitual bone metabolism in FDR and non-athletic reference controls 
(CON).  
 
In order to address the possibility that the observed group differences in bone 
metabolism occurred, or were influenced by, inadequate dietary intake amongst FDR 
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the energy demands needed to be established. Chapter 6 evaluated the validity of an 
on-body sensor (SWP3) to assess energy expenditure in FDR, and compared the total 
and exercise specific energy demands of FDR and CON. The adequacy of energy and 
nutrient intake in FDR is then presented in Chapter 7. 
 
Chapter 8  discusses the overall thesis findings and the implication of these findings 





Chapter 2: Literature Review 
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2.1 General introduction 
The skeleton’s role as a mineral reservoir (Clarke, 2008) directly competes with other 
functions – support and protection. The skeleton’s strength, enabling it to carry loads 
and withstand forces that pose a threat to internal organs is largely affected by its 
mineral component. Mineral accounts for 60-70% of bone tissue (Lacroix, 2019). It is 
embedded within the protein matrix of bone, and is arranged to provide strength along 
lines of stress (Marieb and Hoehn, 2007). As the store of ~98% of the body’s calcium 
supply it is the skeleton that provides calcium in times of increased demand, through 
release facilitated by bone metabolic activity (Khan et al., 2001). Bone metabolic 
activity is conducted and regulated by cells of the basic multicellular unit (BMU) 
(Eriksen, 2010). Where calcium is removed from the skeleton without subsequent 
replacement, the quantity (mass) of bone will reduce, compromising structural 
integrity and consequently increasing fracture risk. 
 
2.2 Bone cells 
The differentiation and characteristics of key cells in the BMU which is responsible 
for bone metabolic activity and regulation is described here. The action of these cells 
is discussed further in section 2.3  
 
2.2.1 Osteoclasts 
Osteoclasts are multinuclear cells derived from fusion of mononuclear progenitors of 
the monocyte/ macrophage family (Teitelbaum, 2000). Within the BMU they are 
responsible for resorption. The receptor activator of nuclear factor kappa-B (RANK)/ 
RANK ligand (RANKL)/ Osteoprotegerin (OPG) pathway is essential for osteoclast 
differentiation. RANK, expressed by osteoclast precursors binds to OPG or RANKL 
both expressed by osteoblasts or stromal cells. Endocrine influences can affect the 
expression of OPG or RANKL. For example parathyroid hormone (PTH) reduces 
RANKL and increases OPG. Oestrogen has the opposite effect. OPG is a decoy 
receptor which binds to RANK preventing RANK/RANKL binding and thus 
osteoclast differentiation and maturation (Eriksen, 2010). Osteoclast differentiation 
and maturation also requires expression of macrophage colony stimulating factor (M-
CSF) which binds to c-Fms, signalling survival and proliferation of osteoclast 
precursor cells (Teitelbaum, 2000). CSF-1 and RANKL lead to the expression of 
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tartrate-resistant acid phosphatase (TRAP), cathepsin K, calcitonin receptor and β3-
integrin, genes which typify the osteoclast lineage and lead to the development of 
mature osteoclasts (Boyle et al., 2003).  
 
2.2.2 Osteoblasts 
Osteoblasts derive from mesenchymal stem cells (MSC) (Ducy et al., 2000). They are 
found in clusters at bone forming sites and have a distinguishing round nucleus and 
prominent Golgi apparatus, facilitating synthesis of proteins (Khan et al., 2001). The 
life cycle of the osteoblasts begins with differentiation of progenitors to proliferating 
pre-osteoblasts, and then bone matrix-producing osteoblasts before differentiation to 
osteocytes or bone lining cells (Eriksen, 2010). Osteoblasts that are not further 
differentiated undergo apoptosis. In addition to bone formation functions osteoblasts 
regulate osteoclastogenesis through expression of osteoclastogenic factors (Raggatt 
and Partridge, 2010).  
 
Osteoblasts have a mineralised extracellular matrix and have two unique gene 
expression transcripts – one to encode a transcription factor and the other encoding 
osteocalcin (Ducy et al., 2000). Runt-related transcription factor 2 (Runx2) and osterix 
are transcription factors required for osteoblast differentiation and proliferation 
(Raggatt and Partridge, 2010). Osteoblast development and maturation is affected by 
a large number of paracrine, autocrine and endocrine factors including bone 
morphogenetic proteins (BMPs), growth factors like fibroblast growth factor (FGF) 
and insulin like growth factor 1 (IGF-1), and hormones (including PTH and 
prostaglandin agonists) (Eriksen, 2010).  
 
2.2.3 Osteocytes 
Osteocytes derive from osteoblast lineage and are the most abundant cells found 
within bone, accounting for 90-95% of bone cells (Bonewald, 2011, Raggatt and 
Partridge, 2010). During bone formation, osteoblasts become engulfed in the 
unmineralised osteoid and become known as osteoid-osteocytes. Following 
mineralisation these cells found in lacunae throughout bone are known as osteocytes. 
They have dendrite-like processes which extend throughout canaliculi in bone to allow 
interactions with other cells including osteocytes and osteoblasts (Raggatt and 
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Partridge, 2010). Osteocytes are responsive to mechanical load. They are proposed to 
have a central role in mechanically induced bone metabolism.   
  
2.2.4 Bone lining cells  
Bone lining cells are flat end-differentiated osteoblasts found on the surface of bone. 
During bone remodeling these cells lift from the surface of bone to reveal adhesion 
sites enabling osteoclasts to attach to the bone.  
 
2.3 Bone remodeling 
2.3.1 Overview of the bone remodeling cycle  
Bone remodeling is a continuous cycle which removes pockets of old bone and 
replaces it with newly formed bone, through carefully orchestrated resorption, reversal 
and formation phases (Manolagas, 2000). Approximately 10% of the skeleton is 
replaced per annum (Manolagas, 2000). The process, requiring approximately 180 
days (30-40 days of resorption, 10 day reversal phase and 150 day formation phase) is 
essential for the maintenance of structural integrity (by removing micro-damage), and 
homeostasis (through release of minerals) (Eriksen, 2010, Raggatt and Partridge, 
2010).  
 
2.3.2 Action and regulation of the bone remodeling cycle 
Key processes and regulatory mechanisms of the bone remodeling cycle are presented 
in Figure 2-1. The BMU is activated in response to either mechanical or metabolic 
stimuli (Raggatt and Partridge, 2010). In response to load, micro-cracks can occur, or 
strains within the bone’s surface are detected by osteocytes. This stimulates the release 
of osteoclastogenic factors, such as RANKL from osteocytes which undergo apoptosis 
(Bonewald, 2011). Humoral changes can occur in tandem with this mechanical signal 
or can independently stimulate BMU activation. Calcium concentration is a potent 
regulator of bone metabolism. Upon detection of reduced serum ionised calcium, PTH 
is secreted from the parathyroid glands and acts directly on kidneys and bone and 
indirectly (through vitamin D) on the gastrointestinal tract to maintain serum calcium 
homeostasis (Raggatt and Partridge, 2010). PTH regulates osteoblast expression of 
RANKL and OPG (Silva et al., 2011), regulators of osteoclastogenesis through their 
interaction with RANK. Presence of M-CSF produced by marrow stromal cells is also 
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required for proliferation, survival and differentiation of osteoclast precursors (Clarke, 
2008). Bone lining cells are thought to have a role in the preparation of a resorption 
site through collagenase mediated digestion of non-mineralised bone, revealing 
binding sites (Kular et al., 2012). Integrins expressed in mature osteoclasts can then 
bind with the bone matrix (Hadjidakis and Androulakis, 2006). Osteoclast adhesion 
results in a sealed zone. The podosomes attaching osteoclasts to bone can then move 
across the surface as bone resorbs (Hadjidakis and Androulakis, 2006). Within the 
sealed zone hydrogen ions are secreted, creating an acidic environment and dissolving 
the mineral component of bone. Collagen degrading enzymes, such as cathepsin K 
then break down the collagen, resulting in the release of cross links which can be 
measured in blood and urine. Degraded collagen is removed from the bone’s surface 
by reversal cells, although the nature of these cells and the coupling signals that 
stimulate the subsequent osteoblast differentiation and action are less clear (Raggatt 
and Partridge, 2010). Osteoblasts, differentiated from the MSC lineage, initially lay 
down osteoid, predominantly composed of type 1 collagen. They then coordinate the 
deposition of hydroxyapatite during mineralization (Raggatt and Partridge, 2010). 
Following mineralisation osteoblasts undergo one of their three fates – further 





Figure 2-1: Bone remodeling cycle (Raggatt and Partridge, 2010) (p. 25105) 
2.3.3 Bone remodeling in the regulation of bone mass   
Under homeostatic conditions the BMUs action is tightly regulated to maintain bone 
mass through balanced resorption and formation (Clarke, 2008). Where this balance 
is disrupted changes in bone mass will occur – a decrease where resorption dominates 
and an increase where formation presides. As addressed in 2.5.2 both the degree of 
uncoupling and the rate of bone metabolic activity will affect the magnitude of the 
structural changes, with an increase in either factor inducing a greater rate of change.  
 
2.4 Changes in bone across the lifespan  
Both bone mass and bone metabolic activity changes across the lifespan, with 
implications for fracture risk. Childhood and adolescence are periods of growth and 
accrual, with a 50% increase in lumbar spine BMD observed in females from 9-14 y 
(Bonjour et al., 1991). Concurrent with this increase, which is also observed relative 
to pubertal stage, bone metabolic marker concentrations that are up to ten fold mean 
adult concentrations have been observed (Blumsohn et al., 1994b), demonstrating an 
inter-relationship of bone metabolism and BMD. This period of rapid bone change, 
mediated by bone metabolic activity, represents a time of opportunity, but also 
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vulnerability (if sub-optimal or detrimental influence is present) to environmental 
influence. Consequently this period is also sensitive to the resultant PBM (Weaver et 
al., 2016) which is attained within the first three decades of life (Matkovic et al., 1994). 
The rapid changes in bone mass during childhood and adolescence can be seen in 
Figure 2-2. Also evident from Figure 2-2 is the accelerated peri-menopausal bone loss 
and an age related decline. Menopausal bone loss is also associated with bone 
metabolic activity. During the menopausal transition (median duration of 2.5 years 
with start point defined as 1 year prior to the final menstrual period) up to 2.5% and 
1.8% BMD loss per year has been observed at the lumbar spine and femoral neck 
respectively. Higher bone resorption is associated with greater losses. Each SD 
increment in urinary N-telopeptide of type 1 collagen (NTX), a marker of bone 
resorption, is associated with 0.6% and 0.4% per year faster decreases at the respective 
lumbar spine and femoral neck sites (Shieh et al., 2016).  
 
Figure 2-2: Typical changes in bone mass across the lifespan 
(adapted from (Weaver et al., 2016) p.1283) 
Fracture incidence also changes across the lifespan; with elevated incidences at times 
of lower bone mass and elevated bone metabolic activity. For example childhood 
fracture incidence at peak height velocity (140 per 10000 person years) is greater than 
that observed pre (<5 y) or post (>14 y) this period (<100 per 10000) (Cooper et al., 
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2004). In women at or near PBM, where bone metabolism is not rapidly changing 
bone mass, fracture incidence (54.3 per 10,000 person years) is one third of those 
reported in women >50 y (155.4 per 10,000 person years) (Curtis et al., 2016). This 
evidence confirms that bone metabolism and/ or bone mass affect fracture risk, making 
them potential candidates for the assessment of bone health.  
 
2.5 Measurement of bone health  
Osteoporosis is a disease “characterized by low bone mass, deterioration of bone tissue 
and disruption of bone architecture, compromised bone strength and an increase in the 
risk of fracture (Cosman et al., 2014) (p.2361). Measurement methods for bone health 
assessments therefore focus on one or more of these influences. As indicated in 
sections 2.3.3 and 2.4 there is an inter-relationship of bone metabolism and bone 
density. Bone metabolism refers to the process through which bone mass or structure 
can be altered. Hence measurements of bone mass and architecture can be thought of 
as outcome measures and bone metabolism a measure of process. The inter-
relationship of elements of bone strength which can be assessed, and their assessment 
methods is shown in Figure 2-3. In this thesis bone metabolism and BMD are used as 
measures of bone health. They will therefore be discussed in further detail in sections 
2.5.1 and 2.5.2 .  
 




2.5.1 Bone mineral density 
In fully mineralised bone, BMD is an index of bone mass (Kanis, 2002). BMD is 
widely used in clinical practice due to its strong ‘gradient of risk’ for fracture 
prediction. A decrease of 1 SD in BMD (at any, lumbar spine or hip site) has a relative 
risk of any fracture of 1.5, with greater (1.9 and 2.6 respectively) risk for hip and spine 
fracture from the site specific measurements (Marshall et al., 1996).  The gradient of 
risk can depend on technique used (Kanis et al., 2008). ISCD provide general 
recommendations on the use of techniques other than central DXA including 
qualitative computed tomography (QCT), peripheral QCT (pQCT), quantitative 
ultrasound (QUS) and peripheral DXA (pDXA) (ISCD, 2019). Trabecular BMD 
measured by QCT at either the spine or hip is deemed effective for fracture risk 
assessment of spine or hip fractures respectively in postmenopausal women. Hip BMD 
assessment for hip fractures is also acceptable in older men, but there is insufficient 
evidence for spine measures in spine fracture assessment for men. In postmenopausal 
women peripheral scanning of the ultra-distal radius predicts hip but not spine 
fragility. Only the heel is a validated site for fracture prediction from QUS. However 
discordance between DXA and heel QUS is not uncommon. Peripheral DXA scanning 
is less effective at fracture prediction than central DXA. In all cases central DXA is 
preferred where therapeutic decisions are being made  (ISCD, 2019). DXA is also the 
measure recommended by the National Osteoporosis Foundation (NOF) (Cosman et 
al., 2014). Validity of methods other than central DXA for fracture risk assessment in 
young adults is not noted in the position statement  (ISCD, 2019). 
 
Areal BMD, calculated by dividing the measured bone mineral content (BMC) in a 
site, by the area measured, is measured in g.cm-2. As a two dimensional measure the 
apparent density is affected by size of bone, larger bones will have higher apparent 
density. In adults this is beneficial as larger bones are stronger, allowing this 
characteristic to improve fracture prediction (Kanis, 2002).  
 
In practice areal BMD measures are expressed in relation to a reference population.  
ISCD (2019) recommend use of the following reference populations:  
• For pre-menopausal females and males <50 y: in comparison to an age, sex 
and ethnicity matched reference population (Z-score, Z-scores should be 
population specific when adequate reference data exits). 
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• In post-menopausal females and males >50 y: in comparison to a young, 
Caucasian, female adult reference population (T-score, T-scores should be 
calculated from the female, white, age 20-29 y, NHANES III database). 
 
The World Health Organisation (WHO) criteria outlined by Kanis (2002) are shown 
in Table 2-1 and are deemed appropriate for post-menopausal women and men over 
50 y.  
Table 2-1: WHO definition of BMD classifications when using T-scores 
Classification BMD T-score 
Normal Within 1 SD of the mean level for a young adult 
reference population 
≥-1 
Low bone mass Between 1.0 and 2.5 SD below that of the mean 
level for a young-adult reference population 
<-1 and >-2.5 
Osteoporosis  2.5 SD or more below that of the mean level for 





2.5 SD or more below that of the mean level for 
a young adult reference population with fracture 
≤-2.5 with fractures 
 
In pre-menopausal females or males <50 y Z-scores are reported with the following 
definition: Z-score of -2.0 or lower is “below the expected range for age” and above -
2.0 is “within the expected range for age” (ISCD, 2019). 
 
The following concepts inform the defined thresholds in the general population: 
1. Lower absolute BMD (g.cm-2) increases fracture risk  
2. BMD is normally distributed in healthy young adults as shown in Figure 2-4 
3. BMD decreases with age, resulting in an increase of the percentage of 





Figure 2-4: Distribution of BMD in healthy women aged 30-40 years (Kanis, 2002) 
(p. 1930) 
 
In athletes, regular exercise is expected to enhance bone mineral accrual (Baxter-Jones 
et al., 2008), resulting in BMD that is up to 20% greater than non-athletic reference 
controls (Fehling et al., 1995). This would be represented as a positive (right) shift in 
the distribution shown in Figure 2-4. This would result in a Z-score of 0 in an athletic 
population occurring at a greater BMD (g.cm-2) than the Z-score of 0 in a non-athletic 
population. Where an athletic population, with a normal distribution of BMD, and who 
have benefited from their regular weight bearing exercise has bone health assessed 
using reference databases for the general population fewer will be classified as ‘at risk’ 
(i.e. included within the low BMD category). This may hinder the detection of 
individuals who are not accruing optimal bone mass. The repetitive loading 
experienced by athletes could also require greater BMD for an equivalent fracture risk, 
due to their frequent exposure to sub-maximal loading and potential fatigue damage 
(Lambers et al., 2013). The American College of Sports Medicine (ACSM) 
acknowledge the limitations of the WHO criteria in the 2007 Female Athlete Triad 
Position Stand (Nattiv et al., 2007). They recommend use of a modified set of criteria, 
also recommended by the International Olympic Committee (IOC) (Mountjoy et al., 
2014) 
• Low BMD: BMD Z-score between -1.0 and -2.0  
• Osteoporosis: BMD Z-score ≤-2.0 with secondary risk factors for fracture (e.g. 




The positive prediction of fracture from low BMD is about 45% (Kanis, 2002). 
However many fractures occur in individuals with normal BMD. Kanis (2002) stated 
that 96% of osteoporotic fractures occur in women without osteoporosis defined by 
BMD. More recently Fuggle et al. (2019) also noted the low sensitivity with non-
vertebral fractures occurring in women with normal BMD and only half of women 
who sustained a hip fracture during a five year follow up in the USA had a T-score <-
2.5 at baseline. Despite its numerous advantages – relatively low cost and radiation 
exposure, and high reliability (minimum acceptable precision is 1.9-2.5% dependent 
on site (ISCD, 2019)), the low sensitivity is problematic. In populations where BMD 
within the reference norm are likely to be found e.g. athletes, this poses a particular 
challenge. Where a population (e.g. athletes) have mean BMD that is greater than the 
mean of the reference population (derived from the general population), bone loss or 
sub-optimal acquisition may go undetected. The individuals will remain within the 
normal range but may be failing to achieve their optimal BMD. The stable nature of 
BMD is good for reliability but may be a hindrance in real time fracture risk 
assessment. BMD is the result of resorption and formation influenced by genetic and 
environmental influences over time. Early changes influenced through environment 
e.g. energy or menstrual status (De Souza et al., 2008) amongst athletes may alter the 
bone metabolic activity. This altered metabolic activity itself can alter fracture risk 
(Heaney, 2003). In a young, athletic population the addition of measures that assess 
the dynamic process itself (bone metabolism), as well as the net outcome (through 
BMD) may enable early indications of maladaptive changes in bone, or altered fracture 
risk independent of BMD to be detected.  
 
2.5.2 Bone metabolic activity  
The interrelationship of bone metabolism and bone mass was indicated in Figure 2-3. 
As discussed in section 2.3.3 changes in bone mass are achieved through a net 
formation/ resorption effect in the bone remodeling cycle. Section 2.4 highlighted that 
greater metabolic activity is present in times of increased fracture incidence, and 
concurs with times of rapid changes in BMD – childhood and adolescence, and in the 




Additionally Heaney (2003) proposed that bone metabolic activity is itself a predictor 
of fracture (Figure 2-5). Bone metabolic activity can be monitored through use of bone 
turnover markers (BTM) which are secreted into circulation during the remodeling 
process. This offers a non-invasive method of capturing acute changes in metabolic 
activity. 
 
Figure 2-5: Illustration of the relationship of remodeling activity to fracture risk,  
including the range of remodeling activity and fracture risk within a population classified as 
“normal” by BMD (adapted from Heaney (2003) p.460) 
 
Fracture risk will be affected by both the rate and balance of bone metabolism (Figure 
2-6). Parfitt (2002) cited high bone turnover as a “mechanical threat”. Resorption 
cavities formed throughout the remodeling process will create a focal weakness. In 
thin trabeculae (found in bone with low BMD) the development of resorption cavities 
have potential to exponentially alter strength due to  the smaller total amount of bone. 
Changes in bone resorption markers offer a more satisfactory explanation for the 3 y 
treatment effect of bisphosphonates on vertebral fractures. Reduced bone resorption 
marker concentrations (uNTX and C-terminal telopeptide of type I collagen (CTX) 
(measured from second morning void urine)) explained 66% and 67% of the treatment 
effect in post-menopausal women (Eastell et al., 2003) compared to the 16% explained 
by change in BMD (Cummings et al., 2002).  
 
Measurement of bone metabolism may have increased relevance in populations who 
are accruing bone mass (up to and including early adulthood) or those expected to 
have BMD values within the normal range (young adults and athletes). Figure 2-5 
shows a large overlap in remodeling activity in populations with ‘normal’ BMD vs 
 
20 
osteoporosis. But it is the remodeling activity that defines fracture risk. In addition to 
the rate of activity, capturing bone metabolic balance has the potential to identify 
individuals who are failing to accrue bone, and ultimately will not attain optimal PBM 
or those who are prematurely (during adolescence of young adulthood) losing bone. 
Without serial BMD scanning detection of such losses would not be evident using 
current methods.  
 
Figure 2-6: Illustration of the BMD independent and dependent effects of bone remodeling on 
fracture risk 
A further advantage of bone metabolism, and a critical reason for its use in this thesis 
is the sensitivity of bone metabolism to environmental influence. In response to acute 
exercise, BTMs have been shown to increase up to double baseline levels within an 
hour of exercise. This response is maintained for 4 h (Kohrt et al., 2018). Feeding 
(self-selected breakfast) is known to suppress bone metabolism up to 18% (Clowes et 
al., 2002); mediated at least in part by gastrointestinal hormone responses (Henriksen 
et al., 2003). This sensitivity to environmental influence facilitates assessment of 
bone’s response to individual pillars of environmental influence (e.g. a specific 
exercise type, intake of a nutrient) and of their synergistic or antagonistic effects (e.g. 
calcium pre-feeding from exercise). This can facilitate understanding of mechanisms 
that regulate changes in BMD in response to repeated exposure to an environmental 




2.6 Measuring bone metabolism  
2.6.1 Bone turnover markers (BTMs) 
BTMs can be by-products of the remodeling process (most often resulting from 
collagen breakdown or formation), enzymes or matrix proteins. They are classified by 
the process they represent i.e. formation or resorption; some newer markers also 
represent regulatory (osteocyte) activity and are measured in blood/ urine (Seibel, 
2005, Chapurlat and Confavreux, 2016). Table 2-2 summarises a number of available 
markers, their measurement medium and considerations in analysis. The wide range 
of markers allows for various phases of the remodeling cycle to be assessed. But this 
can also result in inconsistencies across the literature. In response, the International 
Osteoporosis Foundation (IOF) have published recommendations on marker choice 
(Vasikaran et al., 2011b), sampling protocol (Szulc et al., 2017) and reporting 
(Vasikaran, 2015).  
 
Choice of marker is pertinent. Many of the available markers derive from collagen 
metabolism. Collagen is the most abundant protein in bone but it is also widely 
distributed in the other tissues (Garnero, 2014). Therefore turnover of other tissues 
including cartilage, dentin and muscle could contribute to the circulatory pool. BTMs 
used should therefore be specific to bone. The IOF (Vasikaran et al., 2011b) has 
considered this in their choice of reference BTMs – CTX and P1NP both sampled in 
blood. The reference BTMs have been chosen as they satisfy the following criteria: 
1. Considered to be adequately characterised and clearly defined  
2. Bone specific and perform well in both fracture prediction and treatment/ 
potential treatment (clinical trial) monitoring  
3. The assay and the methodology is widely available and automated analysis is 
available  
4. Have appropriate biological and physicochemical characteristics that make 
them suitable candidates for practical laboratory use.  
5. The measurement specimen is blood; intra-individual variation is lower than 
in urine because there is no need to correct for creatinine concentration. 
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Table 2-2: Source, measurement methods and considerations of common BTMs 
(compiled from information published by Vasikaran et al. (2011b), Lombardi et al. (2012), Seibel (2005) and (Ricos et al., 2004)) 








linking telopeptide of 
type 1 collagen (urine – 




hydrolysis of collagen 
type 1 
• Found in all tissues 





• Urine  
• ELISA, 
RIA 
• Influenced by circadian rhythm 
• uNTX be adjusted to levels of 
urinary creatinine (spot sample) and 





linking telopeptide of 
type 1 collagen (urine – 
uCTX; serum – sCTX) 
Note: unless otherwise 
specified CTX refers to 




hydrolysis of collagen, 
generated by cathepsin 
K 
• Found in all tissues 
containing type 1 
collagen  





• Influenced by circadian rhythm 
• sCTX is dependent on food intake 
and is influenced by renal function 
and liver function 
• uCTX must be adjusted for creatinine 
(spot sample) 
• uCTX can be isomerised (β) or non-












• Proteolytic hydrolysis 
of collagen 
• Found in bone, dentin 
• Urine  • Present in mature collagen only 
• Can be measured as total or free 










• Independent of dietary sources, 





Pyridinoline (PYD) Collagen 
cross link 
• Found in bone, 
cartilage, tendon, 
blood vessels 




• Present in mature collagen only  
• Can be measured as total or free 
(non-peptide bound) (fPYD) 
• Independent of dietary sources, 
influenced by UV radiation, liver 







C-terminal cross linked 
telopeptide of type 1 





hydrolysis of collagen 
generated by matrix 
metalloproteinases  
• Found in bone, skin 
• Serum 
• RIA 
• Highest contribution probably from 
bone; may be derived from newly 
synthesised bone  
• Influenced by renal and liver 
function and circadian rhythm 







• Two isoforms: 
• Type 5a: platelets, 
erythrocytes and other 
sources 





• Influenced by haemolysis and blood 
clotting and circadian rhythm  








• Cathepsin K – cysteine 
protease, cleaves 
helical and telopeptide 
regions of collagen 
type 1 in osteoclasts 
• Serum 
• ELISA  
• Not cited in IOF Position Paper  
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 • Some osteocalcin 
fragments are released 
during osteoclastic 
bone resorption 
• Urine  
• ELISA 
• Not cited in IOF Position Paper 
• Not a specific marker of resorption – 
may reflect formatin also  
 
Formation 





• Precursor molecules of 







• Mostly derived from bone  
• Small circadian rhythm 
• Intact (trimer only) or total (trimer 
and monomer) can be measured   
 





• Precursor molecules of 





• 90% derived from bone collagen type 
1 
• Short serum half life 
• Regulated by hormones 
• Small circadian rhythm 
8.2% 
Bone-specific alkaline 
phosphatase (BAP or 
bone ALP) 
Enzyme  • Ubiquitous, membrane 
bound tetrameric 
enzyme located on the 











• Specific for bone, has some cross 
reactivity with liver isoform 




Enzyme • Upiquitous, membrane 
bound tetrameric 
enzyme located on the 
outer cell surface of 
•  • Non-specific to bone 





various tissues: liver 
bone, intestine, spleen, 
kidney and placenta 
















• Specific marker of osteoclast 
function 
• Subject to rapid degradations in 
serum 
• Influenced by renal function, 
circadian rhythm 
• Large inter-laboratory variation 
7.2% 
ELISA: enzyme linked immunosorbent assay; CLIA: chemiluminescent immunoassay; HPLC: high-performance liquid chromatography; IRMA: 
immunoradiometric assay; RIA: radioimmunoassay 
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2.6.2 Measurement considerations  
Consideration of the biological, pre-analytical and analytical variation of BTMs is 
required to correctly interpret BTM data (Wheater et al., 2013). A summary of pre-
analytical considerations (including biological) identified by the IOF is provided in 
Table 2-3. 
Table 2-3: Participant related pre-analytical sources of variation for sampling of P1NP and 
CTX 
(table adapted from Szulc et al. (2017) 
Source of 
variability 




Highest in early 
morning, lowest in 
early afternoon 
Collect samples from 07:30-
10:00 and longitudinal samples 
at same time of day 
Very 
important 
Food intake CTX decreases (>20% 
with food intake); 
P1NP is minimally 
affected 




Menstrual P1NP higher and CTX 
lower in luteal phase  
Collect sample during 
follicular phase in pre-
menopausal women if feasible 
Moderately 
important 
Seasonal Mild effect for CTX. 
Higher BTM in winter 
due to low 25OHD. 
More effect in older 
individuals 
Consider vitamin D levels, 
particularly in longitudinal 
studies. Consider time of year 
for repeat collections 
Moderately 
important 
Exercise Intensive physical 
training produces 
moderate increase in 
CTX and decrease in 
P1NP. Light exercise 
no effect.  
Record details of exercise type 
and intensity. Avoid vigorous 






Smoking, alcohol, diet More data required Moderately 
important 
Uncontrollable 
Age High in infancy, 
decrease in childhood, 
before  increase in 
puberty.  
Lowest in 5th decade 
(men) and 4th decade 
(women). Increase at 
menopause 






Separate reference ranges 









BTM increase around 
the menopause 
Appropriate reference intervals 






Elevated BTM, highest 
in third trimester, 
elevated during 
lactation 





Differences depend on 
lifestyle 
Multicentre trials – report 
ethnicity and geographical 
location 
Important 
Fracture Increased BTM first 4 
months, elevated for 
12 months 
 Important  
Disease The following conditions affect BTMs: 
Renal failure, primary hyperparathyroidism, 
hypotoxicosis, acromegaly, hypogonadism, vitamin D 
deficiency, immobility, Paget’s disease, rheumatoid 
arthritis, multiple myeloma, Cushing’s disease, Crohn’s 





The relevance of these influences is somewhat dependent on the intent of evaluation 
or analysis. In clinical practice a minimisation of uncontrollable sources of variation 
is important; as is interpretation of results within the correct clinical range (considering 
uncontrollable influences such as age or menopausal status) to accurately ascertain the 
bone metabolic status (and hence fracture risk) of an individual. In research the focus 
of a specific research question and the nature of the data collection (international, cross 
sectional vs longitudinal, variability within the population of interest (age, sex, activity 
level, prevalence of disease) (Szulc et al., 2017)) is pertinent in selecting both BTM 
and timing/ specimen for measurement.  
 
Where an environmental influence is the subject of study, efforts should be made to 
minimise the influence from other variables. During adolescence and peri-menopause 
bone metabolism is known to be elevated (Blumsohn et al., 1994a, Shieh et al., 2016), 
as was discussed in section 2.4 . Avoiding these periods of time and studying adults at 
PBM may therefore be a strategy to minimise the influence of age, growth and/ or 
hormonal changes. Due to differences in pubertal timing and the presence of 
menopause, sex differences in bone metabolism can occur. Van Coeverden et al. 
(2002) reported that bone metabolic marker concentrations decreased (>33% in some 
cases) in the latter stages of puberty in girls, but no significant decrease occurred in 
males. Sex specific reference intervals as recommended by Szulc et al. (2017) account 
for such changes across the lifespan. Where environmental influence is the variable of 
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interest diseases, potential influence of modeling post fracture, pregnancy or lactation 
changes should be avoided by applying these as exclusion criteria. In females 
menstrual status must be considered. Fluctuations in bone metabolism across the 
menstrual cycle (regulated by hormonal changes) have been cited as a consideration 
for assessment of bone metabolism. Gass et al. (2008) reported 4.35% greater CTX 
concentration during the early follicular phase (relative to the mean at luteal hormone 
peak) and a decrease of 5.11% in the luteal phase. P1NP was ~5% lower in the 
follicular phase than the luteal phase. Phase of menstrual cycle is relevant where 
another lifestyle influence is of interest, particularly if the magnitude of effect of the 
variable of interest  is not known. Hormonal contraceptive use must also be 
considered. In some cases hormonal contraceptive offers the advantage of 
standardising hormonal concentrations and hence allowing another variable e.g. 
exercise to be studied. However Elliott-Sale et al. (2013) cautioned that dependent on 
brand and type responses may differ. Furthermore the downregulation of oestradiol in 
particular warrants consideration. Oestrogen is a regulator of osteoclast proliferation 
and apoptosis and downregulation could therefore alter the bone metabolic response. 
Similarly menstrual dysfunction, known to exist in up to 50% of female athletes 
(Gibbs et al., 2013) could have a similar effect. The hypoestrogenic environment could 
increase bone metabolic activity, particularly resorption as is observed peri-
menopause (Shieh et al., 2016). Amongst athletes menstrual dysfunction is often 
explained by low energy availability (LEA) which in itself incurs hormonal changes 
that could alter bone metabolism (De Souza et al., 2008). This may explain the findings 
of Zanker and Swaine (1998) who reported reduced bone metabolism in AMEN FDR 
but not EUMEN FDR, compared to CON. These arguments demonstrate the need to 
acknowledge menstrual status in studies of bone amongst females. However the 
challenge of recruiting females with similar menstrual status cannot be overlooked.  
  
One of most acknowledged considerations for BTM measurement is the diurnal 
rhythm, which is particularly evident in resorption markers. Their peak occurs in early 
morning (~01:30-04:30) while they are at a nadir in the early afternoon (~12:00-15:00) 
(see Figure 2-7). An amplitude of ~60-66% of the mean value is reported (Wichers et 
al., 1999). This daily variation is also a consideration in inter-individual comparisons. 
Figure 2-7 shows inter-individual variation in the late morning considerably lower 




attenuate the effect of diurnal rhythm by ~50% (Christgau, 2000). Feeding also 
attenuates CTX concentration (-18%)(Clowes et al., 2002). Both of these influences 
have informed the use of fasted blood samples, that are collected between 07:30 and 
10:00, recommended by the IOF  (Szulc et al., 2017) to capture homeostatic bone 
metabolism.  
 
Figure 2-7: Individual CTX concentration profiles in in six healthy men across 24h 
(Wichers et al., 1999) 
 
BTMs have also been shown to respond to exercise. Daniel and Jakeman (2008) 
demonstrated that two hours of treadmill walking (total energy expenditure 2 MJ) 
increased CTX by 10% in healthy human participants, with peak concentration 
reported within 60 minutes of exercise completion. Exercise intensity (Scott et al., 
2011) and differences in dietary intake between exercise bouts (Hammond et al., 2019) 
have been shown to have acute effects of BTMs. Although responses are often no 
longer evident in fasted morning samples the next day, suggesting that fasted, morning 
BTMs can be used to assess homeostatic bone metabolic activity, independent of prior 
exercise. This contrasts with the IOF guidelines where vigorous exercise should be 
avoided on the day pre-sampling (Szulc et al., 2017). The training status of the 
participants could contribute to decisions regarding exercise. In trained individuals 
exercise is the ecological norm. Where assessment of habitual bone metabolism is 
intended, removing an exercise stimulus from a habitually active individual may be 
inappropriate.  
 
Although fasted morning samples, obtained in the absence of influence from diet and 
exercise are appropriate for assessing homeostatic bone metabolism, they do not 
inform on the habitual effects of lifestyle influence. Already mentioned are the acute 
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studies of feeding and exercise and the observed response. Neither approach, 
homeostatic or acute exercise/ feeding trials, fully informs on the net effect of lifestyle 
influence on bone metabolism. To do so would require 24 h monitoring capturing the 
multitude of responses to numerous eating occasions and activity bouts throughout the 
day. Using blood analysis this is invasive and impractical in free living individuals. 
However bone resorption markers can also be measured in urine (Table 2-2) enabling 
24 h measurement. No urine BTM is a reference marker identified by the IOF 
(Vasikaran et al., 2011a).  Concerns, regarding standardisation to creatinine (resulting 
in greater variability) and reliability (due to the onus placed on participants) (Bhattoa, 
2018) likely contributed to the IOF’s decision. Furthermore in the absence of 
understanding of the relationship between 24 h resorption and fracture such a 
recommendation would be inappropriate for clinical settings. In research a different 
view could be taken.  24 h sample collection is burdensome but creatinine in this case 
can act to validate sample volume when samples are collected over multiple days. This 
is based on the expected consistent amount of creatinine excretion relative to muscle 
mass (Heymsfield et al., 1983). Where habitual bone metabolism is the intent of the 
investigation measurement of urine BTM excretion in 24 h samples, expressed as an 
amount, allows for measurement in free living participants. In this case creatinine 
measurement adds validity rather than error to the analysis. 
 
With due caution towards the multiple sources of variability that can affect results, 
BTMs provide an attractive method of assessing early changes in bone, changes 
independent of BMD, and notably allow the study of dynamic responses to lifestyle 
influence. These factors are particularly relevant in studying young (PBM age), active 
individuals including FDR.  
 
2.7 Determinants of bone health 
As discussed in section 2.4 numerous changes in bone metabolism, BMD, and fracture 
risk occur across the lifespan. Biological influence accounts for some of these changes 
while environment and the interaction of biology and environment account for others. 
Figure 2-8 summarises the key influences on bone and their synergistic actions in bone 






Elevated fracture risks in early (40% reduction following peak bone accrual) and later 
(three-fold increase in females >50) life. Asian or white ethnic origin and female sex 
are risk factors for osteoporotic fracture (Kanis et al., 2008). Genetics are also known 
to affect bone. Three quarters of variance in PBM is determined by genetics (including 
via a mediating effect of body size) (Heaney et al., 2000). However only a third of 
fracture risk is accounted for by genetics (Peacock et al., 2002) suggesting that other 
influences (including modifiable environmental factors) have great importance. 
Influences including age, race, sex, and in some cases disease or its associated 
medication requirements are non-modifiable; nor are they the subject of this thesis so 
they will not be discussed in depth. Instead it will focus on modifiable lifestyle 
influences.   
 
Figure 2-8: Illustration of the interactive effect of biological and genetic influences on bone 
and fracture risk 
 
Environmental influences 
Diet and exercise are two of the primary environmental influences with known effect 
(Weaver et al., 2016, NIH, 2001). The influence of these factors to support adequate 
body mass and exposure to sex hormones at puberty can also be protective to bone 
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(NIH, 2001). Furthermore exercise and diet can have an interactive effect. Inadequate 
dietary intake, occurring as a result of increased exercise energy expenditure (EEE) 
not being adequately replaced, results in up to 30% reduction in P1NP (Ihle and 
Loucks, 2004). Pre-exercise calcium ingestion alters the exercise induced response, 
with a ~30% reduction observed in female cyclists (Haakonssen et al., 2015). Exercise, 
diet and their interaction are the focus of this thesis and they will be discussed in depth 
in the next two sections.  
 
2.8 Exercise and bone  
2.8.1 Definitions 
Physical activity and exercise are well established to induce a range of physiological 
responses in systems across the human body. Physical activity encompasses a large 
spectrum, defined as “any bodily movement produced by skeletal muscles that results 
in energy expenditure” (Caspersen et al., 1985). This includes exercise: “physical 
activity that is planned, structured, repetitive and purposive in the sense that 
improvement or maintenance of one of more components of physical fitness is an 
objective”. Physical fitness components are related to health or athletic ability 
(Caspersen et al., 1985).  
 
2.8.2 Activity, exercise and bone health outcomes 
A wide spectrum of intensities and modalities of activity and exercise induces a range 
of mechanical and metabolic stimuli which can have differential effects on bone. Even 
low amounts of physical activity (<20 min.d-1 of amounts of cycling/ walking) have 
been shown to reduce hip fracture and any fracture risk by ~20% and ~10% 
respectively (Stattin et al., 2017). During adolescence, a time of elevated metabolic 
activity and thus sensitive to environmental influences, adolescent males and females 
who are in the upper quartile of activity have 7.6% and 7.8% greater total BMC 
respectively than those in the lower quartile of physical activity, one year post peak 
height velocity, with magnified (10.5% and 12.5% respectively) differences observed 
at the lumbar spine (Baxter-Jones et al., 2008). This data indicates that activity has a 
positive effect on fracture risk and on bone mineral accrual in adolescents. In post-
menopausal women exercise interventions have also been effective in offsetting the 




(2*group session, 2* home session including aerobic exercise, jumping, strength 
training) prevented a 3.3.% loss of spine BMD observed in a control group in post-
menopausal women (Engelke et al., 2006).  
 
This evidence of beneficial effects of exercise on bone provides support for the 
inclusion of physical activity in recommendations to prevent osteoporosis (NIH, 
2001). However the exercise habits of athletes differ from those of the general 
population, often including multiple hours of sport specific training each day.  
 
In studies of athletes, differences dependent on type of sport and hence type of training 
become evident. Egan et al. (2006) reported higher (>10%) lumbar spine BMD in club 
and university female rugby and netball players compared to a reference control. No 
difference between FDR and controls was evident. Mudd et al. (2007) report 8% 
greater total body BMD in gymnasts compared to FDR or swimmers/ divers. Track 
and field athletes (field events and sprinters) and hockey players had 6% and 7% 
greater BMD than swimmers also. At the lumbar spine these results became more 
pronounced with a 19% difference observed between gymnasts and runners and 11% 
between gymnasts and swimmers. These studies indicate an effect of loading pattern. 
Sports that include jumps, multi-directional turns, and sprinting appear to benefit more 
than repetitive impact sports (FDR) or those with little to no impact (swimming). The 
regulatory mechanisms of this observation will be explained further in section 2.8.5  
 
2.8.3 Acute exercise and bone metabolism 
BMD studies suggest that exercise response varies according to loading patterns. 
However, the time course required for measureable changes prevents tight control of 
other influences (e.g. diet, seasonal variations in vitamin D status) which could have 
a synergistic, antagonistic or coincidental effect on bone. Furthermore the metabolic 
responses that may mediate such changes cannot be causally investigated through 
imaging techniques only. As indicated in section 2.6 BTMs demonstrate acute 





Daniel and Jakeman (2008) demonstrated that 2 hours of walking (equivalent to 2 MJ) 
in healthy young adults (untrained) resulting in a 22% increase of CTX assessed by 
AUC over 8 h compared to a resting condition. 1 h post exercise a 10% greater 
concentration was observed in the exercise condition. Through comparison to a non-
exercise control over the same period, the magnitude of exercise response, 
independent of diurnal rhythm could be determined. This is a strength of the study 
design not frequently used in other studies of exercise. Therefore knowledge of the 
diurnal rhythm of bone metabolism, in particular the decrease in bone resorption 
during the morning must be applied in the interpretation of other results.  
 
Numerous reports of elevated bone resorption, assessed by CTX in response to cycling 
exist. Barry et al. (2011) reported a 32% increase in plasma volume adjusted CTX 
following a 35 km time trial. Kohrt et al. (2018) report that concentration of CTX 
doubled in response to 60 min of cycling at 80% maximal heart rate, an effect 
sustained 4 h post exercise. Guillemant et al. (2004) reported a 46% increase in 
response to 60 min of cycling at 80% VO2max. Both Kohrt et al. (2018) and 
Guillemant et al. (2004) studied participants in the morning, a time when CTX 
concentrations would be expected to decrease. Each of these studies were in males. 
Elite female cyclists were studied following a low calcium meal. 2 h post exercise 
CTX concentration was >40% greater than baseline (Haakonssen et al., 2015). 
 
BTMs have also been used to evaluate the effect of plyometric exercise, applied 
through jumps. Following two weeks of jump training (10 drop jumps with a ground 
reaction force ≥3 times body weight, 5 times per week) in untrained college aged 
females CTX was reduced 38% (Kishimoto et al., 2012). In response to a single 
session of a much larger (1250 ± 570) number of jumps (delivered as 10-20 
submaximal (65% of maximal ground reaction forces)) in young males CTX was 32% 
greater than baseline 2 d after exercise (Rantalainen et al., 2009).  
 
The mechanical loading patterns of each of the exercise modalities differs. As a weight 
supported exercise cycling is likely to apply minimal mechanical strain to bone. 
Plyometric training in the young females by contrast applied 10 impacts equivalent to 
≥3 times body weight, where a reduction in CTX was observed suggesting that 




with the exercise modality effect previously reported for BMD amongst athletes of 
different sport types because if formation remains consistent increased resorption 
would result in bone loss whereas reduced resorption would enable bone gain. 
 
Rantalainen et al. (2009) used a greater number of impacts and reported an increase in 
bone resorption marker CTX. In contrast to the drop jump protocol employed by 
Kishimoto et al. (2012), Rantalainen et al. (2009) used a bilateral jump protocol where 
both the concentric and eccentric phases involved muscular action, an aerobic training 
component was also likely. This is more similar to the stimulus applied through 
running, which similar to cycling will also be exert a metabolic stimulus.  
 
In response to 60 minutes of morning treadmill running at 75% VO2max CTX did not 
exhibit its characteristic decline for this time of day. No differences were reported with 
exercise intensity for P1NP or OC. Although, P1NP was 25% higher than baseline by 
the end of exercise, prior to returning to baseline (Scott et al., 2011). No difference in 
CTX was evident the day after exercise. Failure to include a non-exercising condition 
is a limitation of this study. Evident from these acute studies is a preference to study 
young males, despite females being a population at risk of osteoporosis (NIH, 2001) 
and therefore a relevant population for the study of lifestyle influence.    
 
2.8.4 Habitual exercise and bone metabolism  
The acute studies demonstrate that bone metabolism is at least temporarily perturbed. 
Prolonged effects of single bouts of exercise, are generally not evident following an 
overnight recovery period (Scott et al., 2011, Scott et al., 2013b). However if 
repeatedly exposed to a stimulus (i.e. the training of athletes) a training adaptation may 
occur.  
 
There are several well established adaptations of endurance training – increased 
mitochondrial activity, plasma volume, shifts in percentage of muscle fibre type and 
cardiac volume (Berg, 2003). It is possible that a shift in skeletal system phenotype 
also occurs. This may occur as a coincidental response to training and dietary 
behaviours or could be a more direct, targeted adaptation that aims to offer a 




CTX and P1NP increased ~20% in female military recruits during their first two 
months of training prior to returning towards baseline in the following two months 
(Evans et al., 2008). This supports the concept that bone turnover may be initially 
elevated in response to unfamiliar activity. Such a response may be necessary to allow 
osteogenesis to occur so that bone can withstand the new loads. The subsequent 
decrease over the following two months may represent an adaptation to the new load, 
removing the requirement for further osteogenesis. Whether the initial increase or the 
decrease alter fracture risk is not clear.  
 
Compared to controls, endurance runners (marathon and orienteers) had 18% and 22% 
lower P1CP (formation) and ICTP (resorption), indicative of a shift in homeostatic 
metabolism. No difference in OC or BAP (both formation) was observed. The runners 
had 10% higher BMD at the femoral neck, with a 3.6% difference in total body (no 
difference was observed in lumbar spine BMD) (Brahm et al., 1997). Creighton et al. 
(2001) reported no difference in bone formation marker OC or urinary bone resorption 
marker NTX (from second morning void) between female controls and high or 
medium impact sport athletes. Approximately 30% lower formation was reported in 
non-impact athletes (swimmers) who would not be subject to the osteogenic impact 
loading. This was also reflected in a calculated uncoupling index using the Z-scores 
of formation and resorption, where swimmers were considered to have uncoupled 
bone metabolic activity, favouring resorption. Relative to the impact sports swimmers 
total bone BMD was 6% lower.  In adolescent male athletes in impact sports or ‘active 
load’ (e.g. swimming) sports had 1-2 fold higher BAP concentration than reference 
controls. Only active load had higher DPD (corrected for creatinine) (~30%) measured 
in a single urine sample (Lima et al., 2001). This finding is in line with the failure of 
swimmers to accrue bone, despite frequent exercise. 
 
The reported bone metabolic results considered with the BMD measures of these sport 
groups suggests a relationship of the measures. Bennell et al. (1997) advanced on this 
through a longitudinal study of BTMs and BMD at baseline followed by re-
measurement of BMD 12 months later. Power athletes, endurance athletes and 
reference controls aged 17-26 y were studied. Increases in height in power athletes 




which must be considered in the results. Power athletes had 19% greater bone 
resorption assessed by DPD from a second morning void and corrected for creatinine. 
No difference in osteocalcin was observed. Despite the elevated bone resorption 
reported at baseline power athletes still accrued BMD, the relationship may not be as 
clear as initially indicated. As indicated in section 2.6 correction of DPD to creatinine 
when measured in a single sample results in greater variability, causing query on this 
data. 
 
In each of the studies comparing bone metabolism in athletes a single blood or urine 
sample was collected in the early morning. This will capture the homeostatic bone 
metabolic activity. However it will not capture the net effect of lifestyle influence 
within a day. 24 h sampling is required for this purpose. The accuracy of results, 
derived from a single measure relies on that measure being representative of habitual 
activity. Where variations exist e.g. periodized training of FDR including training 
sessions of varying intensity and duration, a multiple day approach may be more 
appropriate to capture habitual bone metabolism. 
 
Townsend (2016) used a repeated (blood) sampling approach over 4-5 days in an off-
season and competition phase of training in elite triathletes. The results were 
interpreted as elevated bone metabolic activity in triathletes due to concentrations 
above the average for a reference population in 13/16 participants. However only 6 
(37.5%) participants had concentrations above the +1 SD, of whom 4 (25%) 
consistently were above this for CTX. Most concentrations were within an 80% 
increase from the mean (~0.5 ng.ml-1), with one participant having a three-fold higher 
concentration (relative to the mean). For P1NP concentrations above the +1 SD 
reference population occurred in five participants with two participants consistently 
above this level. Two participants had concentrations > 2 fold the mean concentration 
(60 ng.ml-1). In competition (n=8) one participant had a concentration consistently 
above the +1 SD reference population. A two fold difference (1.6 vs 0.8 ng.ml-1) was 
observed for CTX, a 2.5 fold difference (155 vs 60 ng.ml-1) was evident for P1NP. 
The presented triathlete data appears to be skewed as would be expected based on 




The acute and population based studies discussed in sections 2.8.3 and 2.8.4 
demonstrate the disparity in BTM choice along with a reliance on single measures of 
homeostatic bone metabolic activity (rather than repeated sampling). The influence of 
reported acute perturbations on total (daily) bone metabolism are also unknown. The 
IOF in their recommendations for reference markers (Vasikaran et al., 2011a) have 
directed harmonisation of BTMs which will assist in future comparisons across 
samples. However the effect of habitual exercise on bone metabolism, including its 
net effect across a day, is not currently clear. Studies of the effect of exercise on bone 
metabolism in female athletes in particular are sparse.  
 
2.8.5 Regulatory mechanisms of bone’s adaptation to exercise   
Exercise has a “polypill” effect in human physiology; affecting many systems in 
tandem and in synergy. The effects on the skeleton can be both direct, due to an acute 
stimulus (either mechanical or metabolic) incurred through exercise, and indirect 
through the adaptation of other tissues (muscle and/ or fat). 
 
Direct effects of exercise   
One of the most important influences of exercise on the skeleton is the mechanical 
stimulus it applies. BMD (Mudd et al., 2007, Egan et al., 2006) and bone metabolism 
(Guillemant et al., 2004, Kishimoto et al., 2012) display differential responses based 
on impact. BMD is 6-19% greater in athletes in impact sports (jumps, changes in 
direction) than repetitive impact (running) athletes, non-impact (swimming) athletes 
or controls. Bone resorption is elevated (up to two fold) following cycling and 
suppressed following plyometric training. A role for mechanical loading in the 
development of bone strength is well established. Wolff’s law was published in 1892 
and later translated to English as “every change in the form and function of bone or of 
their function alone is followed by certain definite changes in their internal 
architecture, and equally definite alteration in their external conformation, in 
accordance with mathematical laws”. Advancing on the failure of Wolff’s law to 
predict what those changes would be or what the mathematical laws were (Frost, 1998) 






The mechanostat is based on the concept that load-bearing bones in healthy post-natal 
vertebrates have sufficient strength to keep typical peak voluntary loads from breaking 
bones (either suddenly or in fatigue); and that a system that detects load and responds 
accordingly is required for this function. Typical peak voluntary loads refer to loads 
experienced during typical activities in a week or month.  
 
The “mechanostat” regulates changes in bone metabolic activity that occur in response 
to different load patters. Mechanical load deforms bone, or induces strain. The 
magnitude of this strain determines the response, so that bone strength is adequate to 
resist fracture from habitual load but is not excessive (greater strength would likely 
require higher mass resulting in a greater energy cost during ambulation). An 
illustration of these responses is shown in Figure 2-9.  
 
 
Figure 2-9: Conceptual illustration of the thresholds and response of bone strength 
(adapted from (Frost, 2003) (p.1083) 
 
When bone strength exceeds the requirement for the typical loads placed on, it 
experiences reduced strain (<100 µɛ but possible up to <400 µɛ) signalling metabolic 
activity to remove bone (making it more efficient). Within a “normal” physiological 
range (up to 1000-1500 µɛ) conservation remodeling will maintain bone strength 
(through maintenance of mass). Above this threshold bone metabolism aims to 
increase bone mass, redistributing the load and reducing the experienced strain. Up to 
3000 µɛ lamellar bone formation presides, providing strength. However where strains 
exceed this level rapid changes are required, resulting in woven bone formation that 
has less structural integrity. Fracture due to unaccustomed loading requires a strain 
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that is 10 times greater than that experienced in everyday activities, indicative that a 
large buffer exists and in the absence of sudden very large strains, bone should have 
adequate strength to prevent fracture. Mechanotransduction is the regulatory process 
governing these responses (Frost, 2003).  
 
Mechanotransduction requires sensation of load and then the subsequent signalling to 
initiate response. The osteocyte is proposed as a sensory cell (Robling and Turner, 
2009). Changes in fluid flow in the extracellular matrix may be detected by the 
osteocyte. Increased rates of loading increase the fluid forces being detected on the 
cell membrane, providing a measure of the magnitude of loading so that appropriate 
adaptation can take place. During disuse (or reduced loading) reduced fluid movement 
will represent this absence of stimulus, resulting in osteocyte apoptosis. Osteocyte 
apoptosis can also occur in response to damage (Robling and Turner, 2009). Apoptic 
osteocytes reduces the secretion of osteoclast inhibitors (Raggatt and Partridge, 2010) 
resulting in osteoclastogenesis and subsequent bone resorption.  
 
The exact mechanisms of the detection of fluid flow changes are not clear but Robling 
and Turner (2009) summarise some thoughts. One suggestion is that fluid shifts are 
detected by mechanically sensitive ion channels located in the cell membrane. 
Activation of these channels could lead to depolarisation so that voltage sensitive 
calcium channels can then depolarise facilitating an influx of calcium. Integrin 
mediated connections could also be sensitive (Price et al., 2011). This then signals 
upregulation of extracellular signalling molecules including Wingless (Wnt) and 
prostaglandins along with a downregulation of sclerostin (Wnt antagonist). 
Upregulated Wnt can then bind to lipoprotein receptor related protein 5 (LRP5) and 
Frizzled at the cell membrane, deactivating Axin. With Axin deactivated β-catenin is 
not phosphorylated and degraded and instead can be translocated to the nucleus to 
facilitate gene transcription (Robling and Turner, 2009). Increased production of 
prostaglandins allows binding to G protein coupled receptors initiating further 
intracellular pathways although their role is less definite (Price et al., 2011).   
 
Several other responses can potentiate these responses. Oestrogen receptor α can 
potentiate the Wnt pathway through a downregulation of sclerostin at the genomic 




2011) which has a role in osteoblast development. Systemic hormones, which are 
affected by exercise, can also alter these responses. PTH, which regulates RANKL 
and OPG expression in osteoblasts is one such hormone. In response to decreased 
calcium concentrations (possibly due to an increased cellular uptake) PTH is released 
from the parathyroid gland stimulating RANKL upregulation and OPG 
downregulation, resulting in an osteoclastogenic environment.  
 
PTH has been implicated in exercise induced bone metabolic changes by several 
researchers. Kohrt et al. (2018) demonstrated the interrelationship of PTH and bone 
resorption in exercise with an exercise induced increase in both markers that was 
attenuated (65% for PTH and 71% for CTX ) with a calcium clamp. The absence of a 
complete abolition suggests that a calcium independent pathway for exercise induced 
PTH regulation also exists. The exercise induced PTH response accompanied (or 
followed) by bone resorption is widely interpreted as hazardous for bone. However 
PTH’s action on bone is dependent on exposure (Frolik et al., 2003). Intermittent PTH 
exposure is used as an anabolic pharmaceutical treatment. However continuously 
elevated PTH, as in hyperparathyroidism, is catabolic for  bone. The exercise induced 
PTH response may actually be necessary for osteogenesis, activating the BMU. 
Furthermore PTH may have an interactive effect with mechanical signals (Price et al., 






Figure 2-10: Summary of direct effects regulatory effects of exercise 
 
Indirect exercise effects on bone  
Muscle and fat are malleable tissues that can be regulated by exercise. Both are 
predictors of BMD, explaining 20% and 27% respectively or a combined 31% of total 
body BMD variance in a cohort of multi-ethnic pre-menopausal women (Wang et al., 
2005). As explained in the discussion of direct effects of exercise on bone, mechanical 
loading affects bone’s response to exercise. Loading will be related to body mass. The 
mass of tissue (fat or muscle) will contribute to the load. Attaining adequate body mass 
is a one of the protective factors for bone health (NIH, 2001). Exercise, particularly 
resistance exercise, can induce muscle hypertrophy and associated strength 
(Rasmussen and Phillips, 2003). The resultant mass acquired has the potential to 
magnify gravitational loading and to apply muscle tension. Fat mass would also apply 
a gravitational load. However subcutaneous and visceral fat mass have differential 
effects. Subcutaneous fat mass is a positive predictor of cortical bone mass (β=0.419, 
p=0.001) and indices of bone strength (β=0.393-0.420, p<0.015). By contrast visceral 
fat was a negative predictor of both mass (β=-0.323, p=0.005) and strength (β=-0.287 
to -0.37, p<0.015) (Gilsanz et al., 2009). The differential response to fat mass is 




talk. Through repeated exposure to exercise these signalling pathways can have acute 
(exercise induced) and prolonged (as a result of changes in tissue) effects on bone.  
 
Several adipokines have been identified and examined in vitro, in animal models, and 
to a lesser extent in vivo in humans. Leptin is such a candidate. Its secretion from 
adipocytes is influenced by both number of adipocytes and changes in food intake. Its 
receptor is expressed on osteoblasts (Lombardi et al., 2015). In vitro it has been shown 
to increase osteoblast differentiation and proliferation and decrease osteoclast 
development (via reduced RANK and RANKL production and increased OPG) (Reid 
and Richards, 2009). In vivo recombinant human leptin administration for 2 months in 
women with hypothalamic amenorrhea resulted in a 25% increase in OC without a 
change in NTX. IGF-1 increased 30% and oestradiol also doubled (Welt et al., 2004), 
both with the potential to positively affect bone, however fat mass loss accompanied 
these responses which may be a concern in a lean population. Liu et al. (2013) 
acknowledge that the role of leptin is not clear with both leptin deficiency and 
adiposity (where elevated leptin is expected) being detrimental to bone. There are 
suggestions that leptin receptor may downregulate the response to mechanical loading 
which would augment the effect of exercise (Price et al., 2011). 
 
Adiponectin is another bone regulating adipokine. In vitro it has been shown to act 
favourably for bone health increasing osteoblast differentiation and inhibiting 
osteoclastogenesis (Reid and Richards, 2009). However as stated by Liu et al. (2013) 
adiponectin is negatively related to bone in clinical investigations, making 
interpretation of its role difficult for now.  
 
Other candidates with in vitro support include resistin (proliferation of osteoblasts, 
promotes osteoclast activity and number) and visfatin (osteoblast proliferation and 
maturation, osteoclast formation inhibition) (Liu et al., 2013). The effect of circulating 
levels of adipokines still lacks clarity.  
 
Muscular activity during exercise also leads to changes in its endocrine activity. Irisin 
is a relatively newly discovered myokine with benefits on adipose tissue and bone. Its 
circulating concentration is 20% higher in aerobically trained individuals compared to 
sedentary individuals (Jedrychowski et al., 2015). In vitro irisin reduces osteocyte-like 
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cell apoptosis in a dose dependent manner while increasing sclerostin RNA (Kim et 
al., 2018). If this effect is replicated in vivo osteoclastogenesis would be supported 
through the Wnt-β-catenin pathway.  
 
Insulin like growth factor 1 (IGF-1) which supports osteoblast differentiation is 
integral to skeletal development as demonstrated by peak levels at times of increased 
bone acquisition (adolescence) and decreased concentration in ageing. Understanding 
of its role is challenged by the multiple binding proteins that can alter the biological 
function (Kawai and Rosen, 2012). The mechanisms of effect on bone are unclear.  
Lombardi et al. (2015) suggested an enhancement of local (muscle) IGF-1 and 
downregulation of systemic IGF-1 could explain the discrepancies.  
 
Interleukin 6 (IL-6) is another cytokine with pattern or source dependent effects. 
Chronic IL-6 , synthesized from the liver, has pro-inflammatory effects while acute 
muscle derived IL-6 is anti-inflammatory – an adaptation in response to habitual 
exercise (Lombardi et al., 2015). Upon completion of exhaustive exercise IL-6 was 
14.9 and 9.5 fold higher than baseline in in recreationally active and endurance trained 
males respectively (Scott et al., 2013a).  
 
Although the in vivo action of myokines and adipokines are not yet clear there is 
evidence of cross talk between the tissues.  Changes in both the activity and quantity 
of muscle and bone in response to exercise can indirectly affect bone and/ or alter or 
mediate bone’s response to exercise.  
 
The quantity of tissue (lean or fat) or the metabolic activity of these tissues in athletes, 
individuals who are habitually active, may result in altered myokine and/ or adipokine 
profiles. Kapilevich et al. (2017) reported differences in myokine expression based on 
training status. For example in response to brief (two bouts of 5 minutes) cycling 
exercise IL-8 doubled in middle distance runners with no such response in non-
athletes. IL-6 by contrast increased fourfold in athletes, but both the baseline (90% 
lower) and peak (30% lower) concentrations were lower than that of non-athletes. 
However the role of these metabolites on bone metabolism in athletes are not well 
documented in the literature. This should be an area of further study to assist in the 




2.9 Dietary influence on bone  
Dietary intake, notably intake of calcium is the other lifestyle influence for which there 
is good evidence in supporting bone (Weaver et al., 2016). Vitamin D, in part because 
of its role in modulating calcium metabolism is also established as an important dietary 
condition for bone (IOM, 2011). The importance of these nutrients is evident in the 
skeletal requirements determining the recommended intakes (IOM, 2011). 
 
Amongst athletes energy is also a vital consideration to prevent metabolic and 
hormonal changes that are detrimental to bone (Loucks et al., 2011, Thomas et al., 
2016).  
 
There is potential for timing of nutrients (relative to time of day and/ or time of 
exercise) to also affect bone. However this results in a plethora of dietary combinations 
and this research remains relatively new. The following evidence focuses on nutrients 
with substantial evidence for bone or with particular relevance for athletes.  
 
2.9.1 Calcium 
Section 2.1 indicated the competition for calcium between two of bone’s principle 
functions – strength and mineral homeostasis. Calcium intake must therefore be 
adequate to meet both demands, addressing the metabolic activity and hence calcium 
turnover of different life stages. The IOM (2011) guidelines aim to provide adequate 
nutrient (accounting for percentage absorption and the excreted losses) to cover the 
demands of the life stage. The recommended daily allowance (RDA) i.e. the quantity 
required to meet the requirements of 97.5% of the population for various life stages 
are presented in Table 2-4.  
 
More recent European guidelines for population reference intakes (PRI) differ slightly 
with 1150 mg recommended for adolescent females (11-17 y), 1000 mg for 18-24 year 
olds, and a 50 mg reduction to 950 mg for adults >25 y (EFSA, 2017), this is in line 
with mineralisation in early adulthood that would have a calcium demand prior to 




Female athletes with menstrual disturbances, particularly absence of menses for >90 
days (amenorrhea) will be exposed to a hypoestrogenic environment (Allaway et al., 
2016), exposing them to elevated bone metabolism. Consequently 1500 mg of calcium 
is recommended for amenorrheic (AMEN) athletes (Kunstel, 2005). 
 
Table 2-4: IOM calcium recommendations at life stages 
Age/ sex  Amount  Comments on life stage demands  
9-18 y 1300 mg  Growth and bone mineralisation  
19-50 y 1000 mg Must be adequate for normal bone turnover (~10% 
per annum) 
Females >50 y 1200 mg  Hypoestrogenic environment results in up ~50% 
increase in bone resorption across the menopausal 
transition (Sowers et al., 2013). Age related losses 
extend beyond this.   
Calcium absorption decreases with age 
Males >70 1200 mg Age related bone losses occur. Calcium 
absorption decreases with age.  
 
The National Adult Nutrition Survey (NANS) conducted by the Irish University 
Nutrition Alliance IUNA (2011) report a mean ± SD calcium intake of 824 ± 356 and 
1060 ± 407 amongst women and men aged 18-64 years respectively. The mean intake 
below the RDA amongst women is of concern as the population with a greater risk of 
osteoporosis. Furthermore 16% of women in this age group did not meet the estimated 
average requirement (EAR) i.e. the quantity required to meet 50% of the population’s 
needs. This indicates insufficient calcium intake amongst Irish adult females.  
 
Calcium supplementation has been used as a strategy in populations deemed at risk of 
fracture and/or low BMD. Riggs et al. (1998) demonstrated that daily supplementation 
of calcium (target intake 1600mg split into 4 doses throughout the day; mean intake 
based on tablet counts: 1234mg.day-1) for 4 years increased median BMD at lumbar 
spine (0.3%), proximal femur (1.3%) and total body (0.9%) compared to placebo in 
postmenopausal women. 24 h excretion of bone resorption marker PYD was 32.2% 
lower in the supplemented group, PYD is not however specific to bone so could be 




recruits who received concurrent calcium and vitamin D supplementation (2000 mg, 
800 IU per day, as 4*500 mg tablets available at breakfast and dinner) over an eight 
week basic training period, stress fracture incidence was 20% lower than a placebo 
group (Lappe et al., 2008). Exercise itself is not considered to increase calcium 
demands (Kunstel, 2005).  But military training as an intense period of exercise, is 
likely to increase the activity of its recruits which may stimulate bone formation 
through mechanotransduction, which could incur a transient elevated calcium demand. 
Gaffney-Stomberg et al. (2014) examined the biomarker response to a calcium (2000 
mg) and vitamin D supplement (800 IU) , split into two doses. P1NP decreased 10% 
in the supplemented group. No change in osteocalcin, bone alkaline phosphatase, CTX 
or TRAP5b was observed.  
 
In free living conditions lower calcium intake was found to be a risk factor for stress 
fracture in adult (18-26 y) FDR (average run distance per week 55.5 ± 18.1 km). 
Decreased calcium intake (per 100mg decrease) had a 1.08 rate ratio while dairy 
servings (per one serving decrease) had a 1.41 rate ratio (Kelsey et al., 2007). Within 
this cohort each additional cup of skim milk (~300 mg of calcium) was associated with 
a 62% decrease in stress fracture risk (Nieves et al., 2010).  
 
Calcium intake prior to or during exercise can reduce the bone metabolic response. 
Guillemant et al. (2004) reported suppression of the exercise induced CTX response 
(↑46%) when 972 mg of calcium was ingested over 1.75 hours beginning 1 hour pre-
exercise (60 min of cycling at 80% VO2max). Haakonssen et al. (2015) applied a food 
approach to elevated pre-exercise calcium consumption. An isoenergetic (12 kcal.kg-
1) breakfast with high (1352 ± 53mg) or low (46 ± 7mg) calcium was consumed 2 h 
prior to a 90 min cycle (80 min at max average power followed by a 10 min time trial). 
Median CTX was 1.4 times higher in the low calcium condition immediately post 
exercise and was elevated up to 4 h post-exercise. In this trial the calcium meal also 
had a higher protein intake (0.6 vs 0.2 g.kg-1). The calcium consumption reported by 
both Guillemant et al. (2004) and Haakonssen et al. (2015) was similar to the RDA. 
Replication of this intake in free living individuals would require either consuming 
calcium well in excess of the RDA or a redistribution resulting in little calcium being 
consumed away from exercise. Whether attenuating the exercise induced bone 
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resorption response has any benefit must also be considered. This will be discussed in 
further detail in Chapter 5.  
 
2.9.2 Vitamin D 
Lappe et al. (2008) and Gaffney-Stomberg et al. (2014) reported co-ingestion of 
Vitamin D with calcium. This is in line with IOM recommendations of 600 
international units (IU) or 15 µg for males and females aged 19-70 y,  and 800 IU 
above 70 y. Vitamin D deficiency has long been implicated in bone health; historically 
associated with rickets. Vitamin D has a critical role in elevating serum calcium and 
phosphate levels, required for the mineralisation of bone (Holick, 2007). Vitamin D 
plays a key role in calcium homeostasis, through stimulation of intestinal calcium 
absorption and stimulation of renal distal tubule reabsorption of calcium; these 
accompany the mobilisation of calcium from bone. As serum calcium level rise PTH 
drops and the PTH dependent actions can be reduced (mobilization from bone and 
reabsorption in the kidney) (IOM, 2011). Vitamin D is obtained from the diet although 
sources are limited: fatty fish, fish liver oil, and egg yolk. Foods including milk and 
margarine are often fortified to address the absence of naturally occurring sources in 
the diet (IOM, 2011). Exposure to solar ultraviolet B (UVB) radiation facilitates 
metabolism of vitamin D3. Living above or below the 35th parallels of latitude has been 
assumed to increase risk of deficiency due to decreased UVB exposure (Holick, 2010). 
Although D3 obtained through sunlight is not considered toxic, excessive dietary 
intake can lead to “hypervitaminosis D” or a state of intoxication (IOM, 2011), 
requiring caution, particularly where supplements are contributing to the vitamin D 
intake.  
 
2.9.3 Energy availability  
In athletes energy intake must be considered. Energy requirements from locomotion 
can be elevated 2-4 fold in endurance athletes (Loucks et al., 2011). Where athletes 
fail to meet their energy requirements detrimental metabolic and hormonal changes 
occur. Some of the physiological consequences result in a suppression of metabolic 
rate (Stubbs et al., 2002). Athletes also seek to manipulate specific energy stores (fat/ 
lean mass) for performance. Consequently energy balance is not appropriate for 




is more appropriate. EA refers to the energy remaining for all other physiological 
functions once the metabolic cost of a specific process (exercise in the case of exercise 
physiology and sports nutrition) has been subtracted (Loucks et al., 2011) (Equation 
2-1) 
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Equation 2-1: Energy availability equation  
Loucks and colleagues demonstrated the importance of energy availability for athletes. 
In a repeated measures design participants began the experimental portion of the study 
during the follicular phase of the menstrual cycle. Both measures included an exercise 
treatment of 30-40 minutes of treadmill exercise (70% VO2max) equivalent to 15 
kcal.kgFFM-1. In the energy balanced condition energy intake resulted in an EA of 45 
kcal.kgFFM-1. LEA was achieved by reducing EI to achieve EA of 10, 20 or 30  
kcal.kgFFM-1 (Loucks and Thuma, 2003). With a 33% reduction in EA (45 
kcal.kgFFM-1 to 30 kcal.kgFFM-1) bone formation was reduced 9% with up to a 29% 
reduction at 10 kcal.kgFFM-1 (77% reduction for energy balanced condition). A 29% 
increase in bone resorption was also observed at 10 kcal.kgFFM-1 (Ihle and Loucks, 
2004). A 17% reduction in regulatory reproductive hormone luteinizing hormone was 
also observed in response to a 55% reduction in EA (45 kcal.kgFFM-1 to 20 
kcal.kgFFM-1), amplified to a 33% reduction at 10 kcal.kgFFM-1 (Loucks and Thuma, 
2003). Although exercise induced LEA appears to be less harmful than diet alone (with 
no reduction in bone formation markers) (Papageorgiou et al., 2018), elite FDR with 
low EA (LEA) missed twice as many days of training with bone injuries indicative of 
consequences on bone health outcomes as well as acute effects (Heikura et al., 2017b).  
 
Reductions in EA will also reduce nutrient intake. In Loucks’ experiments 
carbohydrate intake was reduced 43-83% to achieve the 33-77% reduction in EA 
(Loucks and Thuma, 2003). Loucks (2004) acknowledged that carbohydrate 
availability could have a role in skeletal health of athletes (and indirectly through 




2.9.4 Carbohydrate  
Recent studies have supported Loucks’ comments. Following a three week low 
carbohydrate, high fat (energy sufficient) diet during an intense training block in elite 
endurance athletes the exercise bone resorption assessed by CTX increased 20% and 
formation decreased >15%. No changes occurred in a high carbohydrate condition. 
(Heikura et al., 2020). Exercise induced resorption was also augmented. Post exercise 
CTX was 100% higher following the 3 w low carbohydrate, high fat diet. Acute 
(hours) carbohydrate provision between exercise sessions also alters the response with 
a ~30% greater CTX concentration observed both pre and post a second (afternoon) 
exercise session within a day (Hammond et al., 2019).  
 
2.9.5 Protein 
It is reasonable to assume from composition of bone and its remodeling activity 
(characterised by collagen turnover) that protein would be required. The role of protein 
in bone was challenged for many years due to concerns about an acidic load it could 
impose. The sulphur containing amino acids in animal proteins were thought to require 
release (and subsequent excretion) of minerals in bone to neutralise the acidic load 
(Dolan and Sale, 2018, Frassetto et al., 2018). However multiple pathways with a 
potential positive effect also exist. Muscle and its cross talk with bone is relevant here 
(Dolan and Sale, 2018). Protein supports muscle protein synthesis (Witard et al., 2018, 
Rasmussen and Phillips, 2003). Greater muscle mass exerts a higher load (mass) on 
bone and is the predominant force in load bearing bones (Frost, 2003). Protein also 
stimulates growth factors and anabolic hormones that are required for bone (Dolan 
and Sale, 2018).  The IOF website cites adequate protein, calcium and vitamin D intake 
during childhood as strategies to prevent osteoporosis. Only calcium and vitamin D 
and ‘avoid under-nutrition’ are cited in the adult guidelines. The lack of randomised 
trials evaluating the effect of protein on bone probably contributes to this. A meta-
analysis from the NOF cites that adverse response to higher protein intake (generally 
1.4 g.day-1, or >90 g.day-1, or >25% of total energy compared to 1.4 g.day-1, or <80 
g.day-1, or 15-18%) was not evident for BMD. However the evidence for a supportive 






2.10 The paradox of female distance runners – a phenotype at risk? 
Young, athletic females would be expected to benefit from the osteogenic effect of 
habitual exercise. However not all exercise is created equal. Sports that involve 
jumping, sprinting, and changes in direction have 6-19% greater BMD than those in 
repetitive impact (running) or weight supported (swimming) sports, whose BMD may 
not even differ from that of a reference non-athletic control population (Egan et al., 
2006, Mudd et al., 2007). Table 2-5 reports the prevalence of fracture history and low 
BMD amongst FDR. Endurance running applies both a mechanical strain and 
metabolic stimulus that will affect bone. The response to mechanical strain can be 
explained through the mechanostat theory (Frost, 2003) which proposes bone’s 
response to loading is regulated by the magnitude of strain induced. The mechanostat 
theory is based on the principle that load bearing bones have sufficient strength to 
withstand the loads that are typically placed on them. So perhaps FDR require less 
bone to withstand their normal loads? However fracture incidences tell a different 
story.   
 
Stress fractures are indicative of cumulative micro-damage. They occur in response to 
repeated habitual loads – a situation that the mechanostat should prevent. Bennell et 
al. (1996) reported a stress fracture incidence of 21% in a 12 month prospective study 
of FDR (aged 17-26 y). Assessed by athlete-exposures (AEs) (1 student athlete 
participating in 1 sanctioned practice/ competition in which he/she was exposed to the 
possibility of athletic injury regardless of participation time), women’s cross country 
(28.59/ 100,000 AEs) and track (22.26/ 100,000 AEs) have the highest and third 
highest rates of stress fractures amongst collegiate student athletes (Rizzone et al., 
2017). These findings, indicative of bone lacking in strength (resistance to fracture), 
conflict with the widely accepted consensus of exercise’s benefits to bone (NIH, 
2001). Closer examination of the habitual training, dietary patterns and resultant (and 
desirable for performance) physique of FDR raises questions about whether the 
phenotype beneficial for performance may be detrimental for bone. A summary of 




Table 2-5: Summary of prevalence of poor bone health amongst FDR 





Barrack et al. 
(2008) 
High school runners (aged 13-18 
years), (n=93) 




LS or hip between -1 and -2 
<-2 
Burrows et al. 
(2003) 
Endurance runners (1500m-
marathon) aged 18-44 years  





‘Osteopenia’ or ‘osteoporosis’ 
Spine: 
Hip:  
Cobb et al. 
(2007) 
Female runners aged 18-26 years 
(baseline characteristics for an 
RCT) 
36.2% and 
33.3% in the 
treatment and 
control groups 
Not reported  
Duckham et al. 
(2012) 
Female endurance athletes (58 
runners, 12 triathletes) (aged 18-
45 years) 
27% Not reported 
Heikura et al. 
(2017b) 
National (n=12) and international 
(n=27) runners  (mean age 25 and 
25.9 years in athletes grouped by 
EA) 
60% 17% 
Hind et al. (2006) Female endurance runners (3km-
marathon) 19-50 years 
(excluding family history of 
osteoporosis, medication use/ 
condition that would affect bone 
metabolism) (n=65) 
Not reported 










LS (T-score) <-1; <-2.5 
TH (T-score) <-1 
FN (T-score) <-1 
Kelsey et al. 
(2007) 
Cross country runners (n=127) 
(aged 18-26 years) 
30.7% Not reported 
Klomsten 
Andersen et al. 
(2018) 
Middle (800m-3000m)/ long 
(>3000m) distance runners aged 
18-35 years (n=11) 
Not reported 
stratified by sex 
0% 
McCormack et al. 
(2019) 
NCAA Division 1 cross country 












Roelofs et al. 
(2015) 
NCAA Division 1 Cross Country 
Runners (age 19.3 ± 1.3 years) 
(n=15) 
60% Not reported 
Pollock et al. 
(2010) 
Elite endurance (>800m) runners 





All reported as Z-score between -













Tenforde et al. 
(2015) 
Adolescent runners (aged 16.9 ± 
1.3 years) (n= 91) (20% of a 












LS Z-score <-1 
LS Z-score <-2 
Tenforde et al. 
(2017) 
NCAA Division 1 Collegiate 
Cross country runners (n=58) 
(age: 20.0 ± 1.3 years) 
37.9% 17.2% 
Data is compiled from studies evaluating prevalence of fracture/ low BMD or baseline 
data of prospective studies. Stress fractures are reported as previous stress fracture 
only i.e. incidence or fractures incurred during a monitoring period are not included. 







Figure 2-11: Illustration of the environmental influences that affect bone in FDRs and the consequent adaptations.  





2.10.1 Performance determinants of distance running and the FDR phenotype  
Middle and long distance running includes a wide variety of race distances across 
multiple terrains including track events (800m-10000m), road (5k-marathon (and 
longer in some cases)), cross country (4k-10k at junior (under 20) and senior 
international levels respectively) and mountain running. Trail, obstacle and adventure 
races over a wide range of distances (including multiple day events) also exist. For the 
purpose of this thesis distance running refers to middle and long distance races ranging 
between 800m and marathon distance on any surface. Amongst elite FDR race 
durations range from <2 minutes to ~2.5 hours resulting in a predominant reliance on 
aerobic energy systems with lesser contribution from anaerobic (Costill et al., 1973). 
The development of these systems is achieved through frequent, prolonged bouts of 
aerobic running interspersed with higher intensity bouts (threshold, interval training). 
National level runners will typically run >65 km.w-1, with reports of >127 km.w-1 in 
international level runners (Blagrove et al., 2017). They may supplement this training 
with additional activities to contribute to aerobic development or recovery (e.g. non-
weight bearing activities), exercise to promote flexibility or balance, or resistance 
and/or plyometric training (Magness, 2014). Overall this results in a training 
programme with considerable energy demands and repeated exposure to habitual 
mechanical loading patterns.  
 
Cavanagh and Lafortune (1980) reported ground reaction forces of 1.5-3.0 times body 
weight amongst distance runners. This pattern meets the dynamic load requirement 
outlined as a condition for adaptation to bone by Turner (1998). The repetition of 
strides within a run and of similar training on a daily basis results in this becoming an 
accustomed load to the musculoskeletal system of the runner, which is considered less 
effective. Similarly throughout a run the osteocytes may become desensitised, 
resulting in a diminished response as shown in animal studies (Umemura et al., 1997). 
FDR may also be exposed to altered metabolic signalling as has been demonstrated in 
cyclists, with PTH mediated increases (doubling) in CTX concentration (Kohrt et al., 
2018). Whether this bone metabolic response is osteogenic or harmful for bone 
remains unclear for now. But should FDR experience an upregulation of homeostatic 
bone resorption they are likely to be at increased risk of fracture both through BMD 





The energy expenditure incurred through frequent, prolonged (0.5-2+ h) training is an 
additional consideration regarding regulation of this homeostatic bone metabolic 
activity. Training can increase total energy expenditure 60-100% from rest in elite 
FDR (Schulz et al., 1992). As identified in section 2.9 failure to replace this energy 
results in a state of LEA with direct and indirect effects on bone metabolism (Ihle and 
Loucks, 2004, Loucks and Thuma, 2003), potentially related to carbohydrate 
availability specifically (Heikura et al., 2020).  
 
FDR engage in training and dietary behaviours that is likely to favour the development 
of a lean body composition with a lower body mass than the general population, or 
other athletes. Collegiate cross country runners had up to 38% lower body mass than 
basketball, hockey, soccer, tennis and volleyball players. Fat mass was up to 77% 
lower in runners with a 29% lower lean mass observed  (Dobrosielski et al., 2019). 
The lower absolute and lean mass are likely to influence the mechanical loading of the 
skeleton, through decreasing gravitational loading, which is expressed as a magnitude 
of body weight, and potentially reducing muscle tension on bone.  
 
Where athletes seek to achieve a performance advantage related to reduced body mass 
through dietary restriction a further exacerbation may occur through LEA (Loucks et 
al., 2011). It is this state of LEA that is the primary concern in both the female athlete 
triad (TRIAD) and Relative Energy Deficiency in Sport (RED-S), both of which 
include direct and indirect pathways that are detrimental to bone.  
 
2.10.2 The Female Athlete Triad and Relative Energy Deficiency in Sport 
The TRIAD refers to an interrelationship of EA, menstrual function and bone health 
(currently defined by BMD). It has evolved from an interrelationship of three 
components shown in Figure 2-12 to a 2007 ACSM update including a continuum of 






Figure 2-12 Illustration of the original components of the female athlete triad included in 
the 1997 ACSM Position Stand 
(Otis et al., 1997) 
 
 
Figure 2-13: Female Athlete Triad spectrum as defined by Nattiv et al 2007 (p. 1868) 
In relation to bone the TRIAD, is likely the most pertinent evidence based model. The 
TRIAD was developed in response to the observation of female athletes presenting 
with concurrent menstrual disturbances and low BMD (Drinkwater et al., 1984). 
AMEN FDR ran 67% more mileage than EUMEN, but no difference in dietary intake 
was observed. This aligns with the concept of LEA and is supported by a 9% reduction 
in the likelihood of menstrual disturbances with each unit increase in EA (Lieberman 
et al., 2017). Menstrual disturbances are of concern due to the altered hormonal profile 





Figure 2-14: Changes in concentration of key reproductive hormones across various menstrual cycle in healthy and pathological conditions 





The reduced oestrogen exposure experienced during menstrual dysfunction, evident 
from Figure 2-14, reduces oestrogen’s regulating action resulting in activation of 
BMUs and prolonging the resorption phase through reductions in osteoclast apoptosis 
(Riggs et al., 2002). This bone metabolic response would result in bone loss, magnified 
by the elevation in metabolic activity. Menstrual irregularities have been observed in 
36% of collegiate and post-collegiate FDR (Cobb et al., 2003), and 37-67% of elite 
runners (Heikura et al., 2017b, Pollock et al., 2010) indicating a potential risk for FDR. 
Adolescent runners with a menstrual irregularity were 10 times more likely to have 
low BMD (total body or LS) than those without (Barrack et al., 2008). While FDR 
with menstrual irregularity had lower BMD at the lumbar spine (5%), total hip (6%) 
and whole body (3%) than eumenorrheic (EUMEN) (adjusted for weight, percentage 
body fat, eating disorder inventory score and age at menarche) (Cobb et al., 2003). 
Heikura et al. (2017b) reported 4.5 fold greater number of missed training days due to 
bone injuries in AMEN.  
 
The direct effects of EA on bone are more difficult to assess due to the inter-
relationship of menstrual disturbances and LEA. As discussed in section 2.9.3 , LEA 
results in altered  bone metabolism. Ihle and Loucks (2004) documented a dose 
response to LEA while Papageorgiou et al. (2017) showed that the response may differ 
if induced through diet and exercise or diet alone, with a protective effect of exercise 
suggested. Cobb et al. (2003) reported an 18% greater exercise volume in FDR with 
menstrual disturbances compared to EUMEN, while energy intake was 18% lower 
amongst the menstrual disturbance group. This aligns with the observed group BMD 
differences discussed earlier in this section. Heikura et al. (2017b) examined BMD 
and injuries by EA status (low (<30 kcal.kgFFM-1) vs moderate (30-45 kcal.kgFFM-
1)). They report no difference between groups, with a small-medium effect size (0.37) 
for training days lost to bone injuries. Case studies inform the effect of restoration of 
EA. Fredericson and Kent (2005) and Hind (2008) report 25% (over 8 years) and 
18.4% (over 6 years) increased lumbar spine BMD respectively in response to 
improved EA (and menstrual function recovery) achieved through decreased training 
and increased energy intake in two formerly AMEN FDR. A randomised controlled 
trial to further inform on this response is needed. However the role of EA is 
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acknowledged in the Return to Play Guidelines published by the TRIAD Coalition 
group (De Souza et al., 2014a).  
 
Amongst female athletes prevalence of all three TRIAD conditions (LEA (with or 
without disordered eating), menstrual disturbances  and low BMD) ranges from 0-
16% (Gibbs et al., 2013). Low BMD and disordered eating was prevalent in 0.9-3.2% 
(assessed from 2 studies), low BMD and EA in 3.7%,  while menstrual dysfunction 
and low BMD had a prevalence of 0-7.5% (Gibbs et al., 2013). The comparatively low 
prevalence of combinations of TRIAD factors relative to BMD alone (Table 2-5) 
suggesting that an alternative factor could be at play, perhaps exercise itself?  
 
The TRIAD is based on an evidence base that has been built over three decades. 
However in 2014 the IOC challenged that is was not sufficiently inclusive. In response 
they published a consensus statement on Relative Energy Deficiency in Sport (RED-
S) (Mountjoy et al., 2014) which expands the populations at risk (to include males, 
active individuals not explicitly classified as athletes (e.g. dancers)) and the 
physiological systems discussed. 10 health and 10 performance consequences of 
insufficient energy intake are included in the RED-S paradigm (Figure 2-15 and Figure 
2-16).  
 
The RED-S paradigm has been criticized by key TRIAD opinion leaders (De Souza et 
al., 2014b, Williams et al., 2019). Concerns over a lack of scientific rigour, dilution of 
the elevated risk of poor bone health in women, absence of diagnostic criteria for a 
pathological finding in many of the components and a failure to demonstrate the inter-
relationship of the components are cited as some of the limitations (De Souza et al., 
2014b, Williams et al., 2019). Despite the weaknesses the conceptual idea has many 
implications for bone if supporting evidence is found. Aside from the direct influence 
of LEA on bone, indirect influences (similar to menstrual function) through many of 
the other health related variables would likely be detrimental to bone e.g. 
compromised gastrointestinal function may result in malabsorption of nutrients, 
alterations in endocrine function (beyond the hypothalamic-pituitary-ovarian axis) is 
likely to lead to changes in bone metabolism which is largely regulated by endocrine 
influences. The impaired performance variables may result in injury ultimately 





Figure 2-15 Potential health consequences of RED-S (Mountjoy et al., 2014) (p.493) 
 
Figure 2-16 Potential Performance Consequences of RED-S (Mountjoy et al., 2014) (p.493) 
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2.10.3 Evaluating bone health in FDR 
The prevalence of previous stress fracture and/ or low BMD amongst FDR is shown 
in Table 2-5. BMD is currently the recommended measure of bone health (Cosman et 
al., 2014). Amongst athletes the use of modified cut-offs for diagnosis of poor bone 
health is recommended (Nattiv et al., 2007, Mountjoy et al., 2014). However as 
discussed in section 2.5 BMD represents the net effect of formation and resorption 
activity in response to genetic and environmental influences. Athletes in weight 
bearing sports may have BMD that is 15% greater than a non-athletic reference control 
(Egan et al., 2006).  In this case sub-optimal accrual, or early losses are likely to go 
undetected. In the absence of early detection, individuals may lose out on opportunities 
to optimise the remaining limited window of bone growth and mineralisation in the 
first three decades of life. Use of a more sensitive marker that could detect changes 
that a. alter fracture risk and b. could indicate future changes in bone mass would be a 
valuable addition to the clinical toolset. BTMs are a potential method for this purpose. 
As outlined in sections 2.6.2 and 2.8 they are sensitive to environmental influence. 
Within section 2.8.4 habitual bone metabolism of athletes was discussed. The 
limitation that most of these studies only captured homeostatic bone metabolism i.e. 
the underlying rhythm, through a fasted morning blood and/or urine sample on a single 
day was identified. This sampling protocol will fail to capture the exercise induced 
responses during the day which could be a differentiating factor putting FDR at 
elevated fracture or bone loss risk. Capturing multiple days of habitual activity will 
improve the representation of the measure of true bone metabolic activity in FDR.  
 
2.11 Summary and research aims 
BMD, bone metabolism, and fracture risk change across the lifetime with elevated 
fracture incidences observed at times where BMD is either not fully attained (for 
example childhood and adolescence) or has been lost (for example post-menopause 
and ageing). These life phases are also associated with elevated bone metabolic 
activity, which is required to mediate changes in BMD and is an independent risk 
factor for fracture. During early adulthood PBM is expected to have been attained, 
optimised by environmental factors (exercise and diet). However despite their regular 




vary depending on sites of measurement, competitive level and thresholds for low 
BMD used (Table 2-5).  
 
Low BMD is a risk factor for stress fracture (Tenforde et al., 2013, Barrack et al., 
2014). However discordance exists between BMD and fracture history as shown in 
some studies included in Table 2-5, suggesting that BMD is an inadequate explanation 
for fractures amongst FDR. Exercise acutely elevates bone resorption, with a 100% 
increase observed for 4 h in some cases (Kohrt et al., 2018). Bone metabolism is itself 
an independent risk factor for fracture (Heaney, 2003). Hence exercise induced 
perturbations could in fact put FDR at risk. Where inadequate dietary intake or 
menstrual dysfunction exist uncoupled bone metabolism favouring resorption is likely 
to occur. If this is accompanied by augmented rates of bone metabolism the effects are 
likely to be amplified or accelerated (Figure 2-5). The habitual bone metabolism of 
FDR is unknown. Capture of both the homeostatic bone metabolic activity and an 
indication of metabolic response to lifestyle influence is required to inform both 
fracture risk and lifestyle response. In order to understand the exercise response other 
known influences on bone – diet and menstrual function needs to be considered.  
 
This thesis aimed to advance on the current knowledge base through addressing the 
following research questions: 
1. What is the magnitude to poor bone health amongst FDR considering 
a. History of stress fracture and/ or fragility fracture  
b. Low BMD  
2. Does habitual exercise alter bone metabolism assessed by: 
a. Homeostatic bone metabolism  
b. 24 h resorption  
3. Is the energy and intake of specific nutrients (carbohydrate, protein, calcium, 
vitamin D) amongst a cohort of FDR sufficient to support bone health? 
 
The central aim of the thesis was to examine whether habitual endurance exercise, 
completed by FDR, altered habitual bone metabolism. Research question 1 informed 
on the magnitude of poor bone health amongst the population. This provided rationale 
for pursuit of an evaluation of bone metabolism, a potential risk factor for fracture. 
Chapter 5 shows the results of research question 2. However in order to evaluate 
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whether any group difference in bone metabolism can be attributed to exercise, or 
whether dietary influence, particularly energy inadequacy has contributed the dietary 
adequacy of FDR required evaluation. This provided the rationale for research 
question 3. As part of the evaluation of dietary adequacy including energy intake, the 
energy expenditure specific to athletes required evaluation. This was presented as a 












This chapter provides an overview of the research programme and describes the study 
designs, ethical approval, recruitment process and participant criteria for each study.  
The common data collection and sample analysis methods are described. 
Characteristics of the recruited participants and data analysis approaches are detailed 
in the relevant experimental chapters.   
 
3.2 Overview of research programme  
Two study designs were used in this thesis. FDR were studied in all phases. CON were 
used as a reference population to compare habitual bone metabolism based on activity 
level only (Chapter 5 and Chapter 6).  Figure 3-1 outlines the overall research 
programme, the recruitment process and the chapter within which the analysis and 







Figure 3-1: Overview of research programme, recruitment of participants for each phase and 
relevant chapter for analysis and results  
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3.3 Study design, ethical approval and participant inclusion criteria 
3.3.1 Cross sectional BMD and fracture history study 
This study addressed the thesis aim to quantify the magnitude of poor bone health 
amongst FDR by examining the prevalence of fracture history and low BMD amongst 
a cohort of FDR (presented in Chapter 4). The study had two phases: 
1. An online survey to capture fracture history, training habits and basic 
participant information (height, mass, age, competitive level).  
2. BMD and body composition assessment by DXA at the University of Limerick  
A flow chart of the study including participant numbers at each phase is available in 
Figure 3-1. The survey was granted ethical approval by the Faculty of Education and 
Health Sciences Research Ethics Committee (EHSREC) (EHSREC approval number: 
2016_12_10_EHS). BMD and body composition assessment took place under the 
remit of the UL Body Composition Study (approved by the University of Limerick 
Research Ethics Committee UL08/07 and subsequently updated as EHSREC approved 
procedures: 2019_01_07_EHS and 2019_01_08_EHS).  
 
Participants were recruited via email, social media and flyer advertisement, and word 
of mouth. Emails were sent to clubs registered with the National Governing Body 
(Athletics Ireland) or third level athletics association (Irish University Athletic 
Association (IUAA)) and to a list of endurance coaches through Athletics Ireland 
National Endurance Coach, or known to the author. A link to the online survey (housed 
on a password protected Survey Monkey account) was included and recipients were 
asked to distribute the email to FDR in their contacts. A link with an accompanying 
image and request for participation was distributed on Twitter and Facebook. The 
author also distributed the survey link directly to FDR in her personal contacts.  
 
Participant inclusion criteria was as follows: 
1. Aged 18-35 years, inclusive  
2. Female 
3. Competes in distance running events (800m-marathon, any terrain) 
4. Weekly run volume ≥40 km.w-1 





All data was self-reported. A copy of questions included is available in Appendix B. 
Participants reported age, height, and mass. They were asked to self-declare their 
highest level of competitive participation: senior international, junior international, 
national, provincial, county, competitive road racing and recreational athletes. 
Guidelines/ definitions were not provided for each level. Typical training over the past 
12 months was reported as run volume (km.w-1 and h.w-1) and frequency (sessions per 
week, and volume (h.w-1) and frequency (sessions per week) of NWBE, resistance 
training and rehabilitation/ balance training. History of stress fracture and fragility 
fracture (a fracture arising from a fall from standing height or lower) were reported as 
binary responses (yes or no). Where participants responded yes to either fracture type 
they were asked to specify diagnosis method. Only fractures confirmed by x-ray or 
MRI were included as confirmed fractures. Fractures were not time bound. 
Participants reported any fracture that occurred up to the time of data collection. No 
details on fracture severity or fracture number was collected. No information on EA 
or menstrual status was collected in this study. At the end of the survey participants 
were asked if they would be interested in participating in further research. Any 
participant who responded yes, provided a contact email and met the inclusion criteria 
listed above was invited to attend the University of Limerick for a body composition 
and site-specific (spine and dual femur) BMD measurement by DXA, as part of Phase 
B. 
 
Surveys were deemed complete if participant characteristics, training volume and 
fracture history questions were answered. Primary outcome for Phase A was history 
of fracture. Secondary outcomes were run volume, age and mass.  
 
The same participant criteria applied in Phase B. Survey responses regarding fracture 
history of participants in Phase B (n=39) were examined to establish whether the 
sample was representative of the larger cohort. Participants attended the University of 
Limerick and had body composition and bone density assessed by DXA as described 
in 3.4 .  
 
Only BMD results collected through the UL Body Composition study were included 
in analysis. BMD was evaluated at the lumbar spine (L1-L4), femoral neck, and total 
hip sites. Low BMD result was a Z-score <-1. Lumbar spine BMD was assessed by 
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two methods: including L1-L4 and applying ISCD criteria (vertebra is excluded if two 
adjacent vertebrae differ by >1 SD (Z-score)). Prevalence did not differ between 
methods (data not shown). Data reported includes all vertebrae.  
 
The primary outcomes for Phase B were BMD (g.cm-2 and Z-score) and fracture 
history (prior confirmed stress/ fragility fracture). Secondary outcomes were training 
load (run volume in kilometres) and anthropometry (mass, lean mass, region 
percentage fat). Sensitivity and specificity of BMD to correctly identify individuals 
with fracture history was also evaluated. No measures of dietary intake or adequacy 
including symptoms of LEA, or of menstrual status were included.  
 
The approach to data analysis and results (for both Phase A and Phase B) are detailed 
in Chapter 4.  
 
3.3.2 Seven day study 
The data presented in Chapters 5-7 was collected together. A schematic of the study 







Figure 3-2: Schematic of study design to assess bone metabolism in FDR and CON 
 
The study compared two populations stratified by physical activity: FDR and CON. 
Habitual bone metabolism (both homeostatic formation and resorption, and 24 h 
resorption), energy expenditure, training, body composition, BMD, and dietary intake 
were assessed.  
 
Participants were recruited via social media advertisements, email and through word 
of mouth. All participants were aged 18-35 y and did not have any current injury/ 
illness requiring modification of their habitual exercise. Inclusion criteria for each 
group was as follows: 
• FDR: training age ≥2 y, minimum weekly training volume of 60 km.w-1, 
maximum weekly training volume in non-weight bearing activities of 3 h.w-1. 
• CON: habitual activity ≤3 h of vigorous physical activity defined as an average 
session metabolic equivalent of 6.0 MET. CON participants engaged in a 
general physical activity programme. They were not competitive athletes.   
The training volume of 60 km.w-1 rather than 40 km.w-1 used in Chapter 4 was chosen 
to ensure a clear stratification of physical activity between FDR and CON. It was in 
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line with the average training volume reported by the 119 FDR recruited in Phase A 
of the prevalence and fracture history study (67 ± 25 km.w-1). 
 
The following exclusion criteria applied for all: 
1. Fracture within previous 12 months  
2. Pregnancy or lactation within previous 12 months  
3. Under clinical management for any condition known to affect bone health, 
with the exception of functional hypothalamic amenorrhea (FHA) or OLIGO.   
Participants were not clinically screened. Exclusion criteria were assessed by a self-
report questionnaire completed on the same visit as informed consent. The additional 
exclusion criteria in this study were applied in line with IOF guidelines for sampling 
of BTMs (Szulc et al., 2017). Participants were not matched for menstrual status. 
Participants with a known menstrual disorder other than exercise/ energy induced 
disorders (AMEN/OLIGO/ sub-clinical menstrual disturbances) were excluded. 
 
Study protocol 
Potential participants who expressed interest met with the researcher (JH) and the 
protocol was explained and questions answered. If an individual was happy to proceed 
with testing they provided informed consent and completed a questionnaire regarding 
menstrual function and use of hormonal contraceptives. Individuals who were 
currently or in the past 6 months had used hormonal contraceptives were excluded. 
Participants were classified as EUMEN if they had a menstrual cycle between 24 and 
35 days and reported 10-15 menses in the past year. If 4-9 cycles were reported in the 
past year they were classified as OLIGO and if 0-3 they were classified as AMEN. 
Participants eligible for inclusion were provisionally scheduled for testing 
immediately following next menses for EUMEN and OLIGO participants. Participants 
contacted the researcher on the first day of menses to confirm availability and arrange 
a pre-test meeting. AMEN participants were scheduled at an arbitrary, convenient 
date. In the days prior to testing participants met with the researcher who reiterated 






Test week began at 00:00 on day 1 to enable energy expenditure for each 24 h epoch 
to be captured . Data collection methods are described in detail later in this chapter. 
Participants were instructed to wear the SWP3 armband from bedtime on the day prior 
to testing or before 00:00 (day 1), whichever was earlier. Participants were not 
required to attend the laboratory on day 1. Upon waking participants emptied bladder. 
From second morning void 24 h urine collection began. Participants completed 
training log and eFIR from first exercise session and food/ drink consumption up to 
and including final training and meal consumption pre-bed. On day 2 participants 
attended the laboratory following an overnight fast and at least 10 h post-exercise if 
exercise was completed on the first day. A blood sample was drawn and urine sample 
(including first morning void of day 2) returned. This marked the end of data collection 
for day 1. If the first day of testing was a NONEX day body composition and bone 
densitometry were assessed by DXA. If not this was scheduled for the day after a 
NONEX day during the week. Blood samples were drawn, separated and stored, and 
urine samples measured and stored as described (3.5.1 ). Participants repeated this 
protocol for a further 6 days with the final blood sample being drawn on day 8. On 
completion of the protocol all logs were returned and any anomalies clarified with 
participants. Participants were instructed to maintain their habitual exercise and 
dietary habits throughout the test week. They were asked to include at least one 
NONEX day during the test protocol. Four FDR were recruited and tested at a separate 
laboratory. Body composition and bone densitometry was assessed by DXA within 1 
month of test week in UL. 
 
The primary outcome measure was bone metabolism. Homeostatic or basal bone 
metabolism was assessed in fasted morning blood samples by CTX and P1NP. Total 
resorption was assessed by 24 h excretion of uNTX, fPYD and fDPD measured in 
urine samples as described in section 3.5 . The group comparison of BTMs is presented 
in Chapter 5. Energy expenditure was a secondary outcome measure – both the group 
difference in total and source of energy expenditure and the validity of SWP3 to assess 
energy expenditure in FDR over 24 h epochs. This data is presented in Chapter 6. 
Intake of energy and selected nutrients (carbohydrate, protein, calcium, vitamin D) 
amongst FDR was also a secondary outcome measure. Dietary adequacy amongst the 
studied cohort of FDR is presented in Chapter 7.  Menstrual status was not an outcome 
measure due to the widespread (6/7 FDR) menstrual dysfunction amongst the FDR 
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cohort, preventing analysis. Differences in menstrual status of FDR and CON and the 
absence of menstrual status inclusion in study 1 (BMD and fracture history) is 
acknowledged as a limitation within this thesis.  
 
3.4 Body composition and bone densitometry assessment  
Body mass and height were measured on the same day as body composition and bone 
densitometry assessments. Body composition was assessed using a four compartment 
model. Lean, fat and bone mass were assessed by DXA (Lunar iDXA, GE Healthcare). 
A new DXA (hardware and software) was installed part way through recruitment for 
both studies resulting in an upgrade of software (from v14 to v17). All analysis was 
completed using v17.  
 
Body water was assessed by bioelectrical impedance analysis (BIA) (TANITA MC 
180 MA). FDR measurements were completed with ‘athlete’ body type. CON 
measurements were collected using ‘normal’ body type settings.  
 
3.4.1 Pre-test conditions and instrument set-up  
Periodic quality control measurements were performed in line with manufacturer and 
ISCD guidelines (ISCD, 2019). A daily quality assurance (QA) calibration was 
completed using a manufacturer provided calibration block for total body scans during 
the 24 h pre-test. A monthly bone calibration was also completed by a single operator 
(JH) using a spine ‘phantom’ placed inside a fixed volume of water in a container 
provided by the manufacturer. No deviations outside the acceptable 2% from baseline 
were observed.  
 
Participants were instructed to refrain from strenuous exercise in the 24 h pre-test and 
to avoid exercise in the 12 h pre-test. For FDR this meant that only short (≤40 min), 
easy training was permitted the day prior to testing, and no training prior to testing on 
the day of testing. CON were asked not to engage in purposeful physical activity in 
the 24 h pre-test. Measurement prior to 10:00 was completed following an overnight 
fast and scans scheduled later in the day were preceded by a 3 h fast. 1 h prior to 




to empty bladder and defecate if required 10 min prior to lab attendance. Compliance 
with pre-test conditions was verbally confirmed with each participant on arrival.  
 
All measurements were completed in light clothing (shorts, t-shirt and sports bra) and 
participants were asked to wear clothes free of metal/ reflective artefacts e.g. buttons, 
clasps, zips. Despite querying this with all participants, in a minority of cases bra 
clasps were evident during spine bone densitometry scans. If artefact was present in a 
region of interest i.e. L1-L4 participant was asked to change and the scan repeated. 
Where the artefact was not in the region of interest e.g. T12, point typing was used 
and the scan was not repeated in order to minimise exposure to ionizing radiation. 
Where possible testing was scheduled during the follicular phase of the menstrual 
cycle (within 7 d of last menstrual period). Where this was not possible (cases of 
AMEN/ oligomenorrhea (OLIGO)) testing proceeded if participant could provide 
written confirmation there was no risk of pregnancy.  
 
3.4.2 Test procedure 
Body composition and bone densitometry assessment took place under the remit of 
the University of Limerick Body Composition Study (ULREC 08/07, risk assessment 
procedures updated in 2019: 2019_01_08_EHS_RA (Measurement of the body 
composition of adult men and women aged 18-80 y by DXA), 2019_01_07_EHS_RA 
(Measurement of the body composition of adult men and women aged 18-80 y by 
BIA)).  
 
Prior to arrival at the laboratory participants were provided with a copy of the 
participant information sheet and consent form. Upon arrival the procedure was 
explained to participants and any questions answered. If the participant was happy to 
proceed they provided written informed consent, including confirmation that there was 
no risk of pregnancy. Compliance with pre-test requirements was verified with 
participants.  
 
Height was measured to the nearest millimetre in duplicate using a stadiometer (Seca, 
Birmingham UK). Body mass and body water were measured to the nearest 0.1 kg by 
BIA. The participant was then instructed to lie supine on the bed of the DXA for body 
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composition assessment. Head was positioned 2 cm below the top of the scan field. 
All participants were within the height restrictions of the scanner. If a participant was 
off-centre or not vertically aligned they were asked to return to seating, re-position 
and then lie down. Positioning was re-checked. Legs were positioned straight with feet 
neutral. Participant arms were positioned mid-prone, close to sides of the body leaving 
a minimum of 4 cm between hands and legs. A neutral chin position was adopted by 
participants. Off-set scanning was not required for any participant.  
 
Following the total body scan participants remained lying supine. They elevated legs 
by flexion at knee and hip to allow a support block (provided by GE Healthcare) to be 
placed under the legs. Spine scans included part of L5 and T12 and all of L1-L4. 
Following the spine scan the block was removed, scanner repositioned while still in 
“AP spine-dual femur” acquisition mode. The operator positioned legs so that hips 
were internally rotated and slightly abducted so that the femur shaft would be centred 
in the acquired image. Feet were secured with velcro straps on the positioning segment 
(provided by GE Healthcare). Femur scans were started allowing at least one sweep 
prior to appearance of the ischium. Following acquisition of all scans scanner arm was 
returned to home and participants left the bed.   
 
3.4.3 Analysis 
Whole body scans 
Whole body scans were segmented using standard analysis and a custom region of 
interest (ROI) template. Standard analysis created the following ROIs: head, trunk, 
left and right legs, left and right arms, android, and gynoid. The definition of ROIs in 





Table 3-1: ROIs and defining landmarks for standard segmentation 
ROI Areas included and bony landmarks 
Head Superior to the mandible    
Trunk Including the neck, chest, abdominal and pelvic area. Defined by the area 
inferior to the mandible, extending to the point of separation to the arms 
(defined by the most proximal point of the humeral head), and the middle 
of the femoral necks also including the full ischium.  
Left/ right leg Beginning at the middle of the femoral neck including all tissue in the 
leg.  
Left/ right arm Beginning at the point of separation of the trunk defined by the most 
proximal point of the humeral head.  
Android* Enclosed by the trunk region, beginning at the iliac crest and extending 
20% of the distance between iliac crest and base of mandible  
Gynoid* Includes hips and thighs.  
*Android and gynoid regions were automatically calculated by the software based on 





Table 3-2: ROIs and defining landmarks for custom analysis 
 Region Segment number Landmark 
Forearm 1 (right), 6 (left) From the radio-ulnar joint to the radio -carpal joint 
Hand 2 (right), 7 (left) From the radio-carpal joint to outer edge of the distal 
phalanges 
Thigh 3 (right), 8 (left) From the inferior side of the lesser trochanter to the 
tibiofemoral joint 
Lower leg 4 (right), 9 (left) From the tibiofemoral joint to the lateral malleolus 
Foot 5 (right), 10 (left) From lateral malleolus to the outer edge of the 
phalanges 
L1-L4* 11 From the vertebral space superior to L1 to the 
vertebral space inferior to L4 including all tissue in 
this region.  
L1* 12 From the middle of the vertebral space superior to 
the middle of the vertebral space inferior to the 




*L1-L4 segmentation was completed as part of the standard operating procedure. However 
site-specific scan values were used in all analysis. 
 
Site-specific bone scans 
BMD was assessed at the lumbar spine and dual femur sites. Spine scans were 
analysed by creating a ROI for each vertebra in the L1-L4 region (using standard GE 
Healthcare ROI tool) with a segmenting line placed at the narrowest point in each 
intervertebral space. Data was extracted as L1-L4 irrespective of Z-scores to maintain 
consistency across the study population. Analysis was then adjusted in accordance 
with ISCD recommendations (ISCD, 2019); where a vertebra was >1 Z-scores 
different to an adjacent vertebra the vertebra was omitted from analysis. 11/39 FDR 
scans and 4/11 CON scans required adjustment. Unadjusted data is reported in the 
thesis.  
 
Only the angle/ placement of the femoral neck box was adjusted if required, the size 
of the box was unadjusted. The femoral neck ROI box was placed in the centre of the 
femoral neck, at an angle perpendicular to the axis of femoral neck. Inclusion of any 






A precision calculation for all examined sites was completed by this operator using a 
convenience population (n=30) who were recruited by word of mouth. Details of this 
protocol, calculation and full results are available in Appendix A. The following 
precision results were obtained: total fat mass: RMSD 0.2 kg, 1.2%CV, total lean 
mass: RMSD 0.2 kg, 0.5%CV; percent fat mass: RMSD: 0.3%, 1.3%CV; lumbar 
spine: RMSD: 0.010 g.cm-2 (0.8%CV); left femoral neck: RMSD: 0.018 g.cm-2 
1.5%CV; left total hip: RMSD: 0.011 g.cm-2 1.0%CV; right femoral neck: RMSD: 
0.018 g.cm-2 1.5%CV; right total hip: RMSD: 0.007 g.cm-2 0.6%CV. All are within 
the minimum acceptable precision for a single operator (ISCD, 2019).  
 
3.5 Bone turnover marker analysis  
Both bone resorption and formation markers were measured. CTX and P1NP were 
measured in plasma as reference markers in line with IOF recommendations. Further 
markers of resorption (uNTX, fDPD, dPYD) were measured in urine to allow 
quantification of resorption over 24 h. Creatinine was also measured in urine, to allow 
confirmation of urine sample volume based on daily creatinine excretion relative to 
lean body mass (LBM). 
 
3.5.1 Sample collection  
Urine 
24 h urine samples were collected. Participants were instructed to collect full void 
throughout the 24 h epoch starting from second morning void on one day up to and 
including first morning void (FMV) the next day. Samples were collected in 
polyethylene light protected containers (Sarstedt AG & Co. KG, Germany). Samples 
were returned to the lab following collection of FMV. Participants were asked to 
confirm if the full 24 h was collected or if any partial/ full samples were missed. Upon 
return of sample 2x10 ml aliquots were transferred to polypropylene tubes (Sarstedt 
AG & Co. KG, Germany). Where a participant had used more than one collection 
vessel (24 h) the proportion of sample in the aliquot reflected the volume in each 
vessel. Aliquots were frozen at -20 °C until analysis. The total sample volume was 
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then measured in a graduated cylinder to the nearest 10 ml. The volume from the 
frozen aliquots was added to the recorded volume.  
 
Blood  
Blood samples were obtained between 07:30 and 09:00, following an overnight fast 
and having refrained from exercise for at least 10 h. Sample time was scheduled at a 
consistent time across the week for each participant with actual sample time recorded. 
Mean sample time was 08:17 ± 00:13. Within each participant samples were drawn 10 
± 06 min apart. Participants were seated for 10 minutes on arrival at the laboratory. A 
needle was inserted to a superficial vein at the antecubital fossa, or when not possible 
(multiple draws across several days resulting in hindrance to identifying a suitable 
insertion site) from the posterior aspect of the hand. A serum blood sample was drawn 
followed by a K3E EDTA plasma sample. Blood samples for 14/18 participants were 
drawn using Sarstedt monovettes (Sarstedt AG & Co. KG, Germany). Due to 
recruitment of 4 FDRs at an alternative site and support from their research staff, BD 
vacutainers (Becton, Dickinson and Company, United States) were used for sample 
collection in this group. Samples were allowed to sit for 20 minutes at room 
temperature prior to being spun at 2106 g for 10minutes at 22 °C. Serum/ plasma was 
then separated and aliquots frozen at -80 °C until analysis. 
 
3.5.2 Sample analysis 
Urine analysis 
Urine analysis was completed at University of East Anglia (UEA) in collaboration 
with the Musculoskeletal Medicine Group. Samples were transported on dry-ice to 
prevent freeze-thaw cycles. All BTM values were reported in absolute concentrations 
and normalised per millimole (mmol) of creatinine. The methodology is described 
based on method sheets and publications provided by the UEA research group. 
 
uNTX was measured by enzyme-linked immunosorbent assay (ELISA) 
(OSTEOMARK NTx Urine manufactured by Abbott (previously ALERE 
Scarborough Inc)). Antibody conjugate was made up within 1 hour of use. Following 
addition of antibody conjugate to the sample (or control or calibrator) samples were 




washer with a provided wash solution diluted with deionized water. Buffered substrate 
reagent and chromogen reagent were mixed and added to each well followed by 
incubation at room temperature for 15 ± 1 minute. A stopping solution was added to 
each well resulting in the blue colour, indicating bound antibody-horseradish 
peroxidase conjugate, turning to yellow. Following a 5 minute rest period the plate 
was read at 450 nm on a micro well plate reader with a reference filter of 630 nm and 
a maximum optimal density reading ≥3.000.  
 
Both DPD and PYD were analysed by liquid chromatography tandem mass 
spectrometry (LC-MS/MS) using a published protocol (Tang et al., 2016). Free PYD 
(fPYD) and free DPD (fDPD) were extracted during a solid phase procedure. Samples 
were spiked with acetylated PYD and hydrochloric acid, followed by butan-1-ol and 
1 ml of cellulose slurry suspended in butan-1-ol/water/glacial acetic acid. Following 
mixing by vortex, inversion and standing for 30 minutes solid phase extraction 
procedure was carried out on a PRESSURE+48 positive pressure manifold using 
nitrogen gas from a nitrogen generator. Acidified urine was passed through a column 
reservoir which was then washed with butanolic solution and tetrahydrofuran. The 
columns were dried with nitrogen gas. Cross links were eluted from the vials, 
centrifuged at 10000 g for 5 minutes prior to injection into the LC-MS/MS. An 
Accucore C18 50 x 2.1mm, 2.6 µm, reversed-phase solid core particle column heated 
at 55°C was used for chromatographic separation. A gradient elution profile was set-
up starting with mobile phase of 85%:15% of water in 0.1% heptafluoro-butyric acid 
(HFBA) and methanol in 0.1% HFBA. This was increased to 99% and returned to start 
in 4.5 min. LC-MS/MS analysis was performed on a Micromass Quattro Ultima Pt 
mass spectrometer with an integrated electrospray ionisation source operated in 
positive mode. Capillary voltage was kept at 3.0kV and RF lens 1 and 2 were set at 
0.1. Source temperature was maintained at 130°C. Nitrogen was used as both a 
nebuliser gas and desolvation gas. Sample cone voltage was 35 kV, collision energies 
for PYD, DPD and INT-PYD were 40 kV. Argon was used as a collision gas. 
Transitions of each of the compounds were identified by direct infusion of extracted 
standards into the ion source via a T-connector. Lower limits of quantification (LLoQ) 
were 6nmol.l-1 for PYD and 2.5 6nmol.l-1 for DPD. CV at this levels was 14.3% for 




Creatinine was analysed using an automated reaction. This kinetic colorimetric assay 
is based on the Jaffé method (Delanghe and Speeckaert, 2011). During the reaction, 
two reagents (potassium hydroxide with phosphate (pH ≥13.5), and picric acid (pH 
6.5)) are added to samples within the automated system. In alkaline solution creatinine 
forms a yellow-orange complex with picrate. The rate of dye formation is proportional 
to the creatinine concentration in the sample. Creatinine concentration can be 
calculated based on absorbance at 570 nm. Measurement range is 375-55000 µmol/l 
in urine.  
 
Blood analysis 
CTX and P1NP were analysed from K3E EDTA samples by automated 
electrochemiluminescence (ECL) (Roche cobas e411). Samples were analysed in three 
batches. Following installation of new reagents a calibration was completed using 
Roche provided calibrators. Roche CalSets included a two point calibration for both 
CTX (catalogue number: 11972316122) and P1NP (catalogue number: 
03141071190). The calibration curve was validated using non-Roche controls. 
Controls were constituted in house with pooled plasma samples spiked to high or low 
concentration with Roche provided calibrators. 
 
CTX and P1NP assays were measured during the same test using one sample. 
Analytical variability was calculated by completing 5 repeat tests on two samples. CV 
was 2.5% and 2.9% for CTX and P1NP respectively.  
 
Samples were defrosted at room temperature. Samples were transferred to sample cups 
for use on the instrument and programmed manually.  
 
The CTX/ P1NP assay is 18 minutes in duration. Within the automated system 50 µl 
of sample and antibody are incubated together so the antigen in the sample is liberated. 
During a second incubation streptavidin-coated micro particles and a monoclonal β 
cross laps or P1NP specific antibody are added so that a sandwich complex if formed 
that binds to the solid phase. The micro particles are magnetically captured onto the 




chemiluminescent emission is measured and concentration calculated based on the 
calibration curve. 
 
3.6 Energy expenditure  
3.6.1 Sensewear Pro3™ (SWP3) 
Energy expenditure was objectively measured using a wearable activity monitor 
(SWP3). SWP3 calculates energy expenditure based on accelerometry, skin galvanic 
response and heat flux. The device was worn on the posterior, superior aspect of the 
left arm for all participants in accordance with research group procedures. Height, 
mass, dominant hand and smoking status were all inputted during configuration. 
SWP3 were configured and given to participants prior to the start of the study week. 
Participants wore the armband at all times except while exposed to water – bathing, 
swimming, and training outdoors in heavy rain. Physical activity completed during 
‘off body’ periods was documented by participants. On return of armbands data was 
downloaded using Sensewear™ Professional v8 software. Height and mass were re-
checked and if required were adjusted to the measured height and mass obtained on 
the day of body composition and bone densitometry. All analysis was completed with 
data generated from the adjusted height and mass.  
 
For each 24 h epoch (00:00-23:59) the energy expenditure (kJ), wear time and 
estimated off-body energy expenditure was recorded. A valid energy expenditure 
measure was classified as a wear time >95% in a given 24 h epoch as per previous 
protocol in endurance athletes (Koehler et al., 2011). The SWP3 data was compared 
with training and activity logs and annotated to define training times. Where there 
were slight discrepancies in time (energy expenditure increased/ decreased slightly 
before/ after training log time indicating start/ end of exercise) the SWP3 data was 
used as an objective measure of start/ end time. The energy expenditure (kJ) during 
training was noted. When training was completed outside of armband wear time 
(swimming/ training in rain/ SWP3 malfunctioned/ was removed) the training log was 
used to assign a metabolic equivalent (MET) to the activity using the Compendium of 
Physical Activities (Ainsworth et al., 2011). 3.5 ml.kg-1.min-1 is used as a proxy of 
basal metabolic rate (BMR) in the MET classifications. This may result in inaccuracies 







Equation 3-1: Correction of MET based on difference between estimated oxygen 
consumption and oxygen consumption of BMD 
 
Where BMR is calculated using the Henry (2005) equation (Equation 3-2 or Equation 
3-3):  
=)>	 9%A8. ';< = 10.4×-AEE	 9: + 615	×ℎ$0:ℎ&	 - − 282 
Equation 3-2: BMR calculation for females aged 18-29.9 y 
 
=)>	 9%A8. ';< = 8.18×-AEE	 9: + 502	×ℎ$0:ℎ&	 - − 11.6 
Equation 3-3: BMR calculation for females aged 30-59.9 y 
 
Training energy expenditure (Training EE) in kJ was then calculated as follows: 
+#A0/0/:	** = !"##$%&$'	)*+	×'1#A&0"/	 ℎ ×-AEE	 9: ×4.18 
Equation 3-4: Energy expenditure during training  
In Equation 3-4 expenditure is referred to as energy expenditure during training. In 
Chapter 6 and Chapter 7 energy expenditure during training is corrected for the energy 
that would be expended through BMR during this time to provide EEE which is the 
energy expended as a result of exercise. A worked example of this is provided in 
Appendix E.   
 
Energy expenditure (all variables of interest) was converted from kJ to kcal by 
dividing by 4.184. 
 
3.6.2 Doubly labelled water 
A sub-group (n=5) of FDR also had energy expenditure assessed by doubly labelled 
water (DLW). This was completed in collaboration with Maastricht University. On 
the evening prior to the first day of study participants collected a baseline urine sample. 
They then ingested a dose of DLW (2H2 18O) directly from a glass bottle. The bottle 
was rinsed with tap water and the rinse was also consumed from the bottle. Time of 
urine sample and DLW ingestion was noted. The next morning (the start of study day 




instructed to collect a sample every 12 h after this up to and including SMV on the 
morning of the final blood draw (the first urine sample not within the 24 h assessments 
of BTM). A further two samples were collected one week later – one evening and one 
morning. The exact times of samples were noted by the participant. On return to the 
laboratory 2*2 ml aliquots were transferred to glass storage tubes. Samples were 
frozen at -20 °C until analysis. Samples underwent one freeze-thaw cycle during 
transfer to Maastricht University for analysis. Maintaining frozen samples was not 
deemed necessary when discussed with the Maastricht research group. The sample 
collection protocol allowed for analysis of 12 h epochs. At time of thesis development 
only the energy expenditure averaged across the 7 d and for each 24 h epoch had been 
completed. The Maastricht Protocol for energy expenditure measurement by DLW has 
previously been published (Westerterp et al., 1995). The following description is based 
on this publication and a more recent review (Westerterp, 2017). The dose of DLW 
was prescribed based on body water (estimated from body mass), sex (female) and 
activity status (endurance athletes). It aimed to provide a minimum dose of 1.8 g water 
(10% 18O atoms) per kilogram body water and 0.12 g water (99% 2H2 atoms) per 
kilogram body water. Samples were analysed by isotope ratio mass spectrometry. 18O 
is measured in water vapour. 2H2 is measured in hydrogen gas. Samples were analysed 
in duplicate and a difference not greater than 1 ppm is deemed valid. The enrichment 
of the body water pool is calculated from the background (pre-ingestion) sample to 
the first sample post ingestion (morning of day 1 in the current study). This allows for 
an equilibration period of ~10 hours. Energy expenditure is calculated from carbon 
dioxide production assessed from the isotope elimination curve. As a check of sample 
validity the fit of the isotope elimination curve should also be high. Extending the 
sampling period to the end of a second week facilitated this analysis. Carbon dioxide 
production can be calculated using the following formula: 
#!67 -"8 =
L
2.078 1.01N<O − 1.04N7 − 0.0246PQR 
Where rCO2 is the carbon dioxide production in moles. N is the body water volume in 
moles. 2.078 is a constant reflecting that 1 mole of CO2 removes two atoms of oxygen, 
adjusted for the slightly higher (4%) enrichment of carbon dioxide than body water. 
1.01 and 1.04 are constants adjusting for the difference in enrichment between carbon 
dioxide and body water, as well as that of the water vapour lost through skin and 
breath. K18 and K2 are the elimination rates of 18O and 2H2 respectively and rGF is the 
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rate of water loss via fractionating gaseous routes. The energy equivalent of carbon 
dioxide is affected by the substrate being oxidised. Based on a diet with 55% energy 
derived from carbohydrate, 15% from protein and 30% from fat the energy equivalent 
of carbon dioxide is 23.5 kJ.l-1 (~1.05 kJ.mol-1 at standard pressure and temperature 
(STP)).  
 
3.7 Training log 
All FDR completed an electronic training log on Microsoft Excel. Training logs were 
not initially completed by CON but this was changed following completion of four 
CON. Training logs were available for 7/11 CON. Where data was unavailable (CON) 
an activity log detailing on and off body time and time stamps for the SWP3 was used 
to identify activity bouts. Two of the four participants without training data did not 
complete any exercise sessions throughout the week. This was confirmed verbally 
with participants at the time of testing, by inspection of the SWP3 files and log of 
‘on/off’ body time for SWP3.  
  
Training logs included the following information: training start time, end time and 
duration (this was used to verify the start/ end time recorded), training type (steady 
running, running session (incl. high intensity), non-weight bearing endurance 
(NWBE), resistance – rehabilitation, resistance – strength, circuit, team training), 
rating of perceived exertion (RPE), distance run (for running sessions). Exercise, 
repetitions, sets and rest were documented for resistance training. Session RPE (sRPE) 
scores were completed 30 min after the training session. A hard copy log was provided 
for this purpose and the data transferred to the electronic log afterwards. The hard copy 
was also returned on completion of the study week.  
 
3.8 Dietary analysis 
3.8.1 Dietary data collection 
7 day estimated food records (eFIR) were used to collect dietary data. All participants 
were provided with verbal instructions and a written information book detailing 
instructions and providing examples of correctly completed eFIR. Participants also 
had contact information for the researcher (JH) and were encouraged to clarify any 




consumed during the test week. Meal type (breakfast, lunch, dinner, snacks, fluids), 
location of preparation, meal time, food description including brand, quantity (in 
grams), cooking method and any additions to food were documented. Where foods 
could not be weighed e.g. not prepared by the participant, photographs and household 
measures were used to document the quantity. Participants were asked to weigh foods 
after cooking. For composite dishes (e.g. curry with vegetables and meat) participants 
weighed the individual raw ingredients and the entire cooked dish. This allowed a 
weight change to be calculated which could then be applied to the individual portions. 
Participants provided packaging/ photos of nutritional information for foods that were 
purchased but variations are available e.g. pre-prepared sandwiches, supplements, 
fruit/ nut bars. Water consumed throughout the day could be documented as a total 
water intake at the end of the day. Diaries were reviewed on return and any queries/ 
anomalies clarified with the participant.   
 
3.8.2 Dietary data entry 
Data was entered using online password protected dietary analysis software 
(Nutritics©, Dublin, Ireland). eFIR were entered as meal logs, creating a single log for 
each day of study. A research group developed standard operating procedure was used 
to enter the diary. A single meal was defined as all food consumed within a 30 min 
time window. The type of meal was classified according to time of day and time 
relative to training.  
 
Meals could be classified as breakfast, lunch, dinner, snacks, pre/post/during training 
meals, pre-bed meals, fluids, alcohol and supplements. Breakfast, lunch and dinner 
were defined as the meals with greatest energy intake within the following time frames 
respectively 06:00-11:00, 11:01-15:00, 15:01-22:00, unless this meal qualified as a 
peri-training nutrition (PTN) meal. Pre-bed meal referred to food consumed within 1 
hour pre-bed unless this was a PTN meal. Fluids were defined as drinks with no 
energetic value e.g. water. Fluids, alcohol and supplements were only used when this 
was the only food/ drink consumed at the time e.g. if an iron supplement was 
consumed in isolation it was classified as a supplement, if it was taken with orange 
juice it was classified as the relevant meal type according to time of day and relative 
to training. Location of meal preparation, type of day (rest, training, competition) and 
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phase of season (pre-season, in season, off-season, injured, rehabilitation, not 
applicable (for non-athletic participants)) were all documented. All FDR were either 
in pre-season (including some training races) or in season at time of testing. For each 
meal food type was selected based on the description/ brand provided in the eFIR 
(supported by the accompanying labels with nutritional information). Where exact 
food was not available in the database the closest match was chosen provided it was 
within 10% of energy and macronutrients per 100 g. Calcium content was also 
checked. If a suitable food was not available a ‘custom food’ was added. This was 
only done if no suitable match was available, as nutritional information used to create 
a custom food often omits key micronutrients of interest e.g. calcium. Food quantity 
was entered in grams as per the eFIR. Where household measures/ photos were 
provided instead a food atlas (Nelson et al., 1997) was used to estimate mass of food. 
On completion of the study all data was exported and checked for consistency in 
custom fields (date, time, type of day, meal type, phase of season) and log naming 
format. Any alterations were made in the online records and file was then re-exported. 






Chapter 4: Fracture history and prevalence of low BMD 





The National Osteoporosis Foundation reports that physical activity (PA) has a 
positive effect (grade A evidence) on PBM (Weaver et al., 2016). Exercise contributes 
to total PA. However not all exercise is equal in terms of osteogenic potential. Mudd 
et al. (2007) report that female runners (repetitive impact sport) have 19% lower BMD 
than gymnasts and 16% lower than softball players (high rates of loading) at the 
lumbar spine (an 8% total body difference also exists compared to gymnasts). 
Swimmer and divers (non-impact) have 6-8% lower total body BMD than gymnasts, 
softball players and field hockey players (multi-directional impacts), and 11% lower 
than gymnasts at lumbar spine. Amongst collegiate athletes Rizzone et al. (2017) 
report highest stress fracture incidence (28.59/ 100 000 athlete exposures) in female 
cross country runners but second highest was in female gymnasts (25.58/ 100 000) 
suggesting that BMD alone is an insufficient explanation of fracture risk.  
 
Table 2-5 shows a prevalence of fracture amongst FDR of 18-60% while prevalence 
of low BMD was 0-45%. Few studies report prevalence of both. This chapter aims to 
evaluate the prevalence of poor bone health amongst FDR using both fracture and 
BMD. Prevalence was assessed using each index as well as an overall prevalence with 
at least one indication of the two measures (i.e. low BMD or fracture). The agreement 
between both was also assessed with a view to informing on the suitability of BMD as 
a metric of fracture risk amongst FDR.   
 
Typical training of FDR is characterised by repeated exposure to habitual loading 
patterns, a pattern that does not have optimal osteogenic potential (Turner, 1998). The 
performance advantage of a low body and fat mass may accentuate the sub-optimal 
stimulus by lowering the habitual load on the skeleton during ambulation. Due to 
repeated exposure to impacts during running, training volume could increase risk of 
fracture and has been cited as a risk factor (Tenforde et al., 2016).  
 
Amongst young (18-26 y) FDR age (risk ratio 1.12 per year younger, 1.42 within 
multivariate analysis), indicators of bone mass (BMC and BMD at numerous sites, 




lean body mass (risk ratio: 1.14 per kg) and lower body mass (risk ratio 1.1.08) were 
identified as risk factors for stress fractures (Kelsey et al., 2007). A secondary aim of 
this chapter was to compare anthropometric and training variables in groups with and 
without fracture history and/or low BMD.  
 
This chapter addresses the following research questions: 
1. What is the prevalence of poor bone health amongst FDR, indicated by: 
a. History of stress fracture 
b. History of fragility fracture 
c. History of any fracture 
d. Low BMD 
e. History of fracture or low BMD 
2. What is the sensitivity and specificity of BMD to detect FDR with fracture 
history? 
3. Does training volume (km.w-1) differ between FDR with versus without poor 
bone health?* $ 
4. Does body mass (kg) differ between FDR with versus without poor bone 
health?* $ 
5. Does lean mass (kg) differ between FDR with versus without poor bone 
health?$ 
6. Is there an age (y) difference between FDR with versus without poor bone 
health?* $ 
 
*Questions 3, 4 and 6 were evaluated for Phase A where bone health was defined by  
i. Stress fracture status  
ii. Any fracture status  
$Questions 3-6 were evaluated in Phase B where bone health was defined by  
i. Fracture status 
ii. BMD status 





The study design and participant criteria were detailed in section 3.3.1 . Within this 
chapter Phase A refers to the online survey regarding stress/ fragility fracture history 
and training (available in Appendix B). Phase B refers to the survey and BMD/ body 
composition analysis conducted at University of Limerick.  
 
119 surveys were included in the Phase A analysis. Two respondents provided height/ 
mass data that were outliers – one reported a height of 5 cm, one reported data that 
resulted in a BMI of 45 kg.m-2. These participants were excluded from the analysis of 
BMI. Of the 119 participants 80 provided contact emails and received an email invite 
to attend for BMD and body composition assessment at the University of Limerick. 
39 FDR attended.  
 
4.2.1 Criteria  
A positive indication for poor bone health was defined as  
1. History of confirmed stress or fragility fracture (confirmed with MRI or x-ray) 
2. Low BMD using the ACSM and IOC criteria of a Z-score ≤-1 (Nattiv et al., 
2007, Mountjoy et al., 2014) 
 
4.2.2 Data analysis 
The primary aim of this chapter was to assess the prevalence of low BMD and fracture 
history amongst a cohort of FDR. For each variable prevalence was calculated as 
shown in Equation 4-1: 
S#$TA8$/%$	 % = 	
L1-V$#	"W	."E0&0T$	#$E18&E	W"#	E.$%0W0$'	-$&#0%
/	"W	EA-.8$	W"#	E.$%0W0$'	-$&#0% ×100 
Equation 4-1: Prevalence of poor bone health  
 
The suitability of BMD as a metric of stress fracture risk was assessed by sensitivity 
and specificity calculations. Sensitivity assesses the ability of a test to successfully 
identify people with a condition from a group of people known to have a condition 
(e.g. fracture) (Equation 4-2). Specificity assesses the performance of a test in a group 




condition and not incorrectly categorizing people as having a condition (Equation 4-3) 
(Trevethan, 2017). 
 
The sensitivity and specificity of BMD to identify FDR who had experienced stress 
fracture was calculated as shown in Equation 4-2 and Equation 4-3: 
X$/E0&0T0&Y = 	
+#1$	."E0&0T$	(W#A%&1#$ + 8"Z	=)[)
+#1$	."E0&0T$ + WA8E$	/$:A&0T$	(W#A%&1#$ + /"	8"Z	=)[) 




+#1$	/$:A&0T$ + WA8E$	."E0&0T$	(/"	W#A%&1#$ + 8"Z	=)[) 
Equation 4-3: Specificity calculation 
 
Statistical analysis was completed using SPSS v25 (IBM SPSS Statistics). An online 
calculator was used to calculate non-parametric effect sizes (Lenhard and Lenhard, 
2016). Prior to statistical analysis the distribution of anthropometric and training data 
was evaluated by histogram and Shapiro-Wilk test. For two group comparisons 
(positive vs negative indication of poor bone health) an independent samples t-test was 
used (Mann Whitney U where non-parametric test was required). A one way analysis 
of variance (ANOVA) was used to compare groups by competitive level in Phase A 




Table 4-1: Group difference analysis based on fracture (Phase A) or bone health (Phase B) 
status 
Independent variable Dependent variable Phase 
A 







Run volume (km) 
 
 









Lean mass (kg) 
Run volume (km) 




NA Age (y) 
Mass (kg) 
Lean mass (kg) 
Run volume (km) 
BMD (g.cm-2) (site specific) 
Bone health status 
Fracture OR low BMD 
No fracture, no low 
BMD 
NA Age (y) 
Mass (kg) 
Lean mass (kg) 
Run volume (km) 
BMD (g.cm-2) (site specific) 
 
4.3 Results 
4.3.1 Phase A 
Participant characteristics 
Characteristics of participants included in phase A are shown in Table 4-2. Run 
volume (Figure 4-1) and run frequency (Figure 4-2) for all and by group are shown in 
graph form. Data was skewed so a log transformation was performed prior to analysis 
by ANOVA. Main effects of age (p<0.001), height (p=0.033), body mass (p<0.001), 




Table 4-2: Characteristics of participants included in Phase A analysis  




National Provincial County Competitive 
road racing 
Recreational 
N (% of total) 119 (100%) 9 (8%) 16 (13%) 48 (40%) 5 (4%) 5 (4%) 20 (17%) 16 (13%) 






































Mass (kg) Mean ± SD 57 ± 7 54 ± 7 56 ± 6** 57 ± 5** 56 ± 6 51 ± 4** 58 ± 6** 65 ± 7* 
Median 
(Range) 




































Statistical differences are denoted by symbol: * different from senior international, # different from County, & different from competitive road 




Figure 4-1: Weekly run volume by for all (n=119) and by competitive level in Phase A 
analysis.  
Data are presented as median and IQR with the upper and lower ranges shown with dashed 
lines. The mean ± 95% confidence interval is shown with a ■. *illustrates statistically different 
from Senior International (p<0.05) 
 
Figure 4-2: Run frequency (times per week) in all (n=119) and by competitive level in Phase 
A analysis.  
Data are displayed as median and IQR with the upper and lower ranges shown with a dashed 
line. The mean ± 95% confidence interval is shown with a ■. *Represents statistically different 





Table 4-3: Prevalence of each fracture overall and by group 









ALL 119 23% (27) 15% (18) 35% (42) 3% (3) 
Senior 
International 
9 44% (4) 0% (0) 44% (4) 0% (0) 
Junior 
International 
16 44% (7) 19% (3) 56% (9) 6% (1) 
National 48 13% (6) 15% (7) 25% (12) 2% (1) 
Provincial 5 40% (2) 0% (0) 40% (2) 0% (0) 
County 5 20% (1) 20% (1) 40% (2) 0% (0) 
Competitive 
road racing 
20 25% (5) 25% (5) 45% (9) 5% (1) 
Recreational 16 13% (2) 13% (2) 25% (4) 0% (0) 
 
Group comparison based on stress fracture status: 
Age, body mass and training volume violated the assumption of normality. Group 
differences were evaluated by non-parametric Mann-Whitney U. Median (IQR) and 
range are shown in Table 4-4.  
 
Table 4-4: Age, mass and run volume by stress fracture status 



























Age did not differ between groups (p=0.914, d=0.02). Body mass was 7% higher in 
the non-stress fracture group (p=0.006, d=0.5). Run volume was 20% lower in the 
non-stress fracture group (p=0.002, d=0.6).  
 
Group comparison based on any (stress or fragility) fracture 
Assumption of normality was violated in at least one fracture group. Data was 
analysed by non-parametric Mann-Whitney U. Group medians and ranges are shown 
in Table 4-5.  
Table 4-5: Age, mass and run volume by fracture status 






















*indicates statistically significant (p<0.05) difference from no stress fracture group 
 
Fracture status groups did not differ in age (p=0.650, d=0.1) or mass (p=0.153, d=0.3). 
Run volume was 17% higher in the fracture group (p=0.009, d=0.5).  
 
4.3.2 Phase B 
Participant characteristics 
39 participants attended for DXA assessment of BMD and body composition. 
Anthropometry and run training is presented in Table 4-6. This cohort included 3 (8%) 
senior internationals, 7 (18%) junior internationals, 16 (41%) national level athletes, 
4 (10%) who compete at a provincial level, 2 (5%) at county, 3 (5%) at a competitive 





Table 4-6: Characteristics of participants recruited to Phase B analysis (n=39) 
 Mean ± SD Range 
Age (y) 24 ± 5  18-35.8 
Height (m) 1.67 ± 0.05 1.56-1.78 
Mass (kg) 57.6 ± 6.0 45.8-69.3 
BMI (kg.m-2) 20.6 ± 1.9 17.9-26.1 
LMI (kg.m-2) 15.5 ± 0.8 13.6-17.5 
FMI (kg.m-2) 4.3 ± 1.6 1.9-10.5 
% region fat 21 % ± 6 %  11-40 % 
BMD L1-L4 (g.cm-2) 1.13 ± 0.14 0.84-1.55 
Left femoral neck BMD (g.cm-2) 1.04 ± 0.12 0.83-1.27 
Left total hip BMD (g.cm-2) 1.06 ± 0.11 0.85-1.28 
Right femoral neck BMD (g.cm-2) 1.06 ± 0.11 0.85-1.26 
Right total hip BMD (g.cm-2) 1.08 ± 0.11 0.88-1.30 
Run frequency (times.w-1) 6 ± 2 3-11 
Run volume (km.w-1) 67 ± 21 40-130 
 
Prevalence of poor bone health 
Prevalence of low BMD and fracture history is presented in Table 4-7.  
Table 4-7: Fracture history and low BMD prevalence amongst Phase B (n=39) 
 Fracture Low BMD 





n 11 4 14 1 12 4 1 12 
% 28 10 36 3 31 10 3 31 
 
Agreement of indices of poor bone health  
Table 4-8: Number of FDR with and without fracture/ low BMD 
 Fracture No fracture Total 
No low BMD 12 15 27 
Low BMD 2 10 12 




62% of the cohort had at least one positive index of poor bone health (either fracture 
history or low BMD). Excluding fragility fractures an index of poor bone health was 
evident in 54%.  
 
BMD had a sensitivity of 14% and a specificity of 60% to detect FDR with a history 
of fracture.   
 
Group differences according to bone health status 
Age, mass, run volume and L1-L4 BMD violated assumption of normality. Group 
differences between those with an indication of poor bone health (n=24) and without 
(n=15) were examined by non-parametric Mann-Whitney U. Lean mass and hip BMD 
(mean femoral neck and mean total) was examined by independent samples t-test.  
 
Age did not differ statistically between those with or without an index of poor bone 
health (p=0.065 d=0.5). Mass was 7% lower in FDR with poor bone health compared 
to those without (p=0.018, d=0.7) (Figure 4-3A). There was no difference in total lean 
mass (p=0.100, d=0.6) (Figure 4-3B).  
 
Run volume did not differ between groups (p=0.703, d=0.04) (Figure 4-4) 
 
L1-L4 BMD was 8% lower (p=0.001, d=1.1) in group with a fracture. Total hip BMD 
(p<0.001, d=0.9) and femoral neck BMD (p<0.001, d=0.8) were both 8% lower in the 







Figure 4-3: Mass (A) and lean mass (B) (kg) by group with or without poor bone health 
Group without (n=15) and with (n=24) index of poor bone health (any fracture or low BMD 
are displayed in white and grey respectively). Data is shown as median and IQR with the 
upper and lower range indicated by dashed lines. Mean ± 95% CI is shown with ■. *indicates 
statistically significant (p<0.05) group difference.  
 
 
Figure 4-4: Run volume (km.w-1) in groups by bone health status  
(n=15) for poor bone health and (n=24) for those without an index of poor bone health. Data 
are presented as median and IQR with the upper and lower values shown with a dashed line. 




Table 4-9: Site specific BMD by bone health status  
BMD Normal bone health 
(n=15) 
Poor bone health 
(n=24) 
L1-L4 (g.cm-2) Mean ± SD 
Median (IQR) 
1.933 ± 0.117 
1.150 (0.140) 




Mean ± SD 
Median (IQR) 
1.106 ± 0.079 
1.125 (0.151) 
1.017 ± 0.118* 
0.993 (0.180) 
Mean total hip 
(g.cm-2) 
Mean ± SD 
Median (IQR) 
1.126 ± 0.081 
1.134 (0.124) 
1.032 ± 0.113* 
0.991 (0.194) 
*indicates statistically significant (p<0.05) group difference for the appropriate statistical test.  
 
Group differences by fracture or BMD status 
Table 4-10: Group differences by fracture and BMD status 
All data are presented as mean ± SD 
 Fracture history (stress/ 
fragility fracture) 









Age (y) 23.9 ± 4.9 25.2 ± 5.7 24.2 ± 5.2 24.8 ± 5.3 
Mass (kg) 58.4 ± 6.0 56.1 ± 6.3 58.9 ± 6.2 54.6 ± 4.8* 
Lean mass (kg) 43.4 ± 3.3 43.2 ± 4.2 44.2 ± 3.8 41.2 ± 2.7* 
Run volume (km.w-1) 63.1 ± 19.7 75.3 ± 23.1 68.3 ± 21.4 65.6 ± 22.4  
L1-L4 (Z-score) -0.6±1.1 -0.1±1.1 0.1±0.9 -1.7±0.5 
L1-L4  
(g.cm-2) 
1.112 ± 0.141 1.169 ± 0.144 1.199 ± 0.114 0.983 ± 0.064 
0.995* 
Left femoral neck Z-score 0.3±0.9 0.6±1.0 0.8±0.8 -0.5±0.5 
Right femoral neck Z-
score 
0.5±0.9 0.7±0.9 1.0±0.6 -0.4±0.6 
Left femoral neck (g.cm-2) 1.030±0.109 1.065±0.129 1.095±0.096 0.925±0.066* 
Right femoral neck (g.cm-2) 1.052 ± 0.110 1.075 ± 0.110 1.113 ± 0.082 0.942 ± 0.067* 
Left total hip (Z-score) 0.3±0.9 0.7±0.9 0.9±0.7 -0.5±0.4 
Right total hip (Z-score) 0.5±0.9 0.8±0.8 1.0±0.7 -0.4±0.4 
Left total hip (g.cm-2)  1.047±0.110 1.087±0.108 1.115±0.086 1.130±0.083* 
Right total hip (g.cm-2) 1.062 ± 0.114 1.099 ± 0.101 1.130 ± 0.083 0.952 ± 0.045* 





Split by fracture history (yes or no) age and run volume violated the assumption of 
normality, indicated by histogram, non-parametric statistics were used. Mass, lean 
mass, and BMD were assessed by independent samples t-test.  
 
By BMD status age, run volume, L1-L4 BMD violated assumption of normality and 
group differences were examined by Mann Whitney U test. Mass, lean mass, and 
BMD (femoral neck and total hip) were evaluated by independent samples t-test.  
 
4.4 Discussion 
The primary aim of this study was to assess the prevalence of poor bone health 
amongst FDR. Prevention of fracture is the ultimate aim of any bone health screening 
or treatment strategy. This study assessed the prevalence of history of fractures that 
occur in response to low trauma incident (fragility fracture) or repetitive (stress 
fracture) loads up to the time of data collection (childhood fractures were not omitted). 
Amongst 119 FDR 35% reported history of at least one fracture, including 23% with 
stress fracture history and 15% with history of fragility fracture. BMD, a widely used 
index of bone health, was evaluated in a sub-group of 39 FDR. A similar fracture 
history of 36% was observed amongst this cohort. Low BMD was found in 28% of 
this cohort but there was discordance between those with low BMD and those with 
fracture history. Of the sub-group for whom BMD and fracture history was available 
62% reported fracture history and/ or had low BMD.  
 
The history of stress fracture amongst 23% of FDR is about a third lower than the 31% 
reported by Kelsey et al. (2007) amongst cross country runners (aged 18-26 y), with a 
similar sample size (n=127). Average run volume was ~20% higher in the Irish group 
(67 ± 21 km.w-1) compared to that reported by Kelsey et al. (2007) (56 ± 18 km.w-1). 
Heikura et al. (2018) report stress fracture history in 60% of national and world class 
level athletes, where run volume (94 ± 30 km.w-1) was 39% higher than the cohort 
studied in this thesis. Greater run volume would result in greater exposure to loading 
(through prolonged and/ or more frequent training) which could incur micro damage, 
increasing fracture risk. Such a concept (although at much lower volumes) has been 
reported in adolescent runners (Tenforde et al., 2013) where run volume >32 km.w-1 
had a hazard ratio of 2.32. Prolonged exercise is unlikely to elicit osteogenic benefits 
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beyond those incurred during short exercise bouts due to a ‘diminishing returns’ effect 
(Frost, 2003). This may result in a failure of bone to adapt sufficiently to enable it to 
withstand the greater number of loading cycles and associated micro damage.  
 
The frequent occurrence of stress fracture (28.59 injuries per 100,000 athlete 
exposures) and relatively long recovery time (with ~70% stress fractures requiring 
participation restriction of >21 days including ~35% season ending injuries amongst 
collegiate cross country FDR) (Rizzone et al., 2017) are reasons for research to 
examine stress fracture aetiology. Stress fractures occur in response to habitual 
activities of FDR. In contrast fragility fractures will require a fall from standing height 
or less. Such falls are less likely to occur in young athletic individuals engaged in 
habitual physical activity than in older adults with inferior balance and strength. 
However amongst the 119 FDR 15% had a history of fragility fracture. Whether this 
differs to that expected at this life stage requires further research. The fractures 
reported by participants in this thesis were not time bound i.e. childhood and 
adolescent fractures could also be included but were not specified. Due to elevated 
fracture incidence in the years surrounding peak height velocity (40% greater per 
10000 person years) (Cooper et al., 2004) the absence of time bounds is a limitation. 
Should the fractures have occurred peri-growth they may not be indicative of poor 
bone health but rather of a transient period of elevated risk.   
 
Prevalence of low BMD amongst the studied cohort (31%) was double what would be 
statistically expected in a young population (~15% (Kanis, 2002)). It was in line with 
the prevalence reported by McCormack et al. (2019) (~36%, n=33) who also reported 
stress fracture history of 18%. The lumbar spine Z-score of -0.6 ± 1.1 reported by 
McCormack et al. (2019) was similar to the -0.4 ± 1.2 in the Irish cohort. Z-scores 
were also similar to AMEN FDR (-0.3 ± 0.9) reported by Heikura et al. (2017b). 
Heikura et al. (2017b) reported a mean Z-score of 0.3 ± 0.8 in EUMEN, a group who 
had a lower history of repeat stress fractures (23% vs 46%) or any stress fractures 
(55% vs 69%). The group mean amongst the Irish cohort is more comparable to a sub-
group of FDR with elevated risk of fracture. Menstrual status was not assessed 
amongst the Irish cohort preventing more in-depth comparison or a comparison within 





McCormack et al. (2019) reported two (33%) of the FDR with history of stress fracture 
had a Z-score <-1. In the Irish group 18% (2/11) of the FDR with stress fracture had 
low BMD with no low BMD amongst those with history of a fragility fracture. The 
poor sensitivity (14%) and specificity (60%) of BMD to identify people with fracture 
history instigates questions regarding its suitability as a fracture risk assessment 
method amongst FDR. In particular a sensitivity of 14% indicates that BMD offers an 
incomplete explanation for fracture risk. This study accounted for an expected higher 
BMD in FDR, athletes who engage in regular weight bearing exercise, through use of 
Z-score cut-offs suggested by the ACSM (Nattiv et al., 2007) and IOC (Mountjoy et 
al., 2014) rather than ISCD (2019). The adjustment would be expected to improve the 
sensitivity of BMD. Based on the sensitivity amongst a small cohort, BMD does not 
appear to be a measure which would be beneficial to implement in a widespread 
screening programme. Although the value of screening programmes in sport has been 
questioned by Bahr (2016). In the general population screening aims to identify 
individuals without overt symptoms of the disease so that early intervention which is 
more beneficial is possible (Wilson and Jungner, 1968). For this reason BMD 
screening in athletes where the population is considered at risk of poor bone health 
e.g. female athletes in endurance or aesthetic sports (Nattiv et al., 2007) may be 
warranted. However for the purpose of preventing injury, screening may have less 
value (Bahr, 2016). A screening test where the test variable and injury risk are strongly 
related may be able to delineate between individuals with risk and low risk of injury. 
However in many cases there will be overlap in the test scores of injured and uninjured 
individuals (Bahr, 2016). This was evident amongst the studied cohort where the 
specificity of BMD to identify individuals with fracture history was 60%, admittedly 
in a small sample.  Bahr (2016) advocates for consideration of whether an intervention 
is of greater benefit (or of cost) to a high risk individual over a low risk individual. 
The argument for screening is strengthened where the cost (financial or time) of an 
intervention is considerable with limited benefits (health and performance). In the case 
of bone health, lifestyle interventions are recommended to address known risk factors 
(LEA and menstrual dysfunction) (De Souza et al., 2014a). Education around the 
importance of EA and normal menstrual function, and with intent to improve 
nutritional knowledge can serve as a preventative programme and may have additional 
benefits in supporting performance and health as outlined in the RED-S consensus 
statement (Mountjoy et al., 2014). Identifying individuals at risk for the purpose of 
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intervention therefore does not appear to be of great value. Furthermore fracture risk 
is influenced by numerous biological (female sex, genetics, menstrual dysfunction, 
low energy availability) and biomechanical (training patterns, anatomic differences) 
factors (Tenforde et al., 2016). Reliance on BMD alone as a screening parameter 
negates this multi-factorial aetiology.  Instead consideration of risk factors and use of 
screening questionnaires to identify people for whom BMD screening may be of 
elevated benefit would be appropriate. The TRIAD Coalition Return to Play 
recommendations (De Souza et al., 2014a) and RED-S Clinical Assessment Tool 
(CAT) (Mountjoy et al., 2014) are examples of tools which can assist in this decision 
making.  
 
Between group comparisons showed that FDR who had poor bone health had lower 
body mass (7%) and BMD (L1-L4, femoral neck and total BMD) (8%). No group 
differences existed between fracture and non-fracture group. BMD (L1-L4 (15%)), 
femoral neck (15%) and total hip BMD (16%)) were all lower in the low BMD vs not 
low BMD group, as expected. Mass (7%) and lean mass (7%) were also lower in the 
low BMD group. Group BMD difference by bone health status (any index) is in line 
with the expectation that BMD is a risk factor for fracture and by definition would be 
lower amongst the low BMD group. BMD (total body, spine, hip) has rate ratios of 
1.69-1.89 per standard deviation (site dependent) for stress fracture in FDR (Kelsey et 
al., 2007). However Duckham et al. (2012) reported no difference in BMD in groups 
stratified by stress fracture status. Duckham et al. (2012) findings are more similar to 
those observed amongst the Irish cohort when stratified by fracture status. These 
findings support the aforementioned limitations of BMD to detect fracture risk.  
 
Lower mass (7%), observed in the low BMD and poor bone health groups relative to 
their ‘normal’ controls, reduces the absolute load on the skeleton during ambulation; 
lower lean mass (7% lower observed in the low BMD group) is likely to decrease 
muscular forces exerted on the skeleton. Hypothetically this would reduce the 
osteogenic effect of exercise (or everyday activities), requiring less BMD to distribute 
habitual loads, a concept of the mechanostat theory (Frost, 2003). Kelsey et al. (2007) 
reported elevated fracture risk with lower body mass (risk ratio: 1.08 per kg decrease) 
and BMI (risk ratio: 1.20 per 1 kg.m-2 decrease). Lower BMI (18.7 vs 20.0 kg.m-2, 




without and a BMI < 19 kg.m-2 is associated with >2.6 times greater risk of fracture 
(hazard ratio 2.76 in a univariate model and 2.67 in a multivariate model) (Tenforde 
et al., 2013). Mass, lean mass and fat mass were all associated with BMD amongst 
adolescent FDR (Tenforde et al., 2015). Duckham et al. (2012) did not observe any 
difference in mass between stress fracture or non-stress fracture groups. The effect of 
mass on bone health is unclear based on the data presented in this thesis and previously 
published reports. It may be dependent on the index of ‘bone health’, supporting the 
need to have an appropriate, sensitive measure of fracture risk. 
 
Perhaps of greater interest is training which would result in greater exposure to loading 
(through number of impacts with increased run volume). Within Phase A training 
volume was 17% higher in the fracture group exposing FDR to greater loading with 
unlikely osteogenic benefits as mentioned earlier in this discussion. However no 
training differences were observed in Phase B (any stratification). Duckham et al. 
(2012) did not observe any differences either. Despite the loading incurred through 
training (with each foot strike) much research has focused on intrinsic factors (BMD, 
TRIAD factors) rather than extrinsic. This may be linked to the necessity (or perceived 
necessity) to engage in training as currently completed by FDR, essentially making 
training an unmodifiable risk factor and making an understanding of the role of bone 
more important. However should training sensitise bone to other factors (perhaps 
through altered bone metabolic activity) it needs to be considered in order to protect 
the long term health of FDR.  
 
The primary aim of the study was to quantify the burden of poor bone health amongst 
FDR through assessment of fracture history and BMD amongst FDR. Characterisation 
of the participants was a secondary outcome. Training in particular was considered in 
light of the central thesis aim to examine the role of exercise in bone health, 
particularly whether bone metabolism is altered in a habitually active population. 
Although the observed differences are largely in line with the published literature 
neither menstrual function nor EA were assessed in either Phase A or Phase B of the 
study. Both menstrual dysfunction and LEA are known risk factors for both fractures 
and low BMD. Heikura et al. (2017b) report 5% lower BMD in AMEN vs EUMEN 
national-world class FDR. Exercising girls and women with low BMI (<21.0 kg.m-2) 
and elevated dietary restraint (assessed by Eating Disorder Inventory) (both indicative 
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of LEA) had 3.4 times greater odds of developing a bone stress injury (Barrack et al., 
2014). In three factor analysis of fracture risk ≥12 h.w-1 exercise, and low BMI along 
with either elevated dietary restraint, participation in a leanness sport (including 
endurance running) or OLIGO/AMEN resulted in 4-5 times greater odds of a bone 
stress injuries during follow up (Barrack et al., 2014). Causal relationships of factors 
affecting bone was not an aim of this study. However assessment of menstrual function 
and EA status (through validated questionnaire e.g. LEAF-Q (Melin et al., 2014)) 
would enable further analysis and assessment of prevalence of established risk factors. 
In an expansion of this study (to attain a larger dataset), consideration of established 
risk factors should be incorporated.  
 
4.5 Conclusion 
35% of FDR reported history of fracture. The widely experienced injury which incurs 
lost sport participation and an increased risk for subsequent fracture (Rizzone et al., 
2017, Kelsey et al., 2007) indicates a need to identify FDR at risk of fracture. Amongst 
a representative sub-group 31% had low BMD at the spine. However there was 
incongruence between the participants with fracture history and those with low BMD. 
The sensitivity of BMD to correctly identify individuals with fracture history was 14% 
indicated that alone it is not an appropriate tool for screening. Consideration of BMD 
with risk factors may be more appropriate. The presence of fracture history amongst 
one third of participants and prevalence of low BMD amongst almost a third of the 
representative sub-group along with the discordance between BMD and fracture is 
indicative of a considerable health burden amongst FDR . 
 
Injuries are multi-factorial, with intrinsic and extrinsic risk factors; training load, 
biomechanical patterns, and presence of TRIAD factors (low BMD, menstrual 
dysfunction, LEA) have been identified as risk factors for stress fracture. Phase A 
participants with fracture and stress fracture respectively had 17% and 20% higher 
training volumes compared to their respective non-fracture groups, suggesting that 
training could be a risk factor. Lower mass (in fracture group in Phase A, in low BMD 
group and poor bone health group in Phase B) could also decrease the load on the 
skeleton, reducing the need for osteogenic effect of exercise. Although risk factors 




differences in bone health status, the mechanisms through which exercise itself may 
alter the magnitude of effect of these risk factors are not well understood. Acquisition 
of such an understanding will be required in order to develop and assess the efficacy 
of strategies to reduce prevalence of poor bone health amongst FDR.  
 
Considering the poor sensitivity of BMD an alternative, or adjunct, measure of bone 
health may be more appropriate. Elevated bone metabolism is an independent risk 
factor for fracture (Heaney, 2003). Acute increases in bone resorption have been 
observed in response to exercise (Kohrt et al., 2018). Repeated exposure to an exercise 
stimulus, as occurs in FDR, could alter bone metabolism providing a potential 
explanation for the discordance between BMD and fracture risk. Altered bone 
metabolic rate could also potentiate or dampen the effect of other factors (that may 
induce uncoupling). A preliminary examination of bone metabolism in FDR and a 




Chapter 5: Habitual bone metabolism in female distance 





18%-60% of collegiate (McCormack et al., 2019, Tenforde et al., 2017), young adult 
(18-26 y) (Cobb et al., 2007), and national-world class (Heikura et al., 2017b) distance 
runners report history of stress fracture. As shown in Chapter 4 history of stress 
fracture amongst Irish FDR (18-35 y) is 23%; 35% of FDR report at least 1 stress or 
fragility fracture. Amongst the national-world class cohort (stress fracture history: 
60%) (Heikura et al., 2017b) and collegiate FDR (stress fracture history: 38%) 
(Tenforde et al., 2017) prevalence of low BMD was ~17%. In a sub-group of Irish 
FDR (n=39, Phase B Chapter 4) 18% of the 36% who had a history of fracture also 
had low BMD, 36% of those with no fracture history had low BMD. Sensitivity and 
specificity of BMD to identify those with fracture history was 14% and 60% 
respectively. This suggests that BMD may be insensitive as a measure of fracture risk 
amongst FDR. 
 
As already outlined in Chapter 2 BMD has limitations, largely deriving from its static 
representation of a dynamic process. Bone metabolic activity, is an independent 
predictor of fracture (Heaney, 2003). Accelerated bone metabolism which can be 
measured using BTMs is evident at times of greater fracture risk (childhood (Szulc et 
al., 2000) and post-menopause (Shieh et al., 2016)). Bone resorption marker, CTX is 
double baseline concentration post endurance exercise (cycling in trained males), a 
response that is maintained for 4 h post exercise (Kohrt et al., 2018). However this 
effect appears to dissipate and exercise induced differences are not evident in a fasted 
morning samples 23 h post exercise (60 min running) (Scott et al., 2011) i.e. 
homeostatic bone metabolism is unaltered in response to a single exercise bout.  
 
Athletes engage in frequent exercise, with potential for daily or multiple times daily 
perturbations in bone metabolism. If such exposures alter homeostatic bone 
metabolism, this may provide an explanation for fracture in the absence of low BMD 
amongst FDR. In endurance athletes (cross country skiers and biathletes) CTX was 
39% greater compared to CON (Herrmann and Herrmann, 2004). However Bennell et 
al. (1997) report no difference in BTMs between collegiate runners (male and female, 
17-26 y) and CON. Similarly Zanker and Swaine (1998) reported no difference in 
bone formation or resorption in EUMEN FDR compared to CON. But in male runners 
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concentrations of resorption (PYD and DPD normalised to creatinine concentration) 
and formation (osteocalcin) were 120-135% that of CON (Hetland et al., 1993). No 
definitive effect of exercise on bone metabolism can be ascertained from these mixed 
results. These studies were published prior to the IOF’s recommendation for the 
inclusion of reference markers (Vasikaran et al., 2011a) and a mix of markers which 
could represent different phases of formation/ resorption could contribute to the 
inconclusive findings. Most of the reports used spot sample urinary resorption markers 
normalised to creatinine concentration, which is no longer recommended due to the 
additional variation from correcting marker concentration to creatinine concentration 
(Vasikaran et al., 2011b). Additionally reliance on a single sample could fail to capture 
a valid representation of bone metabolic activity, particularly when sampled >24 h 
post exercise i.e. athletes are removed from their ecological norm. Townsend (2016) 
used the reference markers proposed by the IOF (CTX and P1NP) and measured 
BTMs on five consecutive days in elite triathletes during a pre-season training phase. 
Concentrations were interpreted as being above a recreationally active reference range 
(generated from prior studies at Nottingham Trent University) in 13/16 participants 
indicative of greater bone metabolic activity in triathletes. However it should be noted 
that only four and three of these participants consistently had CTX and P1NP above 
the +1SD of the reference range. To this author’s knowledge habitual bone 
metabolism, measured across a time frame capturing representative activities, using 
recommended reference markers, has not been assessed in FDR.  
 
Acute studies of exercise induced responses (Kohrt et al., 2018) and comparisons of 
habitual metabolic activity in athletes vs non-athletic controls inform the effect of 
exercise on bone metabolic activity. However neither approach captures the net effect 
of exercise on daily bone metabolism. Continued monitoring for a 24 h epoch 
including exercise is required for this. Attempting this with the blood borne markers 
CTX and P1NP is invasive, impractical and expensive. It is an unsuitable approach in 
free living athletes.  However, understanding of the net effect of exercise on daily bone 
metabolic activity will help to inform its adaptive or maladaptive effect, particularly 
if concurrent with an assessment of homeostatic bone metabolism. Understanding this 





Although 24 h blood sampling is invasive, 24 h urine collection allows measurement 
of resorption markers. This captures the total daily resorption including responses to 
lifestyle within the measurement epoch. A urine based formation marker is currently 
unavailable. Acute resorption responses to exercise appear more pronounced and 
provide a starting point to understanding habitual bone metabolism in FDR.  
 
This study aims to assess the effect of habitual exercise on bone metabolic activity 
through comparison of two populations with distinct exercise habits: FDR and CON. 
Both homeostatic bone metabolic activity (resorption and formation) and total (24 h) 
resorption are studied. Participants were studied over a time frame that captures 
habitual variation in physical activity (7 d) to provide an ecologically valid 
representation of bone metabolism.  
 
The following research questions are addressed within this chapter: 
1. Is there a difference in homeostatic bone metabolic activity between FDR and 
CON? Differences can occur in: 
a. Resorption  
b. Formation  
c. Metabolic activity (turnover rate) 
d. Balance of resorption and formation  
2. Is there a difference in 24 h resorption between FDR and CON? 
3. Does the variation of BTMs differ between FDR and CON? 
4. Does 24 h resorption differ between EX and NONEX or is there an interaction 
effect (group*type of day)? Type of day refers to EX or NONEX. Group refers 
to FDR or CON.  
 
5.2 Methods 
The study design and participant criteria was described in section 3.3. Briefly FDR 
(n=7) with a training age ≥2 years, weekly training volume ≥60km.w-1 and not 
exceeding 3 h.w-1 of NWBE, and CON (n=11) (engaged in a general physical activity 
programme not exceeding 3 h.w-1 of vigorous (>6.0 METS) physical activity were 
assessed for seven days. Seven days was chosen to capture typical variations in weekly 
physical activity. Bone metabolism, energy expenditure, training and dietary intake 
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were assessed each day as described in Chapter 3. Body composition and bone density 
of spine and hip were also assessed by DXA on one day, using the methods described 
in Chapter 3.  
 
Within this chapter the criteria for valid samples and analysis methods for the research 
questions are detailed.  
 
5.2.1 BTM data validity  
Creatinine excretion (mmol.kg-1LTM.d-1) was used as an index of urine sample 
validity (verification of volume). Creatinine is formed, and subsequently excreted, 
following the breakdown of a fraction of creatine, stored in the muscle pool. 
Approximately 2% of creatine will be converted to creatinine per day. In healthy 
individuals 24 h creatinine excretion will therefore be constant and will be related to 
muscle mass (Heymsfield et al., 1983).  
 
24 h creatinine output (amount) has an intra-individual variation of 11% and an ideal 
analytical variation ≤5.5% (Ricos et al., 2004). The total variation is therefore 12.3% 
calculated using the following equation: 
!"# = !"%& + !"(& 	 
Equation 5-1: Total variation derived from analytical and intra-individual variation 
Where CVT is the total variation, CVA is the analytical variation and CVI is the intra-
individual variation with all variation expressed as coefficient of variations. The CV 
of each participant’s creatinine output per kilogram lean mass across the week was 
calculated as shown in Equation 5-2. 
*+
,-./×100 
Equation 5-2: Intra-individual CV. SD and mean refer to individual’s SD and mean 
 
Where the CV for any participant was >12.3%, the daily amounts were examined. An 
inconsistency was most likely to arise from a sample that was not disclosed as 
incomplete by a participant. Therefore the lowest creatinine value was removed. In all 
except two cases this resulted in the CV returning to within the expected range. One 




this sample. The CV for this participant including this sample was 20.3% (60% higher 
than expected). Upon inspection each of the urinary BTM amounts on this day were 
also at least 30% greater than all other days. The day in question was a NONEX day 
in a participant with 2/7 EX days. This sample was therefore removed from analysis 
as a precaution. An undocumented error may have arisen during sample analysis. One 
participant (CON) was entirely removed from the analysis of urinary BTMs due to 
variation in creatinine excretion greater than expected with no two days falling within 
the agreed range. Three reported values were also >0.1 mmol.kgLTM-1.d-1, lower than 
any other participant, including a participant with a vegan diet. 
 
Blood samples were deemed valid if all pre-test conditions were adhered to. 
Compliance with pre-test instructions was checked daily and food diaries/ training 
logs were also used to confirm no training occurred or food was consumed pre blood 
sample. Three samples were omitted – one due to consumption of coffee ~3 h prior to 
sample (circa 5 am), one due to completing an exercise session on the morning of 
testing and one due to sample timing as participant was late (>90 min).  
 
5.2.2 Data analysis 
Statistical approach 
Inference testing completed using SPSS v25 (IBM SPSS Statistics). Effect sizes are 
also reported in this thesis with 95% confidence intervals shown in graphs. Effect sizes 
were calculated as cited by Cohen (1992) (Equation 5-3).  
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Equation 5-3: Effect size calculation 
Effect sizes can then be classified as small (0.20), medium (0.50) and large (0.80). If 
data violated the assumption of normality a non-parametric Mann Whitney U was used 
to compare groups. Effect sizes for non-parametric tests were calculated using an 
online calculator (Lenhard and Lenhard, 2016). Confidence intervals were calculated 
for each variable in excel (Equation 5-4). 








Prior to inference analysis distribution of data was examined using visual inspection 
of histograms and analysis with Shapiro-Wilk test. As expected based on published 
reference ranges (de Papp et al., 2007, Glover et al., 2009) BTMs were skewed toward 
the lower values and non-parametric statistics were used accordingly.  
 
Group comparisons 
Initial group comparisons were performed independent of participant. However this 
violates the independence of observations assumption of the t-test, or non-parametric 
Mann Whitney U. Within participant means were calculated and the effect size for a 
between groups comparison is reported. 
 
Effect of exercise 
To account for differences in frequency of exercise, mean type of day (EX and 
NONEX) values for each participant were used. Differences in BTMs by type of day 
were compared by Wilcoxon Rank test. To compare if groups differed in their 
response to EX a two factor ANOVA was used (group*type of day). As BTMs violate 
the assumption of normality they were log transformed to achieve an approximately 
normal distribution prior to analysis.  
 
Bone marker plot 
Bone metabolism can change in magnitude or in coupling. The bone marker plot 
(Bieglmayer and Kudlacek, 2009) has been developed to capture both rate and 
direction using both a marker of formation and resorption (blood borne – CTX and 
P1NP). Accounting for the skewed distribution of BTMs, the bone marker plot assigns 
a score to each data point based on the median. Moment of median (MoM) are 









Plotting the MoMF against MoMR produces a vector. The balance of bone turnover 
(referred to as bone balance in the results) can then be calculated as the vector’s slope 





Equation 5-6: Vector slope (balance) 
The vector’s length represents the turnover rate (Equation 5-7). MoMs were calculated 
using the median of CON NONEX.  
(,>,L& + ,>,M&). 
Equation 5-7: Vector length  
 
BTM variation 
Variation in BTMs was analysed independent of analytical variation. The intra-
individual variation of each marker within each participant was calculated as shown 




Equation 5-8: Intra-individual variation (CV) 
Inter individual variation was calculated using means for each participant as shown in 





Equation 5-9: Inter-individual variation 
 
Within subject variance was also calculated and used in group comparisons of variance 














5.3.1 Participant and group characteristics  
Table 5-1 shows participant age, anthropometry and the prevalence of low BMD 
defined as a Z-score <-1. Low BMD at the hip was defined as a Z-score <-1 at any site 
(left or right side, femoral neck or total hip). All CON reported EUMEN menstrual 
function. 6/7 FDR reported a current menstrual dysfunction – 4 with current OLIGO 
and 2 with AMEN.   
 








Age (y) 23.9 ± 4.3 24.1 ± 4.6 23.9 ± 4.1  0.1 
Height (m) 1.684 ± 0.053 1.704 ± 0.054 1.671 ± 0.047  0.6 
Mass (kg) 62.2 ± 5.7 58.5 ± 5.5 64.5 ± 4.4 * -1.1 
BMI (kg.m-2) 22.0 ± 2.3 20.2 ± 1.8 23.2 ± 1.8 * -1.3 
LTM (kg) 42.7 ± 4.0 45.8 ± 3.0 40.7 ± 3.3 * 1.2 
FM (kg) 17.0 ± 6.7 10.4 ± 3.1 21.2 ± 4.7 * -1.6 
BMC (kg) 2.5 ± 0.2 2.6 ± 0.3 2.5 ± 0.2 * 0.6 
FFM (kg) 45.2 ± 4.2 48.4 ± 3.1 43.2 ± 3.5 * 1.3 
Region % fat 27 ± 9 % 18 ± 4 % 33 ± 6 % * -1.7 
BMD L1-L4 (g.cm-2) 1.182 ± 0.128 1.145 ± 0.147 1.206 ± 0.109  -0.5 
Mean femoral neck BMD 
(g.cm-2) 
1.029 ± 0.089 1.066 ± 0.073 1.005 ± 0.091  0.6 
Mean total hip BMD (g.cm-2) 1.052 ± 0.087 1.061 ± 0.066 1.047 ± 0.097  0.1 
Low BMD L1-L4 (n (%)) 3 (16.7%) 2 (28.6%) 1 (9.1%)   
Low BMD hip (n (%)) 1 (5.6%) 0 (0.0%) 1 (9.1%)   
All data are displayed as mean ± SD. All variables were normally distributed except for FFM. 
*denotes statistical difference between FDR and CON (p<0.05). d is Cohen’s d where mean A= 
FDR. Therefore negative effect sizes indicate a higher mean in the CON group.  
 
By design FDR had more frequent and higher volume (time and run distance) than 













Run volume (km.w-1) 
 
31.5 ± 34.9 
(0.0-85.0) 
74.4 ± 7.2 
(65.2-85.0) 
4.1 ± 6.5 
(0.0-21.3) 
* 2.0 
Training volume (h) 
 
5.4 ± 3.6 
(0.0-11.1) 
8.9 ± 1.4 
(6.9-11.1) 
3.1 ± 2.7 
(0.0-7.5) 
* 1.6 
VPA training volume (h) 3.4 ± 3.6 
(0.0-9.4) 
7.7 ± 1.0 
(6.3-9.4) 





5 ± 4 
(0-14) 
9 ± 3 
(6-14) 
3 ± 2 
(0-7) 
* 1.6 
VPA training frequency 
(sessions.w-1) 
3 ± 3 
(0-9) 
7 ± 1 
(6-9) 
1 ± 1 
(0-4) 
* 1.9 
Data are presented as mean ± SD with the range presented in brackets. *denotes statistical 





5.3.2 Distribution of BTMs  
Table 5-3 shows the number of samples included in analysis and the measures of 
centrality, dispersion and range for blood and urine based BTMs across the combined 
sample (FDR and CON).  
Table 5-3: Summary of BTMs sampled across 7 days from 7 FDR and 11 (blood BTMs) and 
10 (urine BTMs) CON 








n 119 119 103 103 103 
Mean 0.526 63.83 442.5 62.2 301.8 
SD 0.227 16.33 301.0 35.7 169.9 
Median 0.465 61.66 329.0 51.7 267.4 
IQR 0.333 20.70 343.1 26.9 121.3 
Min 0.196 38.11 85.8 12.1 56.7 
Max 1.360 111.30 1292.9 222.5 1240.7 






5.3.3 Group comparison of bone metabolism  
Group and group*type of day median (IQR) BTM concentration/ amount are shown 
in Table 5-4.  
Table 5-4: Number of samples, median and IQR for blood and urine BTMS in FDR and 
CON on ALL, EX and NONEX days 












n 46 46 42 42 42 
Median 0.393 55.12 434.2 64.0 307.6 
IQR 0.147 32.39 572.7 49.1 156.7 
FDR EX n 41 41 36 36 36 
Median 0.390 55.30 497.2 65.7 330.9 
IQR 0.142 22.45 602.9 52.3 173.3 
FDR 
NONEX 
n 5 5 6 6 6 
Median 0.446 54.93 354.0 60.3 294.7 
IQR 0.130 25.38 303.3 32.8 50.8 
CON 
ALL 
n 73 73 61 61 61 
Median 0.573 64.43 317.6 47.6 234.7 
IQR 0.333 16.73 302.6 19.8 87.2 
CON EX n 27 27 23 23 23 
Median 0.485 63.94 266.2 47.6 234.7 
IQR 0.329 14.78 227.1 22.4 92.4 
CON 
NONEX 
n 46 46 38 38 38 
Median 0.592 64.68 330.6 46.9 234.1 
IQR 0.337 17.25 261.6 18.0 86.5 
Group*condition data presented in this table refers to the absolute number of samples and 
the resultant median (IQR). Results calculated from participant averages are presented in 






Independent of participant CTX concentration (ng.ml-1) was 31% lower in FDR than 
CON (p<0.001, d=0.7) (Figure 5-1). Using a mean value for each participant 
(independent of type of day) a medium effect size (d=0.6) was observed. 
 
 
Figure 5-1: Concentration of fasted morning CTX independent of participant 
Data is shown independent of group (n=119) and split by group: FDR (n=46), CON (n=73). 
Data are displayed as median and IQR with the upper and lower range shown with a dashed 
line. Mean ± 95% CI is represented by ■. *indicates statistically different from FDR 
(p<0.001). 
 
By contrast 24 h uNTX excretion (nM BCE.d-1) was 37% higher in FDR compared to 
CON using a Mann Whitney U test (p=0.033, d=0.4) (Figure 5-2). A medium effect 






Figure 5-2: Amount of NTX excreted in 24 h independent of participant 
Data is shown independent of group (n=103) and split by group: FDR n=42, CON, n=61. 
Data are displayed as median and IQR with the upper and lower range shown by whisker. 
Mean ± 95% CI is represented by ■. *depicts statistically different from FDR (p<0.05). 
 
Fasted, morning concentration of P1NP independent of participant was 15% lower in 
FDR than CON (Figure 5-3) compared by Mann Whitney U (p=0.012, d=0.5). Using 
a mean for each participant a small-medium effect size (d=0.4) was observed.  
 
Figure 5-3: Concentration of fasted morning P1NP independent of participant 
Data is shown independent of group (n=119) and split by group: FDR n=46, CON, n=73. 
Data are displayed as median and IQR with the upper and lower range shown by whisker. 
Mean ± 95% CI is represented by ■.   
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Analysed by Mann Whitney U fDPD (nmol.d-1) excretion per 24 h, independent of 
participant, was 34% greater in FDR than CON (p<0.001, d=0.8) (Figure 5-4). 
Assessed by mean within participant a large effect size (d=1.3) was detected. 
 
Figure 5-4: Amount of fDPD (nmol.d-1) excreted in 24 h independent of participant 
Data is shown independent of group (n=103) and split by group: FDR n=42, CON, n=61. 
Data are displayed as median and IQR with the upper and lower range shown by whisker. 
Mean ± 95% CI is represented by ■. *depicts statistically different from FDR (p<0.001). 
 
Using a Mann-Whitney U test 24 h fPYD (nmol.d-1) was 31% higher in FDR than 
CON (p<0.001, d=0.7) (Figure 5-5). Using a participant mean a large (d=1.1) effect 





Figure 5-5: Amount of fPYD (nmol.d-1) excreted in 24 h independent of participant 
Data is shown independent of group (n=103) and split by group: FDR n=42, CON, n=61. 
Data are displayed as median and IQR with the upper and lower range shown by dashed lines. 
Mean ± 95% CI is represented by ■. *depicts statistically different from FDR (p<0.001). 
 
 
Figure 5-6: Scatterplot showing MoM (resorption) versus MoM (formation) 
Values for FDR NONEX (∆, n=5), FDR EX (▲, n=41), CON NONEX (○, n=46) and CON 




Figure 5-7: Bone balance and bone turnover calculated from MoM 
Scores were calculated  using median of CON NONEX for FDR (n=46) and CON (n=73). 
Data are displayed as median and IQR with the upper and lower ranges shown with dashed 
lines. The mean ± 95% CI is shown as ■ * denotes group difference p<0.05.  
 
MoM for each sample was calculated using the median of CON NONEX for CTX 
(0.592 ng.ml-1) and P1NP (64.68 ng.ml-1). MoM formation and resorption, balance 
and turnover all violated the assumption of normality, all p values reported are based 
on Mann-Whitney U test. Median MoM resorption and formation were 31% (p<0.001, 
d=0.7) and 15% (p=0.012, d=0.5) lower in FDR (MoMF: 0.66 (0.25), MoMR: 
0.85(0.50)) than CON (MoMF: 0.97 (0.56), MoMR: 1.00 (0.26)). The resultant balance 
was 15% higher (p=0.001, d=0.6) in FDR while turnover was 25% (p=0.001, d=0.7) 
lower. Median MoM in both was >1 indicating a positive net effect of bone 





5.3.4 Bone metabolism on EX and NONEX days 
Type of day and group*type of day data is presented in Table 5-5.  
Table 5-5: Sample sizes, median and IQR by condition and group*condition  






ALL EX n 14 14 14 
Median (IQR) 394.3 (403.9) 329.4 (104.6) 56.7 (20.9) 
ALL 
NONEX 
n 16 16 16 
Median (IQR) 304.3 (209.2) 261.4 (68.8) 57.6 (18.7) 
FDR EX n 7 7 7 
Median (IQR) 491.6 (533.3) 340.3 (55.4) 67.5 (37.0) 
FDR 
NONEX 
n 6 6 6 
Median (IQR) 354.0 (303.3) 294.7 (50.8) 60.3 (32.8) 
CON EX n 7 7 7 
Median (IQR) 347.0 (265.8) 243.6 (70.9) 50.6 (12.4) 
CON 
NONEX 
n 10 10 10 
Median (IQR) 296.7 (152.1) 247.9 (67.0) 49.7 (18.9) 
All data is based on the mean value for each participant in each condition.  
 
Using mean values for EX and NONEX for each participant there was no difference 
in uNTX by type of day (p=0.701, d=0.2). Data violated the assumption of normality. 
Log transformed data analysed by ANOVA showed no group*type of day interaction 





Figure 5-8: Amount of 24 h uNTX (nM BCE.d-1) by group and condition 
CON NONEX (n=10), CON EX (n=7), FDR NONEX (n=6), FDR EX (n=7). Data are 
displayed as median and IQR with the mean ± 95% CI shown with ■. Dashed lines show the 
upper and lower ranges.  
 
Type of day comparison using mean participant values for each type of day showed 
no difference in fDPD (p=0.861, d=0.1). Analysed by ANOVA no group*type of day 
interaction was observed for log transformed data (p=0.530) for fDPD (Figure 5-9).  
 
Figure 5-9: Amount of 24 h fDPD (nmol.d-1) by group and condition 
CON NONEX (n=10), CON EX (n=7), FDR NONEX (n=6), FDR EX (n=7). Data are 
displayed as median and IQR with the mean ± 95% CI shown with ●. Dashed lines show the 




fPYD analysed as mean for each participant for type of day (EX, NONEX) showed no 
difference by type of day (p=0.701, d=0.2). No interaction (group*type of day) was 
observed for log transformed fPYD data (p=0.555) (Figure 5-10). 
 
 
Figure 5-10: Amount of 24h PYD (nmol.d-1) in by group and condition 
CON NONEX (n=10), CON EX (n=7), FDR NONEX (n=6), FDR EX (n=7). Data are 
displayed as median and IQR with the mean ± 95% CI shown with ●. Dashed lines show the 
upper and lower ranges. 
 
5.3.5 Within and between subject variation in BTMs 
Total intra-individual biological variation for CTX was 8.8 ± 3.7% (median: 8.8%, 
range 1.1%-15.8%). The intra-individual variation for FDR (8.6% ± 4.6%; median: 
8.5%, range 1.1%-14.8%) and CON (8.9% ± 2.9%; median: 8.8%, range: 4.0%-
15.8%) was similar. Using mean values for each participant (to account for unequal 
numbers of sample days between participants) inter-individual variation was 41.6% 
for all, 29.3% amongst FDR and 41.4% amongst CON. Daily concentration of CTX 
is illustrated in Figure 5-11 (FDR) and Figure 5-12 (CON). Data are represented 
relative to day of the week (1=Monday, 2 = Tuesday) rather than study day. This 
applies to Figure 5-12 – Figure 5-20. There was no difference in variance of CTX 
between groups (FDR: 0.00148 (0.00159), CON 0.00209 (0.00671)) analysed by 





Figure 5-11: Daily concentration of CTX concentration (ng/ml) in fasted morning blood 
samples in 7 FDR (n=46).  
Data are displayed as daily concentration by participant (colour). Condition is illustrated by 
shape: ○ represents EX days (n=41), □ represents NONEX days (n=5).  
 
 
Figure 5-12: Daily concentration of CTX concentration (ng/ml) in fasted morning blood 
samples in 11 CON (n=73).  
Data are displayed as daily concentration by participant (colour). Condition is illustrated by 






Figure 5-13: Daily concentration of P1NP in fasted morning samples in 7 FDR (n=46).  
Data are displayed as daily concentration by participant (colour). Condition is illustrated by 
shape: ○ represents EX days (n=41), □ represents NONEX days (n=5).  
 
Figure 5-14: Daily concentration of P1NP in fasted morning samples in 11 CON (n=73).  
Data are displayed as daily concentration by participant (colour). Condition is illustrated by 
shape: ○ represents EX days (n=27), □ represents NONEX days (n=46).  
 
Total intra-individual biological variation for P1NP was 5.4% ± 1.7% (range 3.1%-
8.6%). Intra-individual was similar amongst FDR (5.3% ± 1.7%; range: 3.1%-8.2%) 
and CON (5.4% ± 1.6%; range: 3.1%-8.6%). Inter-individual variation across all was 
25.3%. Amongst FDR inter-individual variation was 34.1% and 17.9% amongst CON. 
Daily concentration of P1NP is illustrated in Figure 5-13 (FDR) and Figure 5-14 
(CON). Variance of P1NP in FDR (10.88 (17.91)) and CON (13.83 (16.16)) was not 
different (p=0.791, d=0.2). 
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Total intra-individual biological variation for uNTX (nM BCE.d-1) was 26.6% ± 
14.4% (range 12.4%-73.0%). For FDR and CON respectively the ranges were 15.4%-
73.0% and 12.4%-39.6%, mean ± SD were 29.4% ± 18.6% and 24.6% ± 9.7%. Inter-
individual variation was 61.4% for all, 58.2% amongst FDR and 54.4% amongst CON. 
Daily amounts are shown in Figure 5-15 (FDR) and Figure 5-16 (CON). Variance of 




Figure 5-15: Daily 24h excretion of uNTX (nM BCE.d-1) in 7 FDR (n=42).  
Data are displayed as daily concentration by participant (colour). Condition is illustrated by 
shape: ○ represents EX days (n=36), □ represents NONEX days (n=6).  
 
Figure 5-16: Daily 24h excretion of uNTX (nM BCE.d-1) in 10 CON (n=61).  
Data are displayed as daily concentration by participant (colour). Condition is illustrated by 




fPYD intra-individual variation was 28.3% ± 18.0% (range: 7.4%-77.2%). Intra-
individual variation in FDR was 32.9% ± 20.0% (range: 14.7%-77.2%) and 25.1% ± 
15.6%, in CON (range: 7.4%-63.6%). Inter-individual variation was 40.3% amongst 
all, 37.5% for FDR and 27.7% for CON. Figure 5-17 (FDR) and Figure 5-18 (CON) 
show the daily fPYD excreted (nmol.d-1). There was no difference in variance of fPYD 
between FDR (10258.94 (76001.41)) and CON (3214.22 (4871.55)) (p=0.161, d=0.9), 
however the effect size was large. 
 
Figure 5-17: Daily 24h excretion of fPYD (nmol.d-1) in 7 FDR (n=42).  
Data are displayed as daily concentration by participant (colour). Condition is illustrated by 
shape: ○ represents EX days (n=36), □ represents NONEX days (n=6). 
 
 
Figure 5-18: Daily 24h excretion of fPYD (nmol.d-1) in 10 CON (n=61).  
Data are displayed as daily concentration by participant (colour). Condition is illustrated by 
shape: ○ represents EX days (n=23), □ represents NONEX days (n=38). 
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Total intra-individual biological variation for fDPD ranged from 8.3%-59.2% with a 
mean of 31.8% ± 15.3%. FDR intra-individual variation was 17.6%-59.2%, mean ± 
SD of 39.0% ± 14.1%. CON ranged from 8.3%-51.0% with a mean ± SD of 26.8% ± 
14.0%. Inter-individual variation was 40.9% for all, 34.0% for FDR and 30.1% for 
CON. Figure 5-19 (FDR) Figure 5-20 (CON) show daily excretion of DPD for 
participants. Variance of fDPD was six fold greater in FDR (807.62 (477.91)) than 
CON (125.87 (296.87)) (p=0.019, d=1.5). 
 
 
Figure 5-19: Daily 24h excretion of fDPD (nmol.d-1) in 7 FDR (n=42).  
Data are displayed as daily concentration by participant (colour). Condition is illustrated by 
shape: ○ represents EX days (n=36), □ represents NONEX days (n=6). 
 
Figure 5-20: Daily 24h excretion of fDPD (nmol.d-1) in 10 CON (n=61).  
Data are displayed as daily concentration by participant (colour). Condition is illustrated by 





The primary aim of this study was to compare bone metabolism in FDR and CON. 
Using blood based BTMs, sampled following an overnight fast and prior to any 
exercise or food consumption, homeostatic bone resorption (CTX) and formation 
(P1NP) were 31% (p<0.001) and 15% (p=0.012) lower in FDR compared to CON 
respectively, suggesting a regulatory effect of endurance running. However assessed 
over 24 h (capturing net effect of increases/ decreases of bone resorption in response 
to exercise/ feeding) bone resorption measured by uNTX was 37% higher in FDR 
(p=0.033). 24 h excretion of pyridinoline cross links, fDPD and fPYD, were also 
higher in FDR, by 34% and 31% respectively (p<0.001). The absence of a 24 h 
formation marker prevents evaluation of total daily bone formation.   
 
To this author’s knowledge this is the first study to concurrently measure habitual 
(through sampling over multiple days) homeostatic (CTX and P1NP) bone metabolism 
and total resorption (24 h) in two populations with distinct activity profiles.  
 
No difference in 24 h resorption BTMs were observed by type of day (EX vs NONEX), 
nor was a group*type of day interaction found. Type of day analysis was completed 
using mean values for each participant in each type of day to prevent influence from 
greater frequency of activity amongst FDR. No difference in variance of CTX, P1NP, 
uNTX or fPYD was observed between groups. Large effect sizes were observed for 
uNTX (d=0.9) and fPYD (d=0.9), indicative of greater variance in 24 h resorption 
amongst FDR. A medium-large effect size for CTX (d=0.7) was indicative of less 
variance in the FDR group, in line with the regulatory effect of endurance exercise as 
indicated by lower homeostatic bone metabolism. A small effect size was observed 
for P1NP. Variance of fDPD was six fold greater in FDR (p=0.019, d=1.5). Observed 
effect sizes for 24 h resorption markers including a group difference for fDPD suggests 
that markers capture changes in resorption in response to lifestyle, including exercise, 
which differed between the groups.  
 
There was no difference in age or BMD (any site) between groups. FDR had ~50% 
lower fat mass, and region percentage fat than CON. FDR had 12% greater lean mass. 
Six of the seven recruited FDR (86%) had a current menstrual dysfunction 
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(AMEN/OLIGO). Menstrual dysfunction is an established risk factor for poor bone 
health, included within the TRIAD and RED-S consensus statements (Nattiv et al., 
2007, Mountjoy et al., 2014). Menstrual dysfunction results in decreased oestrogen 
exposure, a regulator of osteoclast action (Riggs, 2000). De Souza et al. (2008) 
demonstrated that active women with oestrogen depletion (AMEN and urinary estrone 
glucuronides <35 ng.ml-1) had increased bone resorption assessed by CTX (50% 
relative to oestrogen and energy replete, 100% compared to oestrogen replete, energy 
deplete) with an interactive (oestrogen*energy) difference in P1NP concentrations 
also observed. In adolescent runners, expected to experience bone accrual, FDR within 
3 years of menarche at baseline and who reported irregular menses over a follow up 
period (3 years) experienced 50% less bone acquisition at the lumbar spine compared 
to those with regular menses during follow up (Barrack et al., 2011). This is indicative 
of suppressed bone accrual (resulting from bone metabolic activity) in the presence of 
menstrual dysfunction. Sampled on a single occasion, Zanker and Swaine (1998) 
reported up to 45% lower formation and 32% lower resorption in AMEN FDR 
compared to EUMEN FDR or CON. No difference was observed between EUMEN 
FDR and CON, suggesting that suppressed bone metabolism could be a characteristic 
associated menstrual dysfunction, rather than exercise. The widespread menstrual 
dysfunction amongst the studied FDR prevents a within group comparison of 
homeostatic bone metabolism by menstrual status. The concept that the observed 
lower homeostatic bone metabolism is related to menstrual status rather than activity 
level cannot be ruled out with the current dataset. Menstrual dysfunction is associated 
with LEA. Loucks and Thuma (2003) demonstrated that reproductive hormone 
profiles are altered with reduced EA. Lieberman et al. (2017) reported an increased 
prevalence of menstrual disturbances with reduced EA however a definitive threshold 
to prevent menstrual disturbances was not evident. Given menstrual dysfunction was 
evident amongst 86% of the FDR the possibility of LEA being present is likely. Acute 
(5 days) LEA has been shown to alter bone metabolism with a reduction in formation 
and increase in resorption (Ihle and Loucks, 2004). Formation demonstrated a dose 
dependent response with a reduction of 10% at 30 kcal.kgFFM-1 and a 29% reduction 
at 10 kcal.kgFFM-1. No change in resorption was observed at 30 or 20 kcal.kgFFM-1. 
It was elevated 29% at 10 kcal.kgFFM-1. Although resorption was lower in the FDR 
cohort in this thesis than the CON, formation was also lower. This would be in line 




exercise induced responses in states of LEA are limited. Hammond et al. (2019) 
reported CTX concentrations both pre and post a second exercise session within a day 
in LEA and adequate EA conditions. Concentrations were  ~30% greater when energy 
was not replaced. The same response was reported when energy was replaced but low 
carbohydrate state was maintained. LEA or insufficient carbohydrate intake for 
demands could potentiate the exercise induced bone metabolic response. This could 
contribute to the greater 24 h resorption observed amongst the FDR. Whether the 
probable oestrogen depletion (a characteristic of menstrual dysfunction (Allaway et 
al., 2016)) alters the exercise induced bone metabolism is unknown. But failure to 
regulate osteoclast action does appear a credible explanation for elevated exercise 
induced bone metabolism. Differences in menstrual status between the FDR and CON 
groups is a limitation of this study. However matching for menstrual status was not 
possible within the population from whom the sample was recruited. The author 
acknowledges this limitation. Within the remainder of this chapter the findings are 
discussed related to exercise, with a particular emphasis on the influence on 
mechanical loading. In Chapter 6 energy expenditure of both groups is examined to 
ascertain the magnitude of energy arising from habitual training of FDR. Chapter 7 
focuses on FDR and whether their energy intake is adequate, in addition to examining 
other nutrients of interest.  
 
Lower homeostatic bone metabolism in FDR contrasts with the findings of Townsend 
(2016) who reported CTX and P1NP values above a reference population average 
(non-athletes recruited in Nottingham Trent University) in 13/16 participants; 
although many of these participants were within 1 SD of the reference population. 
Dolan et al. (2012) reported 38% greater uNTX (morning sample, and therefore a 
measure of homeostatic metabolism) with no difference in P1NP in jockeys compared 
to controls. 39% greater CTX was also observed in cross country skiers/ biathletes 
compared to controls (Herrmann and Herrmann, 2004).  
 
Changes in BMD are elicited through bone metabolic activity. It would therefore seem 
plausible that in order to attain the osteogenic effect of exercise athletes would require 
greater bone metabolic activity; an idea supported by acute elevations in bone 
resorption post exercise (Kohrt et al., 2018, Daniel and Jakeman, 2008). The 
magnitude, duration and coupling (formation and resorption) of perturbations in bone 
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metabolism will influence the resultant effect on fracture risk and BMD. Of notable 
concern would be an increase in homeostatic bone metabolism, which is associated 
with increased fracture risk (Heaney, 2003). Each of the studies mentioned so far 
indicate that athletes have elevated homeostatic bone metabolism, particularly 
resorption which was greater in each of the athletic populations. 
 
However amongst the FDR studied in this thesis homeostatic bone metabolism is 
lower than CON, suggesting a positive regulatory effect of exercise on fracture risk. 
Brahm et al. (1997) also report lower bone metabolic activity in endurance trained 
runners; assessed by ICTP and P1CP resorption and formation were 22% and 18% 
lower in endurance trained runners compared to controls. Zanker and Swaine (1998) 
reported no difference in bone metabolism between EUMEN FDR and CON. Lower 
absolute concentrations and the resultant 25% lower bone turnover and 15% higher 
bone balance in FDR, calculated using the bone marker plot (Bieglmayer and 
Kudlacek, 2009), indicate a beneficial effect of habitual endurance running on bone 
within the studied FDR. Both groups had bone balance scores >1, indicative of net 
bone formation. Positive bone balance scores amongst both cohorts may be reflective 
of their age and skeletal development. All participants were relatively young, with 4/7 
FDR and 7/11 CON under 25 y, a time when mineralisation (and thus net formation) 
may still be ongoing. 
 
The history of fracture (29% (2/7)) and low BMD (29% (2/7, neither of whom had a 
history of fracture)) amongst the cohort was similar to that reported in Chapter 4, 
suggesting a representative sample was recruited. The two FDR who reported history 
of fracture sustained the fractures a number of years ago and both noted rapid increases 
in training volumes (no training to training) preceding the injury. The occurrence of 
stress fractures was noted in conversation with the researcher during testing. It was 
not collected as part of the methods for this study. A history of BMD measurements 
on the same DXA show that one of the FDR with current low BMD had increased 
BMD over 6 y, suggesting her current bone health is more favourable which aligns 
with the observed bone metabolic responses. 
 
Differences in the loading patterns of runners compared to triathletes, jockeys or cross 




Townsend (2016) had a mean training time threefold that of the FDR in this thesis, 
with non-weight bearing disciplines (swimming and cycling) contributing 70% of 
training volume. During training and racing jockeys will also be weight supported. 
Traditionally cross country skiers employed a skating motion across the ground 
thereby minimising gravitational loading. Recent changes to technique including 
jumping and a running style, could increase the gravitational loading experienced by 
skiers (Pellegrini et al., 2018). However each of these sports is likely to have lesser 
gravitational loading than running. During running each stride will incur loading in 
the magnitude of multiples of body weight, increasing with run velocity (Keller et al., 
1996). Muscular action that facilitates movement will apply tension to the skeleton in 
running and the weight supported sports. Both impact loading and muscular action 
contribute to exercise’s osteogenic action (Kemmler and von Stengel, 2011). This 
infers that running will induce a greater strain through the combined gravitational and 
muscular loading. Strain is a potent regulator of bone’s metabolic response to exercise. 
Within the mechanostat theory, strain magnitude regulates changes in bone mass, 
through metabolic activity, with the aim of attaining and maintaining adequate bone 
strength to withstand habitual loads. With adequate loading bone mass will be 
maintained. In states of reduced loading (<400 µɛ) disuse remodeling occurs to 
remove bone in excess of demands (Frost, 2003). Where muscular tension is the 
primary loading modality the strains may be insufficient to stimulate formation, 
resulting in disuse remodeling. The findings of Creighton et al. (2001) comparing bone 
metabolic activity in female athletes with distinct impact loading (high – basketball & 
volleyball, medium – soccer & short-middle distance track <30 miles.w-1, non-impact 
– swimmers) supports this idea. 30% lower bone formation in the non-impact group 
unaccompanied by any change in bone resorption indicates an uncoupled effect 
favouring resorption.  
 
Although the lower homeostatic bone metabolic activity would be expected to 
positively affect fracture risk and the bone balance scores indicates bone acquisition 
amongst the studied cohort this method of analysis does not capture the effect of 
regular exercise on total resorption. As demonstrated by Kohrt et al. (2018) and Daniel 
and Jakeman (2008) non-weight bearing (60 min cycling at 80% maximal heart rate) 
and weight bearing exercise (~2 h treadmill walking) increase bone resorption 
assessed by CTX. In response to cycling CTX concentration doubled from baseline. 
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Relative to a non-exercise condition (allowing a correction for diurnal rhythm) post-
walking concentration was 10% higher, however the change relative to baseline did 
not exceed 0.05 ng.ml-1. The greater magnitude of the resorption response following 
cycling could be affected by intensity and/ or loading, with cycling being weight 
supported and therefore not subject to gravitational loading. Following running at 75% 
VO2max in a fasted condition in the morning CTX concentration was maintained at 
baseline levels (Scott et al., 2011). In the absence of a stimulus that alters bone 
metabolism bone resorption would normally decline during this time period (by 
approximately 60%) (Wichers et al., 1999). Inconsistent analytical approaches 
prevents adequate comparison of the magnitude of response to varying exercise types 
and intensities. However there appears to be a consistent directional (increase) 
response of bone resorption to endurance exercise. Whether these acute augmentations 
have any resultant effect on daily bone resorption was unknown to date. Analysis of 
urinary resorption markers in 24 h samples enabled assessment of daily resorption 
activity. Observed intra-individual variation for uNTX (26.6 ± 14.4%), fPYD (28.3 ± 
18.0%) and fDPD (31.8 ± 15.3%) and the large effect sizes for variance between the 
groups is in line with variable training duration, type and intensity; providing support 
that 24 h markers are sensitive to activity changes. By comparison blood based 
markers were sampled under controlled conditions >10 h post exercise reflected in the 
comparatively small intra-individual variation of CTX (8.8 ± 3.7%) and P1NP (5.4 ± 
1.7%). 
 
The finding of 37% higher uNTX (cleaved from collagen triple helix, as is CTX 
(Wheater et al., 2013)) in FDR indicates greater total resorption. The greater fDPD 
(34%) and fPYD (31%) in FDR corroborates this idea. FDR have a training frequency 
(number of sessions per week) and volume (h) that is almost three fold that of CON. 
The published acute exercise responses considered with the differences in activity 
between FDR and CON make exercise a cogent explanation for the group difference 
in 24 h resorption. Through their habitual training FDR will be exposed to mechanical 
and metabolic stimuli likely to induce bone metabolism. It is currently unknown 
whether this response affects fracture risk. Knowledge of the magnitude of in vivo 
strain, effect of varying loading patterns and exercise induced metabolic changes can 






As already mentioned load induced strain is an established regulator of bone 
metabolism. The mechanostat theory (Frost, 2003) proposes differential bone 
metabolic responses to varying load magnitudes. Disuse remodeling favouring 
resorption is expected with strains below 400 µɛ; 1000-1500 µɛ is sufficient to 
stimulate lamellar bone formation while strains >3000 µɛ require woven bone 
formation. Lanyon et al. (1975) reported maximum compressive strains of 847 µɛ and 
746 µɛ with lower (578 µɛ and 450 µɛ) tensile strains for running (7.9 km.h-1) with 
and without shoes respectively, values that are comparable with those reported by Burr 
et al. (1996) in two participants (running at 10.15 km.h-1). Burr et al. (1996) also 
reported strain results for quicker run velocity (13.88 km.h-1) (968 µɛ and 646 µɛ for 
compressive and tensile strains respectively). They also reported shear strains which 
were 66% and 72% greater during jogging (10.15 km.h-1, 1444 µɛ) and running (13.88 
km.h-1, 1583 µɛ) than walking. The shear strains reported in the latter study, although 
limited to two participants, are within the range considered to stimulate lamellar bone 
remodeling (Frost, 2003). The in vivo reports of bone compressive and tensile strains 
experienced during running are insufficient to stimulate bone metabolism with an 
osteogenic effect but are sufficient to prevent loss. The reported shear strains may 
compensate for the suboptimal tensile/ compressive loading. At greater run velocity 
(17 km.h-1), on a cinder track mean strains of 1378 µɛ (tension), 1675 µɛ 
(compression) and 5027 µɛ (shear) have been observed, values that are 1.6-4.2 times 
greater than walking and 5-8 times greater than cycling (Milgrom et al., 2000). FDR 
report 1-2 sessions per week including higher intensity training. During these sessions 
they are likely to experience greater magnitudes of strain and rates of loading, inducing 
metabolic activity that favours formation. Shear strains >3000 µɛ could be detrimental 
to bone strength as woven bone formation is likely to be favoured in this case (Frost, 
2003). However distance running is characterised by repetitive habitual loading and 
the bone is likely to adapt in order to lessen the habitual strains experienced. Failing 
this adaptation and suppression, the infrequent occurrence of such sessions (a couple 
of time a week) could allow sufficient time for repair and may even be anabolic. 
Further research investigating the effect of run velocity on bone metabolism is 




In contrast to field based sports where accelerations, decelerations and changes in 
direction are frequent, distance running is characterised by repetitive, habitual loading 
patterns. This may result in a desensitisation to the loading.  Rubin and Lanyon (1984) 
report >30% increase in bone mineral content in avian ulnae after 28 days of daily 
loading (36 cycles per day). Additional loading (360 or 1800 cycles) did not elicit 
further benefit. Within this thesis FDR ran 8-18 km per day resulting in thousands of 
impacts, with potential for many of these impacts to be ineffective for osteogenesis. 
Repetitive loading of the same structures could instead result in micro damage (Frost, 
1997). Lambers et al. (2013) reported increased bone damage in ex vivo human 
vertebral samples with increased fatigue loading (r2=0.71). Mean damaged bone 
percentage was four fold higher in samples loaded to failure (5% strain) compared to 
those without loading. This suggests that repetitive loading (as incurred through 
distance running) induces micro-damage resulting in osteocyte apoptosis and 
subsequent recruitment of osteoclasts to remove damage resulting in the development 
of resorption lacunae (Verborgt et al., 2000). This alternate explanation for increased 
bone metabolism would be more likely to compromise bone strength than represent 
an osteogenic effect.  
 
Although Rubin and Lanyon (1984) suggest that increased loading duration doesn’t 
offer additional benefit, Umemura et al. (1997) employed a jumping protocol in 
rodents that offers some encouragement for repetitive in vivo loading. Groups who 
experienced 10-40 daily jumps had 11-17% higher bone mass compared to controls 
with 15-20% and 23-33% greater bone strength (assessed through bending moment) 
at the femur and tibia. The 100 jumps per day group had 22% and 23% greater bone 
mass at the femur and tibia compared to the control group. Compared to the five and 
ten jump groups bone mass was 9-12% greater and strength was 11-13% greater at the 
tibia and femur. This data suggests that additional benefits can be gained with 
increased loading elicited through muscular contraction. Umemura et al. (1997) 
suggested that a concurrent aerobic training stimulus experienced by the 100 jump 
group contributed to the additional benefit. This concurrent stimulus will be 
experienced by FDR.   
 
Calcium metabolism is a key regulator of exercise induced bone metabolism. Calcium 




and gut; a process regulated by PTH, calcitonin and 1,25-dihydroxyvitamin D (Mundy 
and Guise, 1999). Townsend et al. (2016) reported increased ionized calcium within 
the first 5-7.5 minutes of treadmill running (65% and 75% VO2max) followed by a 
decrease. An inverse response was observed for PTH with a peak 5-7.5 min post 30 
min exercise bout. PTH concentrations were 8-17% below baseline following 60 min 
of recovery. PTH is known to have differential effects on bone depending on duration 
of exposure. The documented response suggests exercise stimulates an intermittent 
increase in PTH, an anabolic stimulus for bone (Frolik et al., 2003). Bone resorption 
is considered to precede formation (Eriksen, 2010). Increased CTX response to 
decreased ionized calcium and increased PTH concentration reported by Kohrt et al. 
(2018) if followed by formation supports exercise induced intermittent PTH as an 
anabolic stimulus to bone. However if frequent training (multiple sessions daily) 
results in prolonged PTH exposure a catabolic effect could occur.  
 
Several mechanisms that could regulate bone metabolism have now been discussed. 
Impact induced strain and intermittent PTH exposure are likely to induce osteogenic 
bone metabolic activity. However micro damage incurred through repetitive loading, 
which may or may not have an osteogenic effect would require removal of damaged 
bone through resorption, and prolonged PTH exposure would also have a catabolic 
effect. The initiating stimulus for the observed elevated bone resorption in FDR could 
result in distinct outcomes for bone. If the observed resorption is matched or exceeded 
by formation FDR are likely to have favourable fracture and BMD outcomes. However 
if the resorption represents micro damage removal and formation is absent/ 
insufficient the increased resorption activity will be detrimental to bone health. The 
effect of elevated 24 h resorption on fracture outcomes remains to be seen. An 
understanding of the accompanying (or lack of) formation response is also required.  
 
Furthermore the magnitude of the response should be considered. Based on 1 h of 
exercise and two-fold (200% of baseline) greater resorption activity for 4 h post 
exercise (reported by Kohrt et al. (2018)), a net increase of 20% would be expected in 
response to exercise, if bone resorption remains unperturbed at all other time points 
(net influence was calculated as 24 h * 100% vs 5 h * 200% + 19 h * 100%). This only 
accounts for half of the observed response (37%). This indicates that either the 
exercise induced bone resorption has a more prolonged effect than previously 
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documented and/ or FDR experience a greater magnitude of resorption in response to 
exercise. Whether such a response is protective or harmful for bone is currently 
unknown. The idea that resorption could be elevated independent of exercise (possibly 
influenced by diet) cannot be ruled out either, particularly as 24 h resorption did not 
differ between types of days when a mean for each participant in each condition was 
calculated. 
 
Acute observations of exercise induced bone metabolic responses are documented 
over a number of hours. Scott et al. (2011) reported a maintenance of CTX 
concentration above baseline for 1 h post exercise (60 min of treadmill running 75% 
VO2max); earlier (during exercise) declines from baseline were observed for 55% and 
65% VO2max intensities. In contrast Kohrt et al. (2018) reported a maintenance of 
concentration at ~2 times baseline 4 h post exercise (cycling). It is likely that the post-
cycling elevation is maintained beyond the observation period. This would contribute 
to greater 24 h resorption, accounting for the discordance between hypothesised 
resorption and observed (uNTX) resorption. An alternative hypothesis is that the 
exercise induced response is exacerbated by another factor. The observed prevalence 
of menstrual dysfunction (86% of the recruited FDR vs 0% of CON) is plausible as is 
LEA or inadequate nutrient intake. Energy status, and one of its components – energy 
expenditure, is examined in the following two experimental chapters.  
 
5.5 Conclusion 
Lower homeostatic bone metabolism in FDR, indicated by absolute concentrations of 
CTX and P1NP and bone turnover calculated by the bone marker plot (Bieglmayer 
and Kudlacek, 2009), suggests endurance running has a positive regulatory effect on 
bone metabolism. Lower bone metabolic activity would also provide resilience against 
bone losses as a result of environmental influences (e.g. menstrual dysfunction). Bone 
balance, also calculated by the bone marker plot indicated bone gain in both CON and 
FDR with greater gain in the FDR group, further supporting a regulatory effect of 
exercise on bone metabolism. The net formation assumed from this finding is in line 
with the relatively young population who are still accruing and consolidating peak 




prevalence of low BMD was representative of the larger cohort studied within this 
thesis (Chapter 4). 
 
FDR had greater 24 h resorption, in line with acute studies of elevated bone 
metabolism (Guillemant et al., 2004). By design FDR engaged in more frequent and 
greater volume of training, supporting exercise as an explanation for the difference in 
bone metabolism. Large effect sizes for variance in 24 h urinary BTMs indicative of 
greater variance in FDR supports the sensitivity of the markers to lifestyle influence. 
Whether elevated 24 h resorption has any effect on fracture risk or BMD changes is 
unknown and beyond the scope of this thesis. However several potential stimuli and 
their probable effect on bone health were discussed.  
 
The existence of increased resorption in FDR is in line with published acute effects 
but the magnitude is greater than expected. This could indicate a more prolonged 
response than previously documented, indicative of a need to extend the post-exercise 
monitoring period; or an exacerbated or exercise independent response is an 
alternative hypothesis. Six of seven FDR reported menstrual dysfunction. Decreased 
oestrogen (an osteoclast regulator) exposure would be expected, which could 
potentiate the exercise induced resorption and/ or independently increase resorption. 
The former is more likely in the absence of increased homeostatic metabolism.  
 
Probability of menstrual dysfunction increases with decreasing energy availability 
(Lieberman et al., 2017). LEA could independently exacerbate exercise induced bone 
resorption. Due to their greater training volume FDR are likely to have increased 
energy expenditure with a greater proportion of energy deriving from purposeful 
exercise. This would require additional nutrient support. The energy demands of 
groups will be examined in Chapter 6 followed by an examination of the adequacy of 











FDR engage in frequent, prolonged, energy demanding exercise.  Energy expenditure 
from locomotion can be increased by as much as 2-4 fold in some endurance sports 
(Loucks et al., 2011). Such demands require replacement of nutrients and energy to 
support health. However endurance athletes, particularly female, have been reported 
to consume less energy than their demands require. Mulligan and Butterfield (1990) 
reported a statistically insignificant trend for runners to consume slightly more energy 
than non-runners however they failed to adequately increase their energy intake to 
compensate for the 24-38% increase in energy expenditure (moderate and very active 
runners relative to non-runners respectively), resulting in negative energy balances. 
The magnitude of energy imbalance was amplified with increasing energy 
expenditure. Moderate and very active runners had five and fifteen fold greater energy 
deficits than non-runners with a threefold difference between the runner groups. In 
light weight rowers energy intake was 34% lower than energy expenditure (Hill and 
Davies, 2002). Although under-reporting is an inherent challenge of dietary analysis 
and studies of bioenergetics (Macdiarmid and Blundell, 1998), metabolic and 
endocrine responses (Laughlin and Yen, 1996) suggest that some (or many) female 
athletes are in chronic states of energy deficiency (Loucks, 2004). Energy balance 
refers to the amount of energy added to or lost from body stores after all physiological 
systems have done their work (Loucks, 2004). Athletes may seek to manipulate body 
composition (reflective of different macronutrient stores - fat as adipose tissue, protein 
and carbohydrate in muscle) for performance benefit. Additionally the habitual 
exercise of athletes will stimulate physiological responses, with a metabolic cost, that 
cannot be quantified or perceived by the athlete. This makes monitoring of energy 
balance difficult amongst athletes. Furthermore Stubbs et al. (2002) demonstrated a 
downregulation of total energy expenditure (decline of ~500 kcal over 7 days) in lean 
men when they fail to meet elevated (exercise induced) energy demands through 
increased intake, indicative of downregulated physiological function. In recognition 
of the elevated exercise induced energy demands of athletes energy availability is 
deemed more appropriate (Loucks et al., 2011). EA refers to energy remaining for all 
physiological functions after the energy expenditure for a physiological function of 
interest has been subtracted from energy intake. In exercise physiology and sports 
nutrition this refers to the energy remaining after exercise energy expenditure (EEE) 
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(Loucks et al., 2011). In contrast to energy balance which is a resultant effect (output) 
of energy metabolism, EA is a facilitator (input) of physiological processes. In the 
absence of adequate energy physiological processes are perturbed with documented 
altered reproductive hormone patterns and bone metabolism amongst the 
consequences of LEA    
 
Although exercise presents a physiological stress, metabolic and hormonal disruptions 
in active women are now attributed to EA (Loucks et al., 1998). In states of LEA bone 
resorption has been upregulated (up to 29%) with a commensurate downregulation 
(29%) in formation indicative of an uncoupled, pathological bone metabolic profile 
(Ihle and Loucks, 2004). 
 
Chapter 5 documented 37% greater 24 h bone resorption in FDR compared to CON. 
This was attributed to an exercise stimulus, however a dysregulation due to energy 
insufficiency could not be ruled out. Widespread menstrual dysfunction was observed 
amongst the FDR cohort, indicative that LEA may be at play. The exercise volume 
and frequency of training was greater in FDR than CON, suggesting that the energy 
demands of FDR will be increased, requiring greater energy intake to maintain 
adequate energy availability. In order to evaluate the dietary adequacy of FDR the 
magnitude and source (probably exercise) of the expected elevated energy expenditure 
needs to be assessed (or confirmed). This chapter evaluates the energy demands of 
FDR through comparison to a non-athletic reference population (CON). In order to 
evaluate the energy demands of exercise and its contribution to TEE amongst FDR, a 
measurement tool that captures TEE and facilitates isolated measurement of EEE is 
needed.  
 
Doubly labelled water (DLW) is considered the most valid measure of free living 
human energy expenditure (FAO/WHO/UNU, 2005, Westerterp, 2017). However its 
expense and reliance on laboratory expertise for analysis limits its use. Given that only 
the total energy expenditure between two samples can be determined (usually 
quantifying energy expenditure across 1-3 weeks) (Westerterp, 2017) it is impractical 
for determining EEE. Several on-body devices have been developed/ used to measure 
energy expenditure, including accelerometers, heart rate monitors and combined 




to assess energy expenditure. SWP3 offers the advantage of capturing exercise and 
non-exercise energy expenditure, allowing for retrospective identification and 
confirmation of exercise bouts. Vernillo et al. (2015) reported SWP3 was a valid 
measure of energy expenditure compared to indirect calorimetry during level ground 
walking. However numerous contrasting reports exist. King et al. (2004) report that 
SWP3 overestimated energy expenditure by 10-60% compared to indirect calorimetry.  
The better (10%) agreement during running may suggest the SWP3 has greater validity 
at faster speeds and/ or during running (opposed to walking). However 
underestimation of running at speeds >2 m.s-1 (~13:25 min.mile-1, 8:13 min.km-1) with 
up to 65% mean bias at 4 m.s-1 (van Hoye et al., 2014) provides less confidence for its 
validity in measuring EEE amongst FDR. Each of the aforementioned studies are lab 
based and capture only specific activities. Both Johannsen et al. (2010) and Koehler 
et al. (2011) compared TEE measured by SWP3 and by DLW, capturing the net effect 
of any potential under or overestimations within a day, in healthy adults and male 
endurance athletes respectively. Johannsen et al. (2010) report a 4% average TEE 
underestimation of SWP3 over 14 days. Koehler et al. (2011) did not observe a mean 
bias in TEE averaged over 7 days but a proportional bias with overestimation at lower 
energy expenditures and underestimation at greater energy expenditures was observed. 
This is a concern when seeking to measure energy expenditure amongst endurance 
athletes. van Hoye et al. (2014) reported a gender effect. This could be attributed to a 
body size difference between males and females but should not be ignored until further 
data is available on female energy expenditure. Average TEE calculated across a week 
fails to capture variance in TEE from different training loads. To our knowledge 24 h 
energy expenditure captured by SWP3 has not been compared to DLW as a criterion 
measure, nor has a comparison occurred within FDR, whose training load is likely to 




This chapter aims to: 
1. Assess the validity of SWP3 as a measure of TEE amongst FDR by comparison 
to DLW in 24 h epochs. 
2. Compare energy expenditure in FDR and CON considering: 
a. TEE 
b. EEE 
c. Non-exercise EE  
d. Relative contributions of EEE and non-exercise EE to TEE 
 
6.2 Methods 
6.2.1 Study design and participants  
Data was collected during the seven day study described in 3.3.2 . This chapter is a 
continuation of analysis with a focus on energy expenditure. Analysis within this 
chapter has two foci: 
1. Comparison of methods to assess energy expenditure in FDR 
2. Comparison of energy expenditure in two groups (FDR and CON) 
 
Five FDR who had energy expenditure assessed by both DLW and SWP3 were 
included in analysis 1. The five FDR were a convenience population. The DLW 
measurement was not available at time of recruitment and testing of the first two 
participants. Seven FDR and nine CON who had valid SWP3 (≥95% wear time (see 
section 3.6 ) data on at least 3 days) were included in analysis 2. Two CON were 
omitted, due to only having one and two days respectively of valid SWP3. All FDR 
had at least three days of valid SWP3 data.  
 
6.2.2 Data analysis  
Comparison of SWP3 and DLW measures of energy expenditure  
Validity of the SWP3 was assessed by comparison to energy expenditure measured by 
DLW. Data was analysed in ~24 h epochs, independent of participant. Epoch duration 
was not corrected to an exact 24 h. Instead it was analysed as the TEE during the 
selected time period between two consecutive second morning void urine samples 
used for DLW measurement. The corresponding SWP3 time was then selected. Wear 




(due to water-based activity/ SWP3 failure to collect data) estimated energy 
expenditure was added to the SWP3 TEE (using the Compendium of Physical 
Activities (Ainsworth et al., 2011)). Bias was assessed by Bland-Altman with the 
difference between measures compared to 0 using a single sample t-test. Linear 
regression was used to detect presence of proportional bias. 95% limits of agreement 
were calculated by multiplying standard deviation by 1.96.  
 
Group comparison of energy expenditure  
Group differences in TEE, EEE and proportion of TEE derived from BMR, EEE and 
non-exercise energy expenditure (NonEX EE) were examined. TEE was derived from 
valid SWP3 records or from SWP3 + EEE calculated from metabolic equivalents 
where applicable. BMR was estimated using the Oxford equation (Henry, 2005) 
(shown in 3.6 ). EEE was derived from SWP3 during the time of training outlined on 
the training log as described in section 3.6 . Where SWP3 data was unavailable energy 
expenditure was estimated based on the Compendium of Physical Activity (Ainsworth 
et al., 2011) (also described within section 3.6 ). EEE was corrected for BMR by 
subtracting the estimated BMR for the duration of exercise (e.g. 60 min worth of BMR 
for 60 min of exercise). NonEX EE was calculated by subtracting BMR and EEE from 
TEE.  
 
Data was checked for normality of distribution by Shapiro-Wilk and histogram. 
Levene’s test was used to check homogeneity of variance. Groups were compared 





6.3.1 Participant characteristics  
Table 6-1: Characteristics of participants included in DLW versus SWP3 analysis  
 Mean ± SD (n=5) 
Age (y) 23.4 ± 4.0 
Height (m) 1.716 ± 0.057 
Mass (kg) 58.8 ± 5.4 
BMI (kg.m-2) 20.0 ± 1.9 
LTM (kg) 45.4 ± 2.8 
FM (kg) 11.1 ± 3.1 
BMC (kg) 2.6 ± 0.3 
FFM (kg) 48.0 ± 2.9 





Table 6-2: Characteristics of participants included in group energy comparison 
 All (n=16) FDR (n=7) CON (n=9)  d 
Age (y) 23.9 ± 4.5 24.1 ± 4.6 23.7 ± 4.5  0.1 
Height (m) 1.687 ± 0.054 1.704 ± 0.054 1.673 ± 0.050  0.6 
Mass (kg) 61.8 ± 5.7 58.5 ± 5.5 64.3 ± 4.5 * -1.0 
BMI (kg.m-2) 21.8 ± 2.4 20.2 ± 1.8 23.0 ± 2.0 * -1.2 
LTM (kg) 43.3 ± 3.9 45.8 ± 3.0 41.3 ± 3.3 * 1.2 
FM (kg) 16.0 ± 6.4 10.4 ± 3.1 20.4 ± 4.7 * -1.6 
BMC (kg) 2.5 ± 0.2 2.6 ± 0.3 2.5 ± 0.2  0.5 
FFM (kg) 45.8 ± 4.0 48.4 ± 3.1 43.8 ± 3.5 * 1.1 
Region % fat 25 ± 9 % 18% ± 4 % 32 ± 6 % * -1.6 
BMR (kcal.d-1) 1389 ± 68 1365 ± 75 1408 ± 55  -0.6 
All data are displayed as mean ± SD. All variables were normally distributed except for FFM. 
*denotes statistical difference between FDR and CON (p<0.05). d is Cohen’s d where mean A= 
FDR. Therefore negative effect sizes indicate a higher mean in the CON group.  
 
6.3.2 Energy expenditure assessed by DLW 
Energy expenditure assessment  
Daily and weekly summary TEE are shown in Table 6-3. Two data points (consecutive 
days) for one participant (F416) were excluded. The measured TEE on the omitted 
days was a. less than estimated BMR and b. more than 1000 kcal greater than all other 
days (including training days with multiple sessions), suggesting an analytical or 
sample collection (time) error. NONEX days are identified in bold. F1983 did not 





Table 6-3: Summary daily and weekly energy expenditure assessed by DLW 
ID F1271 F1983 F1985 F1986 F416 
Weekly TEE (kcal.w-1) 24293 18805 19859 22636 22854 
Average TEE (kcal.d-1)$ 3470 2686 2837 3234 3265 
Daily TEE (kcal.d-1)      
Monday  3451 2225 2130 3298 - 
Tuesday 3468 2732 3126 3095 - 
Wednesday 3258 2591 3129 3609 3021 
Thursday 3176 1969 1922 2278 4187 
Friday 2505 3033 3014 3011 2428 
Saturday 4352 3767 3542 3456 3683 
Sunday 4008 2586 3035 3834 3554 












CV (%) 16% 20% 19% 15% 18% 












$ indicates average calculated by dividing TEE assessed over the week by seven 
 
 
Figure 6-1: Comparison of 24h TEE assessed by DLW and SWP3 in 5 FDR over 7 days 
(n=22).  







Figure 6-2: Bland Altman showing average 24 h TEE and difference between SWP3 and DLW 
(kcal) 




Figure 6-3: Bland Altman showing average 24 h TEE and difference between SWP3 and DLW 
as a percentage of average 
5 FDR (n=22) with individual participants identified by colour. 
 
There was a bias of 10% (p=0.007) between the measures (Figure 6-3). The difference 
in TEE between SWP3 (2686 ± 326 kcal.d-1) and DLW (2989 ± 535 kcal.d-1) was -
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303 ± 467 kcal.d-1 (Figure 6-2). Proportional bias was also detected by regression 
(p<0.001) with overestimation of low and underestimation of higher energy 
expenditure (Figure 6-1). The 95% limits of agreement were -1219 - + 613 kcal.d-1 
(Figure 6-3).  
 
6.3.3 Group differences in energy expenditure  
Average energy expenditures by group and group*day and the relative contribution of 
BMR, EEE and NonEX EE to TEE are shown in Table 6-4.  
 
Table 6-4: Average energy expenditure and contribution of components to TEE by group and 































579 ± 281 664 ± 185  180 ± 226 360 ± 193  
NonEX EE 
(kcal.d-1) 
817 ± 219 804 ± 191 907 ± 342 901 ± 204 911 ± 225 891 ± 180 
BMR/ 
TEE (%) 
51 ± 7 50 ± 5 62 ± 9 58 ± 6 54 ± 5 62 ± 5 
EEE/ TEE 
(%) 
20 ± 9 23 ± 5  7 ± 8 13 ± 6  
NonEXEE/ 
TEE (%) 
30 ± 6 29 ± 5 38 ± 9 36 ± 6 35 ± 6 38 ± 5 
 
As shown in Table 6-2 no group difference in predicted BMR was observed (p=0.243) 






TEE is shown in Figure 6-4. Independent of type of day TEE was 9% higher in FDR 
(2683 ± 319 kcal.d-1) compared to CON (2459 ± 288 kcal.d-1) (p<0.001, d=0.7). 
Analysed by ANOVA group*type of day interaction was not statistically significant 
(p=0.801, 1-β=6%). A main effect of type of day was observed (p<0.001). TEE 
between EX and NONEX days differed by 19% for FDR and 13% for CON with 
greater TEE on EX days.  
 
Figure 6-4: TEE in all (n=85), by group and group*day 
(FDR EX n=34, FDR NONEX n=5, CON EX n=23, CON NONEX n=23). Data is shown as 
median and IQR with upper and lower bounds indicated with dashed lines. Mean ± 95% CI is 





Including EX days only, EEE was 85% higher in FDR than CON (p<0.001, d=1.3) as 
shown in Figure 6-5A. The relative contribution to TEE was also higher (77% 
relatively and 10% absolutely) (p<0.001, d=1.3) (Figure 6-5B). 
 
 
Figure 6-5: EE in FDR (n=34) and CON (n=23) on EX days only shown as absolute (kcal.d-
1)(A) and percentage TEE (B).  
Data is shown as median and IQR with upper and lower bounds indicated with dashed lines. 
Mean ± 95% CI is shown as ●. 
 
Non exercise EE (NonEX EE) 
No group*day interaction was observed for NonEX EE (p=0.055, 1-β=48%, partial 
eta2= 0.042). No main effect of group (p=0.786, d=0.4, 1-β=6% or type of day 
(p=0.352, d=0.2, 1-β=15%) (Figure 6-6). As a percentage of TEE a group*type of day 
interaction was observed (p=0.008, 1-β=76%, partial eta2= 0.077). A main effect of 
type of day was also observed (p<0.001, d=1.0). Contribution to TEE was 24% higher 
on NONEX days (9% absolute) in FDR and 9% (3% absolute) in CON (Figure 6-7), 







Figure 6-6: NonEX EE in ALL (n=85) and by group and group*type of day 
(FDR EX n=34, FDR NONEX n=5, CON EX n=23, CON NONEX n=23). Data is shown as 
median and IQR with upper and lower bounds denoted with dashed lines. Mean ± 95% CI is 




Figure 6-7: Contribution of NEAT in ALL (n=85), by group and group*day  
(FDR EX n=34, FDR NONEX n=5, CON EX n=23, CON NONEX n=23).  Data is shown as 
median and IQR with upper and lower bounds denoted with dashed lines. Mean ± 95% CI is 





An underestimation of 10% was observed for SWP3 compared to average (SWP3 and 
DLW) TEE with wide limits of agreement (-1219 to +613 kcal.d-1) that are of limited 
use in applied settings. Proportional bias was also observed with an increased 
underestimation at higher energy expenditure.  
 
Koehler et al. (2011) also reported proportional bias in male endurance athletes, where 
TEE was measured over 7 days and averaged to obtain daily TEE values. The limits 
of agreement expressed as a percentage of TEEDLW were -40% to +22% in FDR 
compared to -37% to 34% reported by Koehler et al. (2011). In contrast to the male 
endurance athletes we also observed a fixed bias (-303 kcal). The measurement of 
actual daily TEE rather than an average derived from a weekly measure could 
contribute to this. While the daily average approach reported by Koehler et al. (2011) 
gives an indication of the TEE it fails to capture the variations in energy expenditure 
within a periodized training week. Underestimation of higher energy expenditure may 
be compensated for by overestimation of lower energy expenditure when the weekly 
average approach is employed. Recent dietary guidelines for athletes favour a 
periodized (macro/ meso/ micro) approach (Stellingwerff et al., 2019). Measurement 
of actual daily energy expenditures has increasing importance for such a dietary 
approach. The proportional bias of underestimation on days of greater energy demand 
is particularly concerning as underestimation of EEE is a probable explanation. Upon 
inspection of the data files intensities >12 MET were not observed. This is equivalent 
to 7:30 min.mile-1 or 4:40 min.km-1 (Ainsworth et al., 2011). Absence of run velocities 
greater than this amongst FDR is unlikely. Koehler et al. (2011) reported an 
underestimation of SWP3 compared to indirect calorimetry at velocities ≥2.8 m.s-1 (11 
min.mile-1/ 6:50 min.km-1). Similarly, van Hoye et al. (2014) reported an 
underestimation of SWP3 energy expenditure and intensity compared to indirect 
calorimetry at velocities ≥2 m.s-1 in women. They also reported a plateau for SWP3 
measurements at 3 m.s-1, equivalent to 9.6 METS (12 kcal.min-1 in males and 10 
kcal.min-1 in females). The underestimation of EEE is of concern when applying the 
SWP3 to the EA paradigm. It will result in an overestimation of energy availability, 
potentially misclassifying individuals in states of LEA (and at risk of health 




methods (most likely a combination of heart rate and accelerometers for EEE and Non-
EX EE respectively) should be evaluated and implemented in group (FDR vs CON) 
comparisons, in an effort to accurately quantify the energy demands of FDR.  
 
Although limitations exist regarding SWP3 energy assessments, group differences 
were observed. Measured by SWP3 and independent of type of day FDR expend 9% 
or 223 kcal more TEE than CON. EEE differed by 85% (305 kcal) when EX only days 
were included. FDR reported a maximum of one rest day during their habitual week 
and when group averages were calculated independent of type of day EEE in FDR was 
three fold that of CON illustrating the magnitude of the energy cost incurred during 
training. If EEE, is the component most affected by the underestimation of SWP3, the 
magnitude of difference between groups could in fact be even greater. Non-EX EE did 
not differ between groups or by type of day but the contribution to TEE did. 
Independent of group the contribution of Non-EX EE to TEE was 18% (relative) 
greater on NONEX days than EX days. Contribution of non-exercise energy 
expenditure was 24% greater on NONEX days in FDR and 9% greater in CON. This 
was unsurprising. In practical terms these results indicate that the greater TEE 
observed in FDR derives from the training activity.  
 
Amongst the FDR who had TEE measured by DLW TEE group average TEE on EX 
days was 27% greater than NONEX. This is further evidence that exercise is the main 
source of elevated energy expenditure amongst FDR. On the three EX days (one day 
in three separate participants) where TEE was lower than NONEX, additional 
engagement in non-training activities could contribute. All FDR studied by DLW used 
cycling to commute. Varying distances and frequency could contribute to the elevated 
TEE on NONEX days.  
 
Assessed by DLW (n=5), TEE (3105 ± 617 kcal.d-1) was similar to the 2991 ± 415 
kcal.d-1 reported by Edwards et al. (1993) in highly trained FDR (DLW measurement) 
and the 2972 (2817-3126) kcal.d-1 (mean (95% CI)) amongst elite female endurance 
athletes (Melin et al., 2015) (ActiGraph for non-exercise activity, heart rate for EEE). 




Neither Edwards et al. (1993) nor Melin et al. (2015) reported differences in EX and 
NONEX days, or whether NONEX days were included within the study period. Schulz 
et al. (1992) reported sedentary exercise energy expenditure (respiratory chamber) of 
1682 kcal.d-1 and TEE during a training week (DLW measurement) of 2826 kcal.d-1. 
These results were 33% and 11% lower than the NONEX and EX by DLW amongst 
the Irish cohort. The difference in TEE on non-training days is likely to be influenced 
by methodology. Schulz et al. (1992) studied FDR in respiratory chamber, limiting 
ambulation and potentially decreasing NonEX EE. Lower body mass (52.4 vs 58.8 kg) 
could contribute to this but due to the greater training volume (10 ± 3 miles.d-1; 16 ± 
5 km. d-1) reported by Schulz et al. (1992) an equal or greater energy expenditure 
would probably be expected.   
 
Melin et al. (2015) reported EEE, measured by heart rate. The mean (95% CI) 879 
(743-1015) kcal.d-1 was 30% greater than 664 (602-727) (EX days only) observed 
amongst the FDR in our study. Melin et al. (2015) studied national team (n=13) and 
club level (n=27) athletes with a mean age of 26.3 ± 5.7 y. At the time of study the 
Irish cohort included two underage (U20/ U23) international athletes. Since the study 
an additional athlete qualified for an international senior championship. The 
differences in EEE could be partially influenced by development stage of athletes with 
a likely lower training volume compared to senior international athletes. However the 
difference could also be attributed to an underestimation of EEE by SWP3.  
 
Perhaps as expected no difference in predicted BMR was found. The moderate effect 
size (d=0.6) would arise from differences in anthropometry. Reductions in BMR or 
RMR is a consequence of LEA (Koehler et al., 2016, Logue et al., 2018a). Predictive 
equations have been shown to underestimate RMR by 10-20%, with a greater 
proportion of individuals classified as energy deficient (by low total triiodothyronine) 
having a predicted: measured RMR ratio <0.9 (Strock et al., 2020). We did not 
measure BMR or RMR. The widespread menstrual disturbances amongst the group 
(6/7 FDR) indicates energy deficiency is probable, likely to be commensurate with 
reduced BMR or RMR. If BMR is reduced in the studied FDR exercise will contribute 
to a greater proportion of TEE (the equivalent BMR subtracted from energy 
expenditure during training to obtain EEE would be overestimated), amplifying its 






In athletes EEE is of particular importance when assessing dietary adequacy. 
Measurement of EEE by SWP3 advances on estimates made using activity logs and 
calculated with the Compendium of Physical Activity (Ainsworth et al., 2011). 
However considering the observed underestimation of SWP3 relative to DLW, the 
previously documented underestimation at run velocities typical for FDR (Koehler et 
al., 2011, van Hoye et al., 2014) and the lower EEE reported amongst our cohort 
compared to endurance athletes (Melin et al., 2015) the validity of SWP3 to assess 
energy demands of FDR is dubious. As outlined by Burke et al. (2018b) a standardised 
method for energy assessment, specifically EEE amongst athletes is not currently 
available. Such an advance would be a valuable contribution to the research and 
practitioner community interested in EEE and its contribution to EA.  
 
Notwithstanding the limitations of SWP3 FDR had 9% greater TEE, derived from a 
threefold greater EEE. Transferring this finding to the EA equation (Loucks et al., 
2011) highlights the importance of elevated energy intake to meet the demands of 
training. However energy deficits have been widely reported amongst FDR. Acute 
(days) energy restrictions resulting in LEA have been shown to reduce bone formation 
with commensurate increases in resorption (Ihle and Loucks, 2004). The possibility of 
the observed greater 24 h resorption in FDR compared to CON being exacerbated by 
inadequate dietary intake was introduced in Chapter 5. Now that the elevated exercise 
derived energy demands of FDR has been confirmed and the magnitude documented, 
the importance of dietary intake to meet these demands is evident. Through 
examination of the habitual dietary intake of FDR and subsequent calculation of EA 




Chapter 7: Energy availability and intake of bone supporting 






The energy demands for locomotion of endurance athletes may double or even 
quadruple (Loucks et al., 2011). Demonstrated in Chapter 6 was the derivation of the 
additional energy demands from exercise (EEE). In addition to the energy cost of 
training itself frequent exercise will upregulate physiological processes that facilitate 
tissue adaptation, growth and repair (including muscle protein synthesis, glycogen re-
synthesis and likely bone metabolism). Nutrient intake should be sufficient to meet 
the energy demands of training, promote tissue adaptation (Maughan, 2002) and 
support the health and performance of athletes (IOC, 2011, Thomas et al., 2016). 
 
Dietary records amongst athletes were previously deemed inaccurate, attributed to 
under-reporting between 10-45% (Magkos and Yannakoulia, 2003). However as 
outlined early in Chapter 6 under-eating rather than under-reporting could be to blame 
for the discordance between energy intake (EI) and energy expenditure. In the absence 
of sufficient energy to meet the demands, disruptions to physiological functions 
(Loucks et al., 2011) result in a suppression of metabolism (Strock et al., 2020) in 
order to conserve energy. Disruptions to reproductive hormones (Loucks and Thuma, 
2003) and bone metabolism (Ihle and Loucks, 2004) are two consequences of reduced 
EA, resulting in indirect and direct deleterious effect on bone health. Although EA is 
well integrated into the TRIAD and RED-S paradigms (Nattiv et al., 2007, Mountjoy 
et al., 2014) the consequent nutrient deficiencies are often overlooked. Where energy 
intake is reduced (as in the seminal work of Loucks) macro and micro nutrient intake 
are likely to also be reduced, potentially inducing nutrient deficiencies. It may in fact 
be these nutrient deficiencies that drive the physiological maladaptation to LEA.  
 
Calcium and vitamin D are well established to have a role in skeletal health (Weaver 
et al., 2016). Maintenance of calcium homeostasis is imperative for numerous 
physiological functions. As identified early in this thesis the skeleton acts as a 
reservoir of calcium which can be released through bone metabolic activity regulated 
by the PTH-vitamin D endocrine system (IOM, 2011). Increased bone resorption in 
the absence of sufficient calcium to maintain homeostasis (through increased demand 
 
166 
and/ or decreased availability (achieved by insufficient calcium intake or failure of 
vitamin D to promote absorption from the intestine)) is therefore a cogent argument. 
 
More recently both protein and carbohydrate have also been implicated in bone health. 
Dietary protein provision is a critical influence on muscle protein synthesis 
contributing to net protein balance, supporting the acquisition and maintenance of 
muscle mass (Rasmussen and Phillips, 2003). Muscle mass in turn provides an 
anabolic stimulus to bone through application of tension. Greater protein intakes were 
previously a concern due to a belief that calcium release from bone would be required 
to counteract a metabolic acidosis occurring as a result of sulphur containing amino 
acids in animal proteins; a concept termed the acid-ash hypothesis (Dolan and Sale, 
2018). Calcium isotope studies demonstrated that although urinary calcium excretion 
is increased ~25% following an acute (4 d) high protein diet (2.1 g.kg-1), intestinal 
absorption is also increased 42% with a reduction in the fraction of urinary excretion 
derived from bone (Kerstetter et al., 2005). This has helped in appeasing the concern 
regarding excessive protein intake and bone. Increased energy demands of training are 
largely met through carbohydrate and fat oxidation. Tens of thousands of kilocalories 
worth of fat are available within body stores and so fat availability is not an issue. In 
contrast muscle and liver glycogen stores combined are limited to <400 g in a typical 
60 kg female athlete (Maughan, 2002). Carbohydrate availability can therefore 
become compromised during exercise (Burke et al., 2011). In an early commentary on 
EA amongst athletes Anne Loucks (2004) acknowledged that in sports where 
carbohydrate availability is a limiting factor for performance (including FDR) it may 
also be a limiting factor for skeletal and reproductive health. Much of the nutrient 
availability discussion has regressed to energy over the past decade. However this 
detail is of increasing importance in the context of contemporary fuel availability 
manipulations employed by athletes. Numerous training and/ or dietary strategies are 
employed by athletes that can result in acute or prolonged low carbohydrate 
availability in an effort to maximise training adaptations (Burke et al., 2018a). Recent 
studies give cause for concern on the implications of such strategies for bone. 
Hammond et al. (2019) demonstrated that low carbohydrate availability between 
training sessions (separated by 2.5 h) resulted in ~30% greater bone resorption 




condition. Heikura et al. (2020) reported a ~20% decrease in fasting bone formation 
markers (P1NP and OC) and an increase in post-exercise CTX following three weeks 
of low carbohydrate high fat training; changes that were not observed following the 
same training block completed with high carbohydrate intake and thus supporting 
greater carbohydrate availability.  
 
Dietary intake varies day to day in the normal population, resulting in a need to capture 
multiple days of food intake in order to deduce the habitual diet. In group studies of a 
population between three and seven days of dietary records are required to capture true 
energy, macronutrient and calcium intakes (Basiotis et al., 1987). In recognition of 
this, analysis is conducted on habitual intakes conducted over 7 days. However the 
varying energy and nutrient demands, depending on varying training loads (Maughan, 
2002) is acknowledged. Consequently the relationship of EA and carbohydrate intake 
are examined relative to EEE on a daily basis.  
 
This chapter aims to quantify the dietary adequacy of FDR for the support of bone 
health. The following research questions will be addressed: 
1. What is the energy availability of FDR? 
2. What is the calcium intake of FDR? 
3. What is the vitamin D intake of FDR? 
4. What is the carbohydrate intake of FDR? 
5. What is the protein intake of FDR? 
6. Is EA related to EEE? 
7. Is carbohydrate intake related to EEE? 
8. Is EA related to carbohydrate intake? 
 
7.2 Methods 
7.2.1 Study design and participants 
Data was collected in during the 7 day study (section 3.3.2). Within this chapter only 
the FDR data (n=7) is presented. The chapter focuses on the adequacy of nutrient 
intake of FDR. Energy expenditure was measured by DLW and SWP3 as described in 
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section 3.6. Habitual dietary intake was assessed by eFIR and analysed using Nutritics 
software (Nutritics™, Dublin, Ireland) as described in section 3.8. The validity of 
SWP3 to assess 24 h energy expenditure was presented and discussed in Chapter 6. A 
10% underestimation was observed. In the absence of an alternative measurement tool 
to capture EEE this chapter relies on the data captured by SWP3.  
 
7.2.2 Data analysis 
MDI  
Energy, carbohydrate, protein, calcium and vitamin D per meal was calculated using 
a pivot table (Microsoft Excel 2016). Meals that were classified as fluids were 
removed from the analysis due to the summation of daily intake within a day in many 
cases and the focus of analysis on bone influencing variables. Actual daily intakes 
(ADI) were calculated by summation of the meal level analysis. Mean daily intakes 
(MDI) were calculated by averaging the ADI. Only MDI, and ADI for carbohydrate 
and energy, are presented within the thesis. 
 
Energy balance 
Energy balance was calculated using Equation 7-1. 
3K	 G5.?. :WU = 3B − X33 
Equation 7-1: Energy balance equation 
Where EB is energy balance, EI is energy intake and TEE is total energy expenditure. 
All values are reported in kcal.d-1.  
 
Energy availability 
Due to the unsuitability of energy balance to assess energy adequacy where individuals 
are undernourished, and the importance of considering EEE in athletes (Loucks et al., 
2011) EA was calculated to assess the energy adequacy of FDR, and determine if they 
met their increased energy requirements derived from activity as shown in Equation 
7-2.  
3Y	(G5.?. GZWU) = 	
3B	(G5.?) − 333	(G5.?)
[[,	(GZ)  





EI was obtained from dietary records. FFM was derived from DXA measures. There 
is variation in the definition of EEE amongst the literature. Energy accrued during 
exercise or training is the most common definition used (Burke et al., 2018b). Loucks 
(2014) defines EEE as the amount of energy expended because of being an athlete. 
Defining EEE as energy expended during training is applied in this thesis. A further 
challenge in maintaining consistency, facilitating comparisons across the literature is 
highlighted by Loucks (2014). Measurement of energy expenditure during exercise 
includes resting metabolism. True EEE is the energy expended as a result of being an 
athlete, not resting metabolism or energy expended during other waking activities. 
Measured EEE typically overestimates EEE by ~2 kcal.kgFFM-1d-1. This correction is 
not frequently applied in the literature. Therefore two EA calculations are reported in 
this thesis: 
1. EA: EEE is the total energy expenditure during exercise 
2. EA corrected: Estimated BMR expended during exercise is subtracted from 
total energy expenditure during exercise to calculate EEE. BMR was estimated 
from the Oxford equation (Henry, 2005) as described in Chapter 6.  
 
A worked example of the calculation of EA is available in Appendix E. 
 
Dietary intake and training demands  
In recognition of varying energy, and carbohydrate demands, with differences in 
training the relationship of EEE with nutrient intake is examined through correlation 
as follows: 
1. EEE vs EA 
2. EEE vs CHO 





Participant characteristics were presented in Chapter 5 and Chapter 6.   
 
7.3.1 Energy  
EB evaluated using energy expenditure values measured by SWP3 and by DLW is 
shown in Table 7-1. The relationship of TEE with EI is shown in Figure 7-1. 
 
Table 7-1: Input parameters and resultant energy balance in FDR 












F1271 2796 2626 169 6% 3460 -664 -19% 
F1680 3339 2989 350 12% - - - 
F1706 2500 2563 -63 -2% - - - 
F1983 2567 2570 -3 0% 2700 -134 -5% 
F1985 3388 2553 834 33% 2842 545 19% 
F1986 2190 2626 -436 -17% 3226 1036 -32% 
F416 2574 2846 -272 -10% 3375 -801 -24% 
Mean 2765 2682 83 3% 3121 -418 -12% 








Figure 7-1: Daily TEE versus EI.  
TEE was measured by SWP3 (A) (n=39) and DLW (B) (n=33) 
 
Assessed by SWP3 mean energy balance was 3% suggesting that FDR consume 
adequate energy. Notably the range amongst the seven studied FDR was -17%-+33%. 
However considering the limitations of SWP3 outlined in Chapter 6 energy balance 
was also calculated using TEE measured by DLW in the five FDR for whom this data 
was collected. An energy deficit of 12% (418 kcal.d-1) was observed. 
 
EA is a more appropriate metric for athletes (Loucks et al., 2011). The mean EA for 
each participant and for the group is presented in Table 7-2. Analysed by group mean 
FDR had adequate EA (≥45 kcal.kgFFM-1) on ALL and EX only days. Corrected for 
BMR only three athletes did not achieve an average EA of 45 kcal.kgFFM-1. One of 
these athletes had an EA <30 kcal.kgFFM-1. There was a moderate negative correlation 
between EEE and EA (r=0.403, p=0.004) (Figure 7-2). When plotting the relationship 
of EEE and EA EX only days were included. The gym only day included by F1983 





Table 7-2: Energy availability parameters and result on ALL and EX days in 7 FDR 















   A B A B  A B A B 
F1271 45.7 2796 579 524 48 50 2736 676 612 45 46 
F1680 52.9 3339 653 579 51 52 3367 762 675 49 51 
F1706 45.9 2500 593 512 42 43 2629 691 597 42 44 
F1983 46.7 2567 538 471 43 45 2567 538 471 43 45 
F1985 48.4 3388 493 434 60 61 3365 575 507 58 59 
F1986 53.4 2190 703 628 28 29 2142 820 732 25 26 
F416 45.8 2575 719 631 41 42 2655 839 736 40 42 
Mean 48.4 2765 611 540 45 46 2780 700 619 43 45 
SD 3.1 413 78 70 9 9 411 107 96 9 9 
A indicates EEE not corrected for BMR.  
B indicates EEE was corrected for BMR.  
 
 
Figure 7-2: Scatterplot showing daily EEE versus EA  






The daily EEE, EI and resultant EA for each FDR is shown in Figure 7-3. 49% (24/49) 
of days were below the 45 kcal.kgFFM-1 threshold, including 16% (8/49) below 30 
kcal.kgFFM-1. 
 
Figure 7-3: Daily EEE, EI and resultant EA in 7 FDR 
EEE (○), EI (■) and resultant EA ( bar) are presented relative to minimum threshold for EA 
(solid black line) and recommended EA threshold (dashed black line). NONEX days are 
identified with white bars. Gym only day completed by F1983 is identified with a white and 
grey striped bar. EA was calculated from EEE measured by SWP3 and corrected for BMR 
(n=7 for each participant).   
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7.3.2 Nutrient intake 
MDI of macronutrient, calcium and vitamin D are presented in Table 7.3.  
 
Increased energy demands arising from elevated EEE will also increase carbohydrate 
oxidation, requiring greater carbohydrate intake to maintain carbohydrate availability. 
The relationship of CHO intake with EEE is shown in Figure 7-4. The relationship of 
CHO intake and EA is shown in Figure 7-5. 
 
Table 7-3: Individual and group mean macronutrient and micronutrient intake in 7 FDR 
 CHO Protein Fat Calcium Vitamin D 
F1271 5.9 ± 1.1 
46 ± 5% 
1.6 ± 0.2  
13 ± 2% 
2.3 ± 0.7  
40 ± 6% 
1166 ± 269 2.7 ± 2.0  
F1680 6.1 ± 0.9 
46 ± 6% 
2.4 ± 0.3  
18 ± 2 
2.1 ± 0.6  
35 ± 6%  
1774 ± 520 3.6 ± 3.0 
F1706 5.5 ± 0.9 
46 ± 4% 
2.7 ± 0.3  
23 ± 2% 
1.6 ± 0.3 
31 ± 3%  
2013 ± 319 18.9 ± 5.3 
F1983 4.4 ± 0.7 
36 ± 2% 
3.0 ± 0.9 
25 ± 6%  
2.1 ± 0.5 
39 ± 6% 
1481 ± 230 4.4 ± 4.7 
F1985 5.9 ± 1.6 
41 ± 7% 
2.8 ± 0.3   
20 ± 3% 
2.5 ± 0.5 
39 ± 7 
1223 ± 263 21.6 ± 11.8 
F1986 3.7 ± 0.5  
46 ± 5% 
2.0 ± 0.5  
25 ± 5% 
1.1 ± 0.2  
29 ± 5 
1315 ± 287 9.3 ± 3.9 
F416 6.0 ± 0.7  
56 ± 5% 
1.7 ± 0.2  
16 ± 2%  
1.6 ± 0.3 
33 ± 5% 
1356 ± 261  0.9 ± 0.9 
Mean ± SD 5.3 ± 0.9 
45 ± 6% 
2.3 ± 0.5 
20 ± 4% 
1.9 ± 0.5 
35 ± 4%  
1474 ± 287 
 
8.8 ± 7.7 
Macronutrient data is presented as g.kg-1 (line 1) and as a percentage of total energy intake 
(line 2). Calcium data refers to intake in mg, vitamin D refers to intake in µg. 
Participant mean ± SD are presented. Group mean ± SD were calculated from the 







Figure 7-4: Scatterplot showing EEE vs CHO 
(n=49). Individual participants are identified by colour. 
 
 
Figure 7-5: Scatterplot showing CHO versus EA 
(n=49). Individual participants are identified by colour. 
 
No relationship of carbohydrate intake with EEE was observed (p=0.480) (Figure 7-4). 




7.3.3 Dietary intake and bone metabolism 
To date BTM data has been presented as daily values to capture the variability within the data and the environmental influences or as a group 
(FDR and CON) mean. Within this chapter the focus has been on using a 7 d diary to capture habitual intake. Hence the mean BTM concentration/ 
amount for each participant is presented with the MDI of carbohydrate, calcium and EA (corrected for BMR) in Table 7-4.  
 
Table 7-4: Mean EA, carbohydrate, calcium and BTM concentration in 7 FDR  
 EA CHO Ca CTX P1NP uNTX fPYD fDPD 
 (kcal.kgFFM-1) (g.kg-1) (mg.d-1) (ng.ml-1) (ng.ml-1) (nM BCE d-1) (nmol.d-1) (nmol.d-1) 
F1271 50 5.9 1166 0.389 58.44 145.4 270.2 40.0 
F1680 52 6.1 1774 0.363 41.43 347.4 392.8 113.9 
F1706 43 5.5 2013 0.444 56.08 465.3 213.6 66.8 
F1983 45 4.4 1481 0.284 42.00 651.7 345.6 66.6 
F1985 61 5.9 1223 0.687 84.74 742.2 270.4 65.2 
F1986 29 3.7 1315 0.506 104.26 1074.8 699.2 124.9 
F416 42 6.0 1356 0.325 54.28 213.3 331.5 56.4 
Mean 46 5.3 1475 0.428 63.04 520.0 360.5 76.3 





Energy balance refers to the energy lost or gained from the body’s energy stores after 
physiological systems have done their work for the day (Loucks et al., 2011). Where 
TEE is measured by SWP3 the energy balance of the studied FDR was negligible 
(+3%) although considerable variability was observed (SD: 15%, range -17% to 
+33%). With TEE obtained for DLW measurements, to avoid misrepresentation due 
to underestimation of TEE (as shown in Chapter 6), an energy deficit of 12 ± 18% was 
observed. Using the metabolizable energy equivalents cited by Hall (2008) (17.6 
MJ.kg-1 (4207 kcal.kg-1) for glycogen,  39.5 MJ.kg-1 (9441 kcal.kg-1) for fat and 19.7 
MJ.kg-1 (4708 kcal.kg-1) for protein) the expected body mass loss with this energy 
deficit would be <0.1 kg and would hence be undetectable over a one week period. 
However in chronically undernourished athletes energy balance is inappropriate for 
determining energy status due to an underestimation of the energy requirements 
(Loucks et al., 2011). Therefore EA was evaluated. The group average EA of 46 ± 9 
kcal.kgFFM-1 suggests that FDR sufficiently compensate for their increased EEE 
through dietary intake. The maintenance of EA above 45 kcal.kgFFM-1 is considered 
sufficient to prevent excessive resorption and to support bone formation (Ihle and 
Loucks, 2004) and for the maintenance of normal physiological functions. Sub-
optimal EA (30-45 kcal.kgFFM-1) is likely tolerable for athletes but should be 
periodized within the training programme. LEA (<30 kcal.kgFFM-1) should be 
avoided by athletes to prevent unfavourable health and sports performance outcomes 
(Logue et al., 2018a).  Amongst the seven FDR two had average EA that were sub-
optimal with LEA evident in one FDR.  
 
The EA calculated in the Irish cohort was greater than that reported in Danish and 
Swedish elite weight bearing endurance athletes (international or competitive regional 
athletes) whose average EA was within the sub-optimal EA range (40 kcal.kgFFM-1 
(Melin et al., 2015), 43 kcal.kgFFM-1 (Melin et al., 2016)) where EI was calculated 
from 7 d food diary and EEE was calculated from heart rate related to oxygen 
consumption. Amongst national-world class athletes energy availabilities of 32 ± 12 
and 35 ± 9 kcal.kgFFM-1 were observed in AMEN and EUMEN runners respectively 
(Heikura et al., 2017b) (EEE was calculated from training logs). Melin et al. (2015) 
and Melin et al. (2016) reported energy intakes (2580 and 2766 kcal) similar to the 
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Irish cohort. However the EEE of 879 kcal and 940 kcal respectively (corrected for 
RMR and for non-exercise activity thermogenesis) was >50% greater than that of the 
Irish cohort. The reported LEA may therefore arise from a failure to sufficiently 
increase EI with elevated exercise demands above a certain threshold. The moderate 
negative correlation observed between EEE and EA amongst the Irish cohort would 
align with this. This may represent a problem in waiting should the studied FDR fail 
to adjust their intake with increased training demands in future. Exercise is known to 
acutely suppress appetite (Dorling et al., 2018). Amongst untrained men a failure to 
increase intake with elevated energy expenditure was observed (Stubbs et al., 2002). 
Where exercise frequency is increased (> 1 aerobic training session per day) this could 
expose the FDR to more frequent appetite suppressions putting them at risk of LEA. 
 
Although LEA was not observed on a group level and only one FDR had an EA <30 
kcal.kgFFM-1 51% of days were observed to have EA <45 kcal.kgFFM-1 including 
16% of days with EA <30 kcal.kgFFM-1. Whether these acute periods of reduced and 
low EA affect bone is currently unknown and is difficult to study in free living 
individuals.  
 
EA is widely implicated to have ill effects on bone in related position stands (Nattiv 
et al., 2007, Mountjoy et al., 2014). However the studies of bone metabolism are much 
more limited. The well cited study by Ihle and Loucks (2004) demonstrated that below 
EA of 30 kcal.kgFFM-1 bone formation was reduced 9-29%. Bone resorption was not 
affected when EA was reduced to 20-30 kcal.kgFFM-1 but an increase of 29% was 
observed at 10 kcal.kgFFM-1. Reduced EA (15 kcal.kgLBM-1) induced by diet alone 
resulted in a 20% reduction in bone formation. However induced through diet and 
exercise no change was observed (Papageorgiou et al., 2018). The mean baseline CTX 
(0.47-0.50) and P1NP (54.8-56.7)  concentrations reported by Papageorgiou et al. 
(2018) at baseline in the group were similar to those in the Irish cohort, as would be 
expected when EA is adequate. The mean EA and BTM values for individuals were 
presented in Table 7-4. F1986, who had an average EA <30 kcal.kgFFM-1, has the 
second highest CTX concentration and highest urinary resorption marker excretion, 
indicative that a maladaptation may occur. However this was accompanied with 
highest P1NP concentration suggesting that P1NP is not suppressed by the reported 




metabolic activity despite an average EA considered well within the adequate range 
suggesting the relationship of EA and bone metabolism is not as clear cut as is 
portrayed. Larger studies to further inform on this relationship are warranted.  
 
The relative absence of LEA is surprising, in part due to reports of LEA amongst 
endurance athletes globally (Melin et al., 2015, Heikura et al., 2017b, Muia et al., 
2016) and because 39.7% of active Irish females are deemed at risk of LEA (Logue et 
al., 2018b) when assessed by symptoms within the Low Energy Availability in 
Females Questionnaire (LEAF-Q) (Melin et al., 2014). FDR accounted for ~10% of 
this sample. Challenges in obtaining valid measures of the components of EA (EI, 
EEE and FFM) could contribute to the differences in EA reported amongst FDR 
(Burke et al., 2018b). In this study FFM was measured by DXA with precautions 
(detailed in Chapter 3) that endeavoured to minimise error. EI was obtained from a 7 
d prospective diary, deemed adequate for the collection of dietary intakes in athletes 
(Magkos and Yannakoulia, 2003). EEE was measured by SWP3. As outlined in 
Chapter 6 SWP3 underestimated energy expenditure and this could be biased towards 
EEE. This is a limitation of this study. Future EA observations should employ an 
alternative method of EEE measurement (heart rate related to oxygen consumption is 
commonly reported). Ideally a common method of measurement would be established 
by the community who include EA in their research. Widespread menstrual 
dysfunction was evident amongst the FDR causing a query regarding whether the 
intake captured was representative. In future studies of EA inclusion of a biomarker 
of energy status (triiodothyronine has been used previously (Strock et al., 2020)) 
would also help to validate whether the observed EA is truly adequate.  
  
A further consideration of EA is the resultant nutrient availability. Acknowledging the 
increased carbohydrate oxidation with exercise has resulted in increased carbohydrate 
recommendations for athletes (Burke et al., 2011). Noted in this chapter’s introduction 
was Anne Loucks’ commentary that carbohydrate availability could be the regulating 
factor in reproductive and skeletal health (Loucks, 2004). Mean carbohydrate intake 
amongst the FDR was 5.3 ± 0.9 g.kg-1. This is within the lower range (5-7 g.kg-1) of 
carbohydrate recommendations for moderate exercise (~ 1 h.d-1) and below the 
endurance training (moderate to high intensity exercise 1-3 h.d-1) recommendations 
(6-10 g.kg-1). Average intake considered in the context of the reported training volume 
 
180 
(8.9 ± 1.4 h.w-1) suggests that the carbohydrate intake may be sub-optimal amongst 
the studied cohort. Two FDR reported intakes <5 g.kg-1. Although these intakes are 
likely to be sub-optimal for performance the influence of carbohydrate itself on bone 
is relatively unexplored. One of the FDR with low carbohydrate intake also presented 
with LEA supporting the concept that EA is related to carbohydrate intake. A strong 
(r=0.7) positive correlation between carbohydrate and EA suggests that carbohydrate 
intake is in fact a determinant of EA. This finding could be a double edged sword. It 
suggests that adequate EA can be maintained through increased carbohydrate intake. 
However increased exercise (which has an appetite suppressing effect) would require 
increased carbohydrate intake which in itself has been shown to result in a decreased 
energy intake (Horvath et al., 2000). For this reason the relatively low (45 ± 6%) 
contribution of carbohydrate to total energy may protect the studied FDR by not 
amplifying the appetite suppressing responses experienced by FDR. No relationship 
between EEE and carbohydrate intake was observed in the studied cohort, suggesting 
that FDR do not respond (ad libitum or intentionally) to the increased demands. 
Although this may promote a greater energy intake (through reduction/ omission of 
appetite suppressing responses), whether failure to increase carbohydrate intake 
affects skeletal health is unknown. Furthermore this absence of dietary periodization 
could indicate a potential problem should these athletes increase their energy 
expenditure. As discussed earlier the more favourable EA observed in the Irish cohort 
appears to arise from similar EI to groups with greater EEE. The greater EEE was 
observed in international athletes including data collected during a training camp 
(Heikura et al., 2017b) where training volumes were ~25% greater (74.4 ± 7.2 vs 93.9 
± 29.9 km.w-1). If training volumes of the studied cohort increase without addressing 
the elevated carbohydrate demand FDR are likely to find themselves in a state of LEA 
with potential for deleterious skeletal and other health outcomes.  
 
The reported protein intake (2.3 ± 0.5 g.kg-1) was in the upper range of 
recommendations for athletes (up to 2.4 g.kg-1during energy restriction) (Phillips and 
Van Loon, 2011). This is advantageous is supporting lean mass. Considering the 
protein matrix in bone, which evidenced by the higher 24 h bone metabolism in FDR, 
appears to have a greater turnover in FDR the elevated protein intake could be 
beneficial in supporting formation required to maintain bone. Although the elevated 




carbohydrate intake which appears to be suboptimal, replacement of a proportion of 
the protein intake with the energy equivalent of carbohydrate could be beneficial.  
 
Amongst athletes a large portion of the dietary considerations for bone health focuses 
on EA. Amongst the general population two micronutrients, calcium and vitamin D, 
take precedence in discussions. The calcium intake reported in the studied FDR (1474 
± 287 mg.d-1) met the population reference intake (PRI) of 860 mg in 18-24 y and 750 
mg in ≥ 25 y (EFSA, 2017). The intake is close to but does not exceed the elevated 
recommendation of 1500 mg in athletes who present with menstrual dysfunction 
(Kunstel, 2005, Sale and Elliott-Sale, 2019) despite widespread menstrual dysfunction 
amongst the sample. Mean calcium intake was similar to that reported by 18-26 y 
female runners in the United States (1358 ± 681 mg) (Kelsey et al., 2007), and male 
and female runners in Norway (1503 ± 674 mg) (Klomsten Andersen et al., 2018).  
 
From population recommendations that are primarily based on supporting skeletal 
health (IOM, 2011) to catchy songs that have made television adverts ‘dem bones, dem 
bones need calcium’, the role of calcium in bone health is well established by scientists 
and the general population alike. What is less frequently discussed is calcium’s critical 
role in mediating vascular contraction and vasodilation, muscle function, nerve 
transmission, intracellular signalling and hormonal secretion (IOM, 2011). It is bone’s 
function as a mineral reservoir that makes calcium intake so important. Calcium 
homeostasis is crucial to many physiological functions and in response to disturbances 
calcium is released from bone. Continued release without replacement through bone 
formation will result in bone loss. Whether upregulation of numerous calcium 
regulated physiological processes alters the demand has not been widely discussed. In 
fact Kunstel (2005) stated that increased exercise in itself did not pose a reason for 
increased calcium requirements.  
 
Reduced calcium (8% per 100 mg) and dairy (41% per serving) has been associated 
with increased stress fracture risk in female runners (18-26 y) (Kelsey et al., 2007). 
High school runners who had elevated bone metabolism (>97% percentile of 
paediatric reference range) consumed 16% less calcium (1055 vs 1262 mg) than 
runners with normal bone metabolism (Barrack et al., 2010). 1300 mg is recommended 
for adolescents and 85% (elevated bone metabolism) and 50% of the runners failed to 
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achieve this intake. Gibson et al. (2004) reported no influence of calcium intake on 
BMD in elite FDR despite widespread (30%) low (<600 mg) calcium consumption 
and Bennell et al. (1996) reported no difference in calcium intake in female track and 
field athletes who sustained (1075 mg, 1277 mg by food frequency questionnaire) 
versus did not sustain (985 mg, 982 mg by food frequency questionnaire) a stress 
fracture during a 12 month prospective study.  
 
The influence of calcium on bone health indices – BMD, bone metabolism, fracture is 
somewhat unclear. A confounding variable may be a likely coexistence of calcium and 
energy insufficiencies. However challenges in assessing habitual calcium intake also 
contributes. Retrospective dietary analysis methods including food frequency 
questionnaires are more common amongst studies of calcium intake (Kelsey et al., 
2007, Klomsten Andersen et al., 2018) than were evident in the EA studies. 
Retrospective collection methods are challenged by the athletes’ ability to correctly 
recall and accurately describe portion sizes which could over/ underestimate actual 
intake (Larson-Meyer et al., 2018).  
 
Although increased calcium requirements due to greater exercise per se is not 
advocated, elevated calcium requirements due to increased sweat losses has been 
suggested (Sale and Elliott-Sale, 2019). Pre or during exercise ingestion of calcium 
was postulated to off-set the assumed losses diminishing the exercise induced bone 
resorption response. However increased sweat losses with different thermal conditions 
(warm vs cool) have recently been shown not to affect PTH or CTX response to 
exercise (Kohrt et al., 2019). Despite this, ionized calcium is a potent regulator of PTH 
and CTX response to exercise (Kohrt et al., 2018) suggesting that an alternative 
mechanism is at play – perhaps an upregulation of muscle activity or other 
physiological functions that rely on calcium signalling. In this case the timing of 
calcium may be more relevant. Haakonssen et al. (2015) reported downregulation of 
the exercise induced bone resorption response in female cyclists. However the pre 
exercise calcium consumption (1352 mg) was akin to the MDI amongst the studied 
FDR.  
 
In military recruits (who engage in physical activity ~60 min.d-1, 6 days per week) 




to reduce stress fracture incidence by 20% (Lappe et al., 2008) during basic military 
training. This could be interpreted as a beneficial effect of increased calcium intake. 
However given the magnitude and distribution (4*500 mg), calcium availability circa 
exercise is also likely to be greater than that achieved with habitual intakes and the 
distribution rather than absolute amount could be more pertinent.  The overall calcium 
intake was not reported. As the study occurred within a military training set up where 
meals were available in a galley, the meals consumed by the supplemented vs non-
supplemented groups are likely to be similar resulting in a considerable group 
difference in calcium consumption. The magnitude of supplementation could risk the 
daily intake exceeding the upper tolerable limit (2500 mg). Due consideration of the 
potential risks of such intakes in athletes should be addressed prior to widespread 
recommendation of increased intake, particularly as athletes train consistently over 
years in contrast to the short (8 w) period of supplementation reported by Lappe et al. 
(2008).  
 
Another consideration of the effect of supplement is the accompanying vitamin D 
which supersedes the recommended 15 µg (IOM, 2011). The studied FDR failed to 
consume the recommended amount with a mean intake of 8.8 ± 7.7 µg. Notably three 
FDR failed to consume even a third of this with intakes <5 µg. No FDR reported 
consumption of vitamin D supplements. Vitamin D has a key role in the regulation of 
calcium homeostasis through increased intestinal resorption and subsequent regulation 
of PTH. In states of reduced calcium absorption PTH will be activated increasing 
tubular reabsorption of calcium and stimulating osteoclast formation (Holick, 2010).  
Vitamin D is found in fish, eggs and fortified foods (IOM, 2011). These foods may 
not be consumed every week, particularly amongst collegiate athletes with limited 
budgets. The idea that the 7 d time frame failed to capture the habitual intake cannot 
be ruled out. However the observed vitamin D intake is of particular concern amongst 
Irish athletes studied between September and March. Ireland’s latitude of 51-56°N 
results in reduced sunlight exposure for six months of the year. Vitamin D status 
assessed by serum 25 OH D has been shown to decline over the winter months. 
Without vitamin D supplementation serum 25 (OH)D declined (~20%) in elite Irish 
athletes with 74% of athletes classified as vitamin D insufficient/ deficient in April/ 
May compared to 35% at baseline (Magee et al., 2013). The absence of  serum 
25(OH)D measurement in this study is a limitation but considering the time of year 
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and reported dietary intake, FDR are likely vitamin D insufficient which could 
compromise skeletal health. The IOC consider vitamin D a micronutrient supplement 
often required in athletes depending on UVB exposure (Maughan et al., 2018). The 
studied FDR would likely benefit from vitamin D supplementation, a predictor of 
vitamin D status (Todd et al., 2016). However it should be monitored to avoid toxicity 
(Maughan et al., 2018). Supplementation should not be considered a replacement for 
an inadequate diet (Larson-Meyer et al., 2018). Therefore addressing the dietary intake 
of vitamin D should be the first course of action amongst the studied cohort.  
 
7.5 Conclusion 
In summary, the findings in this chapter suggest that FDR studied in this thesis 
consume adequate energy for their requirements, assessed by both energy balance and 
EA where EEE was measured by SWP3. The EA of the studied FDR was greater than 
numerous other reports amongst FDR (Melin et al., 2015, Heikura et al., 2017b). 
Greater EEE amongst those groups rather than a greater energy intake amongst the 
Irish cohorts appears to explain this finding. EA is moderately negatively related to 
EEE and strongly positively related to carbohydrate intake in this cohort although 
increased carbohydrate intake in response to increased EEE was not evident. 
Appropriate periodization of carbohydrate intake in line with demand (Burke et al., 
2011) could be a strategy to prevent LEA occurring. Although mean EA was adequate 
a large prevalence of days with sub-optimal or low EA was observed. Further research 
is required to evaluate whether acute periods of LEA are detrimental to bone. adequate 
calcium and protein was consumed by FDR but vitamin D intake was below the IOM 
(2011). Due to the interactive effect of vitamin D on calcium absorption and knock on 
effect on bone metabolism to maintain calcium homeostasis further assessment of 
vitamin D status is warranted through assessment of serum 25(OH)D.  
 
Due to the small sample and the relatively homogenous energy and nutrient intake 
statistical analysis of nutrient intake and bone metabolism was not completed. Future 









8.1 Thesis summary 
This thesis examines an apparent paradox of bone’s response to exercise, one of the 
main modifiable influences on bone mass and fracture risk (NIH, 2001). As examined 
in Chapter 2 up to 60% of FDR present with a history of fracture, although there is 
variation in the literature (Table 2-5). Oftentimes low BMD and fracture data are not 
presented concurrently. Amongst Irish FDR 35% have a history of fracture as shown 
in Chapter 4. Amongst a sub-group with a similar fracture history (36%), 31% had low 
BMD assessed by DXA. However BMD had poor sensitivity (14%) in identifying 
individuals with prior fracture.  
 
Poor bone health amongst athletes counters the widely accepted benefits of exercise 
on fracture risk and bone mineral accrual (Stattin et al., 2017, Baxter-Jones et al., 
2008). However poor bone health has been evident in female athletes for over three 
decades now (Drinkwater et al., 1984). Traditionally inadequate energy intake and/ 
menstrual dysfunction has been used to explain poor bone health amongst female 
athletes (Barrack et al., 2014). Both the TRIAD and RED-S include energy, 
specifically EA, and menstrual dysfunction within the models (Nattiv et al., 2007, 
Mountjoy et al., 2014). Both LEA and menstrual dysfunction are known risk factors, 
and have been documented to alter bone metabolism (De Souza et al., 2008). Extensive 
research on the role and prevalence of LEA and menstrual dysfunction is warranted. 
However the role of exercise itself (rather than the interaction of diet and exercise) is 
not adequately acknowledged within the literature.  
 
BMD is the recommended measure of bone health. However in athletes it is challenged 
by their expected higher BMD and by the stable nature of the measure. BMD’s 
stability can result in long periods of time elapsing before maladaptive changes occur. 
In Chapter 5 a more dynamic measure, bone metabolism, was applied to examine 
differences in populations stratified by physical activity. Bone resorption, assessed by 
blood based marker CTX, has been reported to double in response to 60 min of 
endurance exercise (cycling) (Kohrt et al., 2018). Bone metabolism itself has been 
identified as an independent risk factor for fracture (Heaney, 2003). Reports of 




athletes, although some of this data was collected prior to the IOF recommendation of 
reference markers (Vasikaran et al., 2011a), and relies on a single blood or urine draw. 
The approach within this thesis captured habitual bone metabolic activity using a 7 d 
cross sectional design, measuring both homeostatic bone metabolism and 24 h bone 
resorption. Relative to a non-athletic reference CON, FDR had 31% lower CTX and 
15% lower P1NP. Using the bone marker plot (Bieglmayer and Kudlacek, 2009) bone 
turnover was calculated to be 25% lower in FDR compared to CON. However 24 h 
resorption, capturing within day perturbations in response to exercise and diet, was 
37% greater in FDR (assessed by uNTX). Together this suggests that FDR experience 
a positive adaptation of homeostatic bone metabolism but there is evidence of greater 
total metabolic activity that is likely exercise induced. The elevated 24 h resorption is 
indicative of exercise induced resorption, which may be necessary for osteogenic 
adaptation. Unfortunately absence of a urine based formation marker prevents a 
similar analysis of total formation. Widespread (86%) menstrual dysfunction amongst 
the FDR cohort with no menstrual disturbances reported by CON must be 
acknowledged. AMEN FDR have been reported to have suppressed turnover relative 
to EUMEN FDR and CON (Zanker and Swaine, 1998). The potential for menstrual 
status to be the influence differentiating the FDR and CON (rather than exercise as 
intended) cannot be excluded within the current dataset. Menstrual disturbances are 
closely linked with LEA (Lieberman et al., 2017). EA must also be considered, 
particularly given the menstrual disturbances reported.  
 
Dietary energy and nutrient intake has the potential to alter the homeostatic or 24 h 
bone metabolic responses, either exercise dependent or independently for 24 h 
metabolism. With 40% of active females in Ireland (not specific to FDR) known to be 
at risk of LEA (assessed by the LEAF-Q (Melin et al., 2014)) (Logue et al., 2018b) 
consideration of dietary intake was particularly pertinent. In Chapter 6 the TEE of 
FDR was 9% greater than CON, arising from a threefold greater EEE. Whether FDR 
successfully met this energy demand through dietary intake was addressed in Chapter 
7, as was dietary intake of nutrients known to support bone and of importance for 
athletes.  
 
Assessed by MDI, group EA was adequate at 46 ± 9 kcal.kgFFM-1. However 
evaluating the individual FDR, and particularly the daily EA sub-optimal and LEA 
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was prevalent amongst 3/7 FDR and in 49% of days. FDR consumed CHO (5.3 ± 0.9 
g.kg-1) within the lower range of the recommended CHO (5-7 g.kg-1) for their activity 
(Thomas et al., 2016) and CHO intake was strongly correlated with EA (r=0.7, 
p<0.001), suggesting that elevated CHO intake assists in maintaining adequate EA 
with elevated energy demands. Calcium (1474 ± 287 mg) and protein (2.3 ± 0.5 g.kg-
1) intake met recommendations (IOM, 2011, Phillips and Van Loon, 2011). FDR (8.8 
± 7.7 µg) failed to consume the IOM (2011) recommendation (15 µg) for Vitamin D.  
 
To this author’s knowledge habitual bone metabolism in FDR has not been previously 
examined using the extensive approach documented in this thesis. The novel finding 
of lower homeostatic metabolism, co-existent with greater 24 h resorption suggests 
that exercise does not adversely affect bone metabolism but does induce transient 
elevations in resorption. Such elevations may be necessary for osteogenic adaptation 
to exercise. In the absence of groups matched for menstrual status, and with the 
limitations of SWP3 to measure energy expenditure the potential for LEA and/ or 
menstrual dysfunction to be confounding influences cannot be ruled out.  
 
Within this chapter the implications of these findings for bone health of FDR, 
relevance of the findings to both applied and research communities and suggested 
advances in research are discussed.  
 
8.1.1 Poor bone health in FDR  
Fractures (mainly examined as stress fractures) have been observed in 18-60% of FDR 
(McCormack et al., 2019, Heikura et al., 2017b). By contrast low BMD has been 
documented in 0%-45% of FDR (Klomsten Andersen et al., 2018, Hind et al., 2006). 
Few have simultaneously assessed fracture and BMD. Both Heikura et al. (2017b) and 
(Tenforde et al., 2017) reported low BMD in ~17% of participants despite stress 
fracture histories in 60% and 38% respectively indicating poor sensitivity to identify 
FDR at risk of fracture. In many cases stress fractures are reported as incidence (per 
year) (Rizzone et al., 2017); an appropriate approach to estimate the burden or 
compare to other injuries but inappropriate to understand the number of individuals 





Using self-reported retrospective fracture data and cross-sectional BMD measurement 
by DXA amongst FDR in Ireland, fracture history was 35% (23% with stress fracture, 
15% with fragility fracture, 3% with both). Amongst a sub-group (n=39, fracture 
history: 36%), low BMD at the spine was observed in 31% of participants, including 
10% who also had low BMD at ≥1 hip site. In contrast to Tenforde et al. (2017) and 
Heikura et al. (2017b) the prevalence of poor bone health amongst FDR initially 
seemed in better agreement. However poor sensitivity (14%) and specificity (50%) of 
BMD to identify those with fracture history was observed. Use of BMD may be 
challenged by osteogenic effect of exercise. In young females who were active during 
adolescence and early adulthood total hip and femoral neck BMC was 8.6% and 9.5% 
greater than their low activity counterparts (Baxter-Jones et al., 2008). Even with use 
of the modified ACSM recommended Z-scores (Nattiv et al., 2007) this method may 
be insensitive as an index of bone health in FDR. A possible reason for this finding 
could be changes in BMD within the ‘normal’ range that will be undetected without 
serial scanning. This is particularly problematic where failure to accrue potential PBM 
is likely to elevate the risk of osteoporosis in later life (Hernandez et al., 2003). Where 
early intervention of an important health problem (accounting for severity and 
prevalence) has greater benefit than a later detection and intervention, screening is 
recommended (Wilson and Jungner, 1968). However an appropriate measure and valid 
tool that detects early stages of disease is needed for this function. The data presented 
in this thesis indicates that BMD is not a sensitive measure and will have limitations 
in screening. However the limitations of any one measure cannot be disregarded. 
Fractures, in particular stress fractures, are established to have multiple risk factors 
(Tenforde et al., 2013, Tenforde et al., 2016). Assessment of any one of these indices 
in isolation is likely to have limitations. A more comprehensive assessment of risk 
factors, as proposed by both the authors of the TRIAD Coalition Statement (Nattiv et 
al., 2007) and IOC RED-S Consensus Statement (Mountjoy et al., 2014), is likely more 
appropriate. Such an approach assigns a scoring system to identify varying levels of 
risk rather than the presence of absence of a disease. It enables individual risk factors 
to be identified and addressed. Where menstrual dysfunction and LEA are notable risk 
factors in bone health this may offer an advantage for other areas of health and for 
performance. Alternative measures of bone health may also contribute to the 
assessment of fracture risk. Where treatment is initiated a more sensitive measure, 
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bone metabolism, capturing the dynamic nature of bone metabolism may be of benefit. 
This approach may capture changes in fracture risk that occur independent of BMD.  
 
8.1.2 Bone metabolism and exercise – friend or foe? 
Exercise supports bone mineral accrual (Baxter-Jones et al., 2008), prevents loss 
(Engelke et al., 2006) and is associated with decreased fracture risk (Stattin et al., 
2017). Acute increases in bone resorption have been observed in response to weight 
bearing (Daniel and Jakeman, 2008, Scott et al., 2011) and non-weight bearing (Kohrt 
et al., 2018) endurance exercise. The observation of greater total bone resorption in 
FDR, an active population, compared to CON, assessed by uNTX is in line with these 
observations. Exercise induced bone metabolism, particularly resorption, is often 
interpreted as detrimental to bone; a reasonable interpretation when bone metabolism 
is an independent risk factor for fracture (Heaney, 2003). However bone metabolism 
plays a critical role in supporting the integrity of bone, through removal of micro 
damage and perhaps more significantly through facilitating changes (including 
increases) in bone mass. Resorption is accepted as the initial stage of the bone 
remodeling cycle which is followed by formation (Eriksen, 2010). Perhaps the acute 
increases in bone resorption are an essential part of the adaptive process. Changes in 
P1NP are generally not observed in acute trials, but a time delay between processes 
may account for this. Blunting of bone resorption could attenuate/ prevent crucial 
adaptive processes within bone.  
 
Where changes in bone metabolism could be deleterious is if homeostatic metabolism 
is increased. However assessed by CTX, bone resorption was 31% lower and 
formation assessed by P1NP was 15% lower in FDR, resulting in a 25% lower bone 
turnover and 15% greater bone balance (indicative of formation) when assessed by the 
bone marker plot (Bieglmayer and Kudlacek, 2009). This preliminary finding offers 
encouragement that endurance running itself is not harmful to bone. The potential 
influence of LEA and/ or menstrual function has been discussed in Chapter 5 and noted 
earlier in this Chapter. A larger study including prospective observation of fracture 
incidence and longitudinal changes in BMD is warranted prior to extrapolation of this 
finding. Should further evidence emerge BTMs may in time become a biomarker of 




processes that underpin changes in bone mass, reflected in BMD. BMD itself reflects 
the net effect of genetic and environmental influences over the lifetime. Change in 
BMD captures the net effect over a specified time. Where low BMD is detected BMD 
is an effective measure of fracture risk. Heaney (2003) proposed that change in 
fracture risk occurred independent of BMD and that bone remodeling could be a more 
appropriate measure. The dynamic nature of measuring bone metabolism, reflecting 
bone remodeling, may enable a real time measure of fracture risk. It is however 
unlikely to perform any better for identification of individuals with retrospective 
fractures than BMD (Chapter 4). Bone metabolism can be assessed from blood 
samples which may make it an attractive measure where DXA access is not possible. 
Similar to recommendations for BMD it is likely best used as part of a battery of tests 
to evaluate fracture risk. Changes in BTMs have been shown to explain changes in 
fracture risk in response to pharmaceutical treatment (Eastell et al., 2003). But there 
is a need to examine their efficacy in fracture risk assessment amongst athletes. A 
large prospective study will be required for this purpose.  
 
Although the direction of response  in 24 h resorption (i.e. elevated) is in line with the 
existing literature, the magnitude of the observed response (37%) suggests that either 
the duration of exercise induced resorption is longer than previously documented (4 h 
(Kohrt et al., 2018)) or the magnitude of response is accentuated in the studied cohort. 
Feeding has been shown to suppress (-17.8%) bone resorption (Clowes et al., 2002) 
whereas failure to consume sufficient energy to meet the demands of exercise and 
other physiological functions can result in a 29% reduction in formation and a 29% 
increase in resorption (Ihle and Loucks, 2004) (at 10 kcal.kgFFM-1). The observed 24 
h resorption response is indicative of an exercise induced response. However 
assessment of the nutrient adequacy of FDR must be considered before drawing such 
a conclusion.  
 
8.1.3 Energy demands of distance running and their role in bone health  
In order to assess the nutrient adequacy, an understanding of the demands is required. 
The work of Anne Loucks who demonstrated altered bone metabolism in LEA (Ihle 
and Loucks, 2004) has been central in the recognition of nutrient adequacy in bone 
health. Amongst athletes EEE in particular should be considered in the analysis of 
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energy and nutrient adequacy (Loucks, 2004, Loucks et al., 2011). It is EEE that 
determines the energy requirement, in order to maintain EA at a given FFM, as 
operationally defined by Loucks:  
!" = !$ − !!!&&'  
 
Measurement of energy expenditure, particularly in free living athletes, is challenging. 
Despite common use of the term ‘energy availability’ amongst scientific and applied 
sports communities (Ackerman et al., 2020), measurement methods and activities 
included within exercise energy expenditure vary within the published literature 
(Burke et al., 2018b). Loucks (2014) stated that EEE refers to energy expended as a 
result of being an athlete, this infers that only training sessions should be included, 
this is the most common approach in the existing literature (Burke et al., 2018b).  
 
Heart rate (Melin et al., 2015) and estimation based on the MET equivalent of 
activities (Heikura et al., 2017b) are two methods used to quantify EEE. Heart rate 
calculations requires prior lab based measurement of oxygen consumption. MET are 
an estimation. Neither method facilitates TEE and EEE to be calculated from a single 
device. An on-body device that can accurately measure energy demands would 
support appropriate dietary recommendations. SWP3 is such a device, but in a 
comparison of TEE to DLW in 24 h epochs SWP3 underestimated TEE by 10% with 
wide limits of agreement (-1219 - + 613 kcal.d-1).  
 
Even acknowledging the underestimation of energy expenditure by SWP3, TEE 
assessed by SWP3 was 9% greater in FDR than CON, arising from a threefold greater 
EEE. These elevated energy demands need to be accompanied by energy intake to 
maintain adequate EA to support all other physiological functions, including bone 
health.  
 
At a group level the mean EA (46 ± 9 kcal.kgFFM-1) (corrected for BMR to replicate 
the analysis of Ihle and Loucks (2004)) replicated the energy balanced condition 
documented by Ihle and Loucks (2004)). No deleterious effect (arising from an energy 
inadequacy) on bone would be expected at this level. Notably amongst the studied 




lower rate of activity and positive bone balance suggests that FDR benefit from the 
regular exposure to exercise. Regarding the 37% greater 24 h resorption observed 
amongst FDR, an energy inadequacy is not evident, and supporting the idea that 
exercise is the driver of this response.  
 
Some consideration of the variability in energy is however required. Amongst the 
seven studied FDR three had average (corrected) EA between 30 and 45 kcal.kgFFM-
1. With a further one FDR reporting an EA <30 kcal.kgFFM-1, resulting in 57% of the 
cohort failing to maintain optimal EA. Additionally sub-optimal EA (<45 kcal.kgFFM-
1) was observed on 49% of days. A moderate negative correlation (r=0.403, p=0.004) 
was observed between EA and EEE, showing that with elevated EEE FDR can fail to 
adequately increase their intake. This is in line with a suppressive effect of exercise 
on ad libitum energy intake (Stubbs et al., 2002), resulting in appetite not being a 
reliable indicator of energy needs in athletes (Loucks et al., 2011). Whether these acute 
energy deficiencies, in the presence of an average adequate EA, either are harmful to 
bone, or hinder the response to exercise is unknown. There is a need to compare bone 
metabolism during these different patterns of EA adequacy, in order to ascertain 
whether these acute periods of LEA are of concern.  
 
8.1.4 Beyond energy – nutrient regulation of bone     
EA is a key component of both the TRIAD and RED-S (Nattiv et al., 2007, Mountjoy 
et al., 2014). Evident through the strong correlation of carbohydrate and EA (r=0.7, 
p<0.001) carbohydrate intake appears to play a critical role in maintaining EA. In the 
key paper of LEA induced alterations of bone metabolism (with up to 29% reductions 
in formation and 29% elevation in resorption) carbohydrate restriction played a central 
role in inducing these restrictions, with an 83% reduction in carbohydrate availability, 
contributing to a  58% reduction in EA (Ihle and Loucks, 2004, Loucks and Thuma, 
2003). This poses the question of whether carbohydrate or energy has greater 
influence. Recently Heikura et al. (2020) showed that both fasting and exercise 
induced bone resorption was increased following a three week low carbohydrate high 
fat diet during intense training, with no change observed when a high carbohydrate 
diet was followed, raising further concern regarding carbohydrate availability. The 
carbohydrate intake of the FDR studied within this thesis was 5.3 ± 0.9 g.kg-1, within 
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the lower recommended range (Burke et al., 2011). The individual average intakes 
ranged from 3.7 ± 0.5 g.kg-1 to 6.1 ± 0.9 g.kg-1. The relationship of carbohydrate intake 
and EA, combined with the moderate negative relationship of EEE and EA suggests 
that carbohydrate intake may be an area requiring further interrogation. This future 
research needs to further inform the effect of acute carbohydrate restriction on both 
homeostatic and exercise induced bone metabolism. Hammond et al. (2019) have 
published preliminary data which suggests that carbohydrate availability could be as 
important as EA in regulating exercise induced bone metabolism. CTX was elevated 
~30% in both a carbohydrate and energy restricted  (3 g.kg-1, 20 kcal.kgFFM-1) and 
carbohydrate only restricted condition (3 g.kg-1, 60 kcal.kgFFM-1) relative to a high 
carbohydrate (12 g.kg-1, 60 kcal.kgFFM-1) condition. However provision of 
carbohydrate (vs no energy) during exercise could have influenced the response. 
Armed with this knowledge a consideration of whether FDR periodize their 
carbohydrate intake, to support bone (as well as performance) needs to be considered. 
Heikura et al. (2017a) report limited evidence of elite endurance athletes 
microperiodizing their intake with no difference in daily carbohydrate intake between 
days of differing training demands, but approximately 30% greater post-exercise 
carbohydrate intake on days including prolonged or intense training. Whether a failure 
to periodize carbohydrate, likely resulting in transient periods of low carbohydrate 
availability alters bone metabolism needs to be addressed.  
 
EA and carbohydrate are key nutrient considerations for athletes. However adequate 
provision of known bone supporting nutrients, notably calcium and vitamin D are 
equally important. FDR consumed adequate calcium to meet the RDA (IOM, 2011). 
Whether exercise requires elevated, or redistributed calcium is unclear (Kunstel, 
2005). The RDA for calcium in adolescence and post-menopausal females/ males >70 
y is 20-30% greater than that of adults at PBM, in recognition of the need to accrue 
bone and to minimise losses. Similarly a 50% increase (relative to adulthood 
recommendation) is recommended for female athletes with a menstrual dysfunction. 
This thesis reports 37% greater bone resorption amongst FDR compared to CON. This 
is a novel finding and could indicate an elevated need for calcium, to provide adequate 
nutrient for the replacement of mineral stores. The timing of such calcium intake 
should be considered though. Haakonssen et al. (2015) attenuated the exercise induced 




exercise meal. Following a low calcium (46 ± 7 mg) meal CTX concentration was 1.2-
1.4 times greater than the calcium rich condition in the 100 minutes post-exercise. 
However as discussed in section 8.1.2 attenuation of exercise induced bone 
metabolism may inhibit the osteogenic effect. A greater understanding of the 
cumulative effect of exercise induced bone metabolism on fracture risk is needed prior 
to further investigation of nutrient modification of the response. However if FDR do 
have elevated calcium requirements the timing of such requirements relative to diurnal 
rhythm could be an approach. In post-menopausal females night-time calcium and 
protein supplementation reduced CTX, analysed by area under the curve by 32% 
resulting in a 10 ± 16% 24 h reduction of uNTX (Hettiarachchi et al., 2019). A similar 
approach could be employed in FDR to prevent interaction with exercise.  
 
The reported vitamin D intake (8.8 ± 7.7 µg) only achieved 58% of the recommended 
15 µg (IOM, 2011). This is of particular concern amongst a cohort where samples 
were collected during the winter at a northern latitude, likely resulting in a vitamin D 
insufficiency or deficiency, assessed by 25(OH)D. In the absence of vitamin D 
adequacy, the regulatory actions of vitamin D on calcium homeostasis including 
stimulation of release (from bone, mediated through PTH) and upregulated absorption 
(from the intestine and some reabsorption for the renal distal tubules) could be altered. 
Where calcium homeostasis is challenged daily, or multiple times daily, through 
exercise this could be particularly problematic. Examination of vitamin D status by 
25(OH)D amongst the studied cohort is needed to assess if they are at risk of ill effects 
from vitamin D deficiency.  
 
8.2 Strengths of study design   
This study employed a novel, thorough examination of bone metabolism amongst a 
cohort of clearly defined athletic individuals. This resulted in a sample with a 
relatively similar training schedule (a maximum of 1 day without exercise), and 
including similar types of training – with 1-2 key training sessions, a longer run and 
some steady runs, along with strength and conditioning (an emphasis on calisthenics 




Through use of a 7 day design the habitual exercise and diet of FDR was captured, 
providing a representation including typical day to day variation. 7 days is deemed 
adequate for the assessment of energy and macronutrients in athletes (Magkos and 
Yannakoulia, 2003). The nature of the study also involved daily interaction with the 
participants, allowing for queries regarding documentation of the eFIR or training log 
to be addressed in conversation. 
 
Both 24 h resorption and homeostatic bone metabolism were captured, the first study 
in athletes to do, to this author’s knowledge. Although urine BTMs have been a 
concern due to the requirement to correct for creatinine, the approach employed 
allowed creatinine to be advantageous in this case, allowing for verification of the 




The success in studying a clearly defined population is a strength of the thesis. 
However recruitment of this population, a relatively small population, limited the 
sample sizes attained and resulted in prolonged recruitment processes.  
 
Neither EA nor menstrual status was recorded amongst the FDR recruited in the study 
reported in Chapter 4 (fracture history and prevalence of low BMD). Both are 
established risk factors for poor bone health. Addition of this data via questionnaire 
(e.g. LEAF-Q (Melin et al., 2014)) would have provided an indication of whether the 
FDR studied in Chapters 5-7 were representative regarding risk factors of the larger 
sample.  
 
In developing a novel, thorough approach to examine bone health amongst FDR, a 
commitment that was somewhat onerous and required daily lab attendance was 
required by participants. This limited the recruitment to individuals within the vicinity 
of either lab which may not have been fully representative of the population. However 
establishing a test site at a university with an established scholarship programme, and 
notable success (DCU won all intervarsity competitions during the academic year of 




Recruitment at universities resulted in participants being in their late teens and 
twenties, who may not have fully mature skeletons.  
 
Four of seven data sets from FDR were collected in Dublin City University (DCU). 
The support from researchers in DCU was essential for this. This resulted in use of 
blood collection containers from a different manufacturer which may have added to 
the pre-analytical variability, but is likely negligible relative to the magnitude of 
influence of environmental factors.  
 
Participant criteria aimed to clearly differentiate between groups. However, there was 
considerable variation within the CON group with 0-4 d of activity reported although 
none exceeded 3 h of vigorous PA as per criteria.  
 
Omission of females from research has been criticised in recent years (Costello et al., 
2014). Fluctuations in reproductive hormones pose an additional challenge for the 
study of females (Elliott-Sale and Martin, 2013). Many studies occur within the early 
follicular phase to minimise fluctuations in hormone concentration. Due to collection 
of 24 h urine samples, testing began in the mid-follicular phase. Changes in oestradiol 
within the test week could affect results. Resources available did not allow for 
measurement of oestradiol to assess its influence on bone at the current time. 
Hormonal contraceptive users were excluded from the study. However groups were 
not controlled for menstrual status. Current or past menstrual dysfunction was evident 
in all FDR and not in CON. Although this could contribute to the group differences 
this was considered appropriate due to the possibility that menstrual dysfunction 
amongst athletes could be representative (although harmful) of the phenotype. 
Menstrual dysfunction amongst athletes is most likely functional hypothalamic 
amenorrhea arising from states of LEA, a common characteristic amongst the 
population. Amongst CON menstrual dysfunction as a result of another clinical 
condition e.g. polycystic ovarian syndrome is more plausible. If suppressed oestrogen 
were mediating changes in bone metabolism, elevated activity would be expected, a 




8.4 Practical relevance of findings 
The TRIAD was first discussed almost 28 y ago (Yeager et al., 1993). A prevalence 
of 35% and 31% of fracture history and low BMD respectively amongst FDR indicates 
FDR remain a population at risk almost three decades on. Benjamin Franklin’s axiom 
“an ounce of prevention is worth a pound of cure” is particularly admissible in the 
context of bone health. A limited window of opportunity exists to acquire bone mass 
sufficient to support daily life and have a reserve to withstand the well-documented 
age-related decline in mass and increase in fracture risk (NIH, 2001). Athletes, coaches 
and their support team face an additional challenge where some training or dietary 
behaviours, and the resultant phenotype that may be favoured for performance pose a 
threat for the development of bone. Tools that can identify early maladaptation are 
crucial to inform athletes and coaches, before they face time away with injury, or 
worse put themselves at long term risk of health.  
 
Although stress fractures are multi-faceted, influenced by biomechanical factors, and 
training load, and training history in addition to bone health, the low sensitivity of 
DXA described within Chapter 4 indicates limitations of DXA as a common 
measurement tool in young, active individuals. By definition BMD requires the 
development of pathological bone status prior to diagnosis of poor bone health, a 
process which could take years, preventing early intervention during a window of 
opportunity (adolescence and early adulthood). In a similar fashion to resting heart 
rate being used within early detection of non-functional over-reaching (Kellmann, 
2010), BTMs may provide an early index of altered bone health. This thesis presents 
evidence of lower homeostatic bone metabolism amongst FDR, relative to CON. The 
studied FDR had adequate EA assessed over 7 d. There may be a need to interpret 
BTM results within a specific ‘athlete’ range (similar to the principles of modified 
ACSM BMD thresholds in athletes (Nattiv et al., 2007)). Over time such a database 
may become available.   
 
A shorter term advance in BTM use in practice could be in monitoring treatment (to 
lifestyle changes) as evidenced in pharmaceutical response monitoring (Naylor et al., 
2016). Such an advance would allow early detection of response or non-response, 




could also encourage compliance with increased dietary intake, the recommended 
treatment strategy for poor bone health arising from TRIAD or RED-S associated 
conditions (De Souza et al., 2014a, Mountjoy et al., 2018). This final point may be 
particularly useful in monitoring athletes with a history of disordered eating/ eating 
disorders who may be reluctant to engage in considerable behavioural changes.  
 
For applied scientists and researchers alike, who work in the area of exercise 
physiology and sports nutrition, quantification of the energy demands of athletes is of 
great importance. The underestimation of energy expenditure amongst FDR, measured 
by SWP3, supports previous evidence amongst triathletes (Koehler et al., 2011) that 
SWP3 is not an ideal measure of energy requirements in athletes.  
 
A further application of the research exists beyond athletes. With sufficient EA, 
endurance exercise appears to induce a more favourable homeostatic bone metabolic 
profile (25% lower rate and 15% greater balance) evidenced through a comparison of 
two distinct populations. This infers a reduced fracture risk (Heaney, 2003). Weight 
bearing, endurance exercise may therefore be an appropriate modality to promote bone 
health. In a country where only 41-51% of females aged 15-34 y achieve the current 
physical activity guidelines, students spend the most time sitting and time is cited as a 
barrier to change (Healthy Ireland, 2019), an activity that can be initiated from home 
or work, provide a social outlet or time outside, and is of relatively low cost can 
contribute to a positive public health strategy.  
 
8.5 Summary and recommendations for future research 
The history of fracture (35%) and prevalence of low BMD (31%) supports previous 
evidence that poor bone health is a concern for FDR. The discordance between 
individuals with fracture history vs low BMD, resulting in poor sensitivity (14%) 
provides some explanation to a wide variety of prevalence estimates amongst FDR 
(although this is also influenced by population (e.g. age, competitive level)). More 
importantly this finding indicated limitations of using BMD to assess bone health in 
young, active individuals to assess fracture risk. This thesis documents a difference in 
bone metabolism in two groups stratified by PA which is indicative of beneficial 
effects of activity. However whether bone metabolism does actually predict fracture 
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risk in FDR is currently unknown. Using a prospective approach, similar to an 
investigation of nutritional effect on stress fracture and changes in BMD (Nieves et 
al., 2010), baseline bone metabolism and its relationship to future fracture 
development and BMD would assist in informing on whether bone metabolism is an 
appropriate measurement tool to assess bone health in FDR.  
 
With the aim of advancing the understanding of the exercise induced adaptation (or 
maladaptation) of bone this thesis employed a novel design to concurrently study 
habitual homeostatic bone metabolism and total daily resorption, revealing a 
differential response – with a lower homeostatic metabolism but greater 24 h 
resorption in FDR. This begs the question of whether acute exercise induced 
perturbations are required to elicit the beneficial effects of exercise on the skeleton, 
whether these are BMD dependent or independent.  
 
In order to confirm the stimulus for elevated 24 h resorption in FDR is in fact exercise, 
a lab based study (as opposed to one conducted in free living subjects) delivering an 
ecologically valid exercise stimulus should be conducted. This study would compare 
EX vs NONEX conditions, with concurrent measurement of the acute response of 
CTX and P1NP and 24 h resorption by uNTX (due to its similarity to CTX). The 
nutrient provision in each condition needs to account for a difference in demand (by 
providing greater energy and carbohydrate to replace the expenditure during exercise) 
and should be delivered in an equal number of feeding occasions. CTX and P1NP 
measurement should at minimum allow for collection of a pre-intervention sample and 
continue for at least 4 h post exercise, the period of known response to endurance 
exercise. This in itself informs on the acute response to running, which to date has not 
be satisfactorily examined. Continued collection of blood samples over 24 h would 
enable understanding of the magnitude and time course of the exercise induced 
response. Such as study would require access to a clinical set up. This approach has 
previously been used to examine the effect of EA on reproductive hormones (Loucks 
and Thuma, 2003).  
 
An advancement on this study would then be to examine whether the acute 
perturbations to exercise differ between FDR and CON i.e. is there a group*condition 




considered and should be of ecological validity. A time matched approach may be 
most appropriate. In a time matched approach, at a constant relative intensity 
(prescribed as a percentage of VO2max) both the number of steps (impacts) and 
metabolic cost are likely to be greater in FDR, in line with the habitual exercise of the 
groups. This would inform whether the observed group difference in 24 h resorption 
arose from lower frequency of exercise amongst the CON, or a difference in the 
magnitude of the response.  
 
In the studied cohort of FDR, menstrual dysfunction was prevalent. Whether this has 
any interactive effect on exercise is not known. A comparison of FDR with and 
without menstrual dysfunction would inform whether exercise induced bone 
metabolism is altered depending on menstrual status. Similarly group EA was 
adequate in the small sample studied. An examination of both homeostatic bone 
metabolism and total resorption based on EA status is warranted. In spite of the 
onerous task of collecting 7 d of data this approach allows capture of habitual 
responses. In comparison of responses by menstrual or EA status a capture of multiple 
days would be best. For the comparison of EA in particular, where acute (5 d) energy 
restriction is known to alter homeostatic bone metabolism, a cross over design may be 
more appropriate, although if the 7 d approach is employed this would require 2*7 d 
collection of 24 h urine. Compliance needs to be considered in this scenario.  
 
Similar to the need to assess the influence of homeostatic bone metabolism on fracture 
and BMD outcomes, the effect of total resorption on BMD also needs to be 
understood. This task will be a considerable undertaking. However understanding the 
role of exercise induced perturbations is necessary in order to ascertain whether 
attenuation of the response through nutrient provision, particularly in close proximity 
of training sessions, is beneficial or detrimental to bone health.  
 
As identified in Chapter 7 the mean group EA was adequate and carbohydrate intake 
was within the recommended range. However sub-optimal or low EA was evident on 
49% of the studied days. Whether these transient periods of LEA can be tolerated 
(preventing harmful bone metabolic responses) with a mean adequate EA is currently 




Throughout these investigations, some of which will require large sample sizes, a 
biobank of bone metabolism can be formed. In time an appropriate reference range 
which can be used to identify individuals who may be at risk can be generated. If this 
biobank can be successfully constructed with known associations of fracture risk and 
changes in BMD this may provide athletes, coaches and support staff with an early 
indicator allowing them to intervene and monitor responses.  
 
8.6 Conclusion  
Through published literature and the findings in this thesis poor bone health is 
identified as a problem for at least a third of FDR. Through a novel study of bone 
metabolism, differential effects of exercise were observed depending on modality of 
measurement. Future research should take advantage of the methods developed in this 
thesis to understand the mechanisms of adaptation or maladaptation that ultimately 
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 Body composition and bone densitometry 
precision assessment  
Following approximately 100 scans a precision calculation was completed by the 
single researcher who performed all body composition and bone densitometry scans 
used in this thesis (JH).  
 
Methods: 
A convenience population approximately representative in age (19-38 y) was recruited 
by word of mouth under the remit of the UL Body Composition Study (ULREC 08/07, 
risk assessment procedures updated in 2019: 2019_01_08_EHS_RA (Measurement of 
the body composition of adult men and women aged 18-80y by dual energy x-ray 
absorptiometry), 2019_01_07_EHS_RA (Measurement of the body composition of 
adult men and women aged 18-80y by bioelectrical impedance analysis)). The 
procedure was explained to participants as per the research methodology described in 
Chapter 3. The recommendation for a precision calculation as cited in an ISCD White 
Paper (Baim et al., 2005) was also explained to participants prior to consent.  
 
The standardised pre-test conditions were applied and participant compliance was 
verbally confirmed on arrival at the laboratory. Following re-iteration of the protocol 
participants provided informed consent. Data was collected as described in Chapter 3. 
On completion of the first set of scans (total body, lumbar spine, proximal femur 
(dual)) participants were asked to stand up. They then returned to the bed, were 
repositioned and a second measurement was completed. Of the initially recruited 
population off-set scanning was required in one participant. This participant was 
excluded from the analysis and a further participant was recruited so that 30 
participants (11 male, 19 female) were scanned in duplicate. The previously described 
ROI analysis was completed on all scans.  
 
Following extraction of the data the mean and standard deviation (SD) of trial 1 and 
trial 2 were calculated for total fat mass, total lean mass, region percentage fat mass, 
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and BMD of L1-L4, femoral neck, total hip measurements. The precision error was 
calculated as follows: 
()*+,-.
/  
The precision error was expressed in absolute terms and as a percentage relative to the 
mean (coefficient of variation (CV)) (Baim et al., 2005).  
 
Results: 
Demographics of the sample are shown in Table A-1. 1 male participant had a Z-score 
≤-1 at the spine. No female participant had a Z-score ≤-1 at any site.  
 
Table A-1: Demographics of the participants recruited for a precision calculation 
  All (N=30) Male (n=11) Female (n=19) 
Age (y) 27.7 (4.6) 27.2 (1.8) 27.8 (5.3) 
Height (m) 1.713 (0.083) 1.777 (0.041) 1.664 (0.051) 
Mass (kg) 71.2 (10.7) 79.0 (7.8) 66.4 (9.2) 
BMI (kg.m-2) 24.2 (2.9) 25.1 (2.7) 24.0 (3.1) 
Fat mass (kg) 17.4 (7.3) 13.9 (3.2) 18.8 (8.1) 
Lean mass (kg) 49.9 (9.3) 62.0 (7.5) 44.8 (3.4) 
BMC (kg) 2.9 (0.5) 3.4 (0.4) 2.6 (0.3) 
% region fat (5) 25% (9%) 18% (4%) 27% (9%) 
L1-L4 BMD (g.cm-2) 1.296 (0.153) 1.330 (0.186) 1.282 (0.135) 
Left femoral neck (g.cm-2) 1.157 (0.176) 1.258 (0.252) 1.115 (0.105) 
Left total hip (g.cm-2) 1.171 (0.164) 1.266 (0.202) 1.131 (0.125) 
Right femoral neck (g.cm-2) 1.154 (0.169) 1.256 (0.235) 1.112 (0.106) 
Right total hip (g.cm-2) 1.181 (0.159) 1.270 (0.195) 1.144 (0.123) 
 






Table A-2: Precision errors calculated from 30 young, healthy participants scanned on the 
same day with repositioning between scans 
 Variable Absolute CV (%) Minimum acceptable 
precision 
Total fat mass (kg) 0.2 1.2% 3% 
Total lean mass (kg) 0.2 0.5% 2% 
Total region % fat (%) 0.3% 1.3% 2% 
Total BMC* (kg) 0.0 0.4%  
L1-L4 (g.cm-2) 0.010 0.8% 1.9% 
Left femoral neck (g.cm-2) 0.018 1.5% 2.5% 
Left total hip (g.cm-2) 0.011 1.0% 1.8% 
Right femoral neck (g.cm-2) 0.018 1.5% 2.5% 
Right total hip (g.cm-2) 0.007 0.6% 1.8% 
*BMC is not a measure required by ISCD 
 
Discussion: 
The calculated precision errors are within the minimum acceptable range for single 
operator outlined by ISCD (2019). The recruited sample were of a similar age (range 
19-38 y) to the sample included within Chapter 4-7. The inclusion of a greater 
proportion of females (19/30 (63%)) within the studied sample is also in line with the 
recommendation to complete a precision assessment with a sample representative of 
the population of interest. The sample chosen is reflective of young adult population 
studied as part of the UL Body Composition study however it did not specifically 
target FDR and this may be a limitation particularly if the included participants have 
higher tissue or mineral mass than the participants in the main thesis studies. This is 
particularly important if the absolute precision error was being used to establish a least 
significant change (LSC) threshold. In this case a precision calculation including 
participants with higher tissue and mineral mass and/or density would result in a 
greater LSC.  
 
This precision calculation demonstrates that scans were performed by a researcher 
with acceptable precision error. If a longitudinal study had been included it would 




 Survey questions  
Survey was hosted online. The survey information, questions and potential responses 
available to participants are shown in this appendix.  
Volunteer information  
An investigation of the prevalence of poor bone health among female middle and 
long distance runners 
EHSREC 2016_12_10 
Thank you for considering participating in this research study. This project aims to evaluate 
the bone health of female middle and long distance runners. 
What is the project about? 
Healthy bones are important both in the prevention of injury during sport participation and 
reducing fracture risk throughout a lifetime. Female middle and long distance runners have 
been identified as a population at risk of bone related injuries and poor bone health. This 
study aims to assess the prevalence of injuries and bone health among Irish middle and long 
distance runners. 
 
What will you have to do? 
This survey will ask you about bone injuries and your current bone health if known. The 
survey will take a maximum of 15 minutes to complete and you can start and return to the 
survey at a later time if needed. At the end of the survey you will be asked if you would 
like to be contacted at a future date should assessment of bone health be available at the 
University of Limerick. Providing contact details for this 
section is optional. 
 
What are the benefits? 
You will be contributing to a population bone health reference base of middle and long 
distance female runners. 
 
What if I do not want to take part? 
Participation in this study is voluntary. You can discontinue your participation in the 
research at any time and this will be dealt with in an unhesitating and confidential manner. 
What happens to the information? 
The information retrieved will be dealt with and handled in complete confidence. Only 
researchers involved in the study will have access to the information. 
 




At the end of the study the information will be used anonymously to present the results in 
thesis form and, potentially, as a communication. All subject detail/information and data 
will be held by the principal investigator for up to 7 years in a password protected computer 
at UL. Each participant will receive a copy 
of their body composition analysis. Upon completion, a report containing the result of the 
overall study will be available to participants on written request to the Principal Investigator  
 
What if I have more questions or do not understand something? 
If you do not understand any aspect of the study please contact Jennifer Higgins 
(jennifer.higgins@ul.ie) or Phil Jakeman (phil.jakeman@ul.ie) 
 
This study has been approved by the ethics committee of the Faculty of Education and 
Health Science (EHSREC 2016_12_10). If you have any concerns about this study and 
wish to contact someone independent, you may contact The EHS Research Ethics Contact 
Point of the Education and Health Sciences Research Ethics Committee, University of 




Should you agree to participate in this study please read the statements below and if you 
agree to them please indicate by ticking the box at the end of the page. 
• I have read and understood the participant information sheet. 
• I understand what the project is about, and what the results will be used for. 
• I understand that what the researchers find out in this study may be shared with 
others but that my name will not be given to anyone in any written material 
developed. 
• I am fully aware of all of the procedures involving myself, and of any risks and 
benefits associated with the study. I know that my participation is voluntary and 
that I can withdraw from the project at any stage without giving any reason. 
• I consent to the data obtained from the conduct of this project to be used, 
anonymously, for presentation and publication. 
 
1. Do you consent to participating in this research project after agreeing to ALL the 
above statements 
(Response was compulsory to this question. Only respondents who answered yes were 






2. Are you female? 
Yes  
No  
3. Are you aged between 18 and 35 years? 
Yes  
No  
4. Do you compete in running events between 800m and marathon (this can include 




5. What age are you (years)? (open response limited to numeric) 
6. What is your current height (cm) (open response limited to numeric) 
7. What is your current mass (kg) (open response limited to numeric) 
8. How would you describe your highest level of participation in distance running 
(one option available) 
 Senior international 




 Competitive road racing/ open meets 
 Recreational  
9. What events do you regularly participate in? (please tick all that apply) 
 Track 800m-1500m 
 Track 3000m-5000m 
 Track 10000m 
 Road 5k/ 10k 
 Road – half marathon 
 Road – marathon 
 Cross country 




10. Have you been diagnosed with any of the following conditions: 
• Thyroid disease 
• Coeliac disease 
• Crohn’s disease 
• Chronic kidney disease 
• Chronic liver disease 
• Any condition you have been told will affect bone metabolism  
Yes  
No  
11. As far as you are aware have you taken any of the following medication on a regular 
basis for longer than 6 months at a time? 
• Glucocorticoids 
• Eltroxin 
• Bisphosphonates  
• Anticoagulants (including aspirin, warfarin, heparin) 
• Chemotherapy drugs 
• Any other drug you have been told affects bone metabolism  
Yes  
No  
12. How many TIMES a week do you run? (open answer limited to numeric) 
13. How many KILOMETERS do you run per week? (open answer limited to numeric) 
14. How many HOURS a week do you typically run? (Please give answer to nearest 
0.5 hours) (open answer limited to numeric) 
15. How many TIMES a week do you typically participate in non-weight bearing 
endurance activities (e.g. swimming, cycling, aqua jogging, rowing)? (open answer 
limited to numeric) 
16. How many HOURS a week do you typically participate in non-weight bearing 
endurance activities (e.g.swimming, cycling, aqua jogging, rowing)? (Please give 
answer to nearest 0.5 hours) (open answer limited to numeric) 
17. How many TIMES per week do you typically participate in resistance exercise or 
plyometrics (e.g. weights, bounding exercise, circuits)? (open answer limited to 
numeric) 
18. How many HOURS a week do you typically participate in resistance exercise or 
plyometrics (e.g. weights, bounding exercise, circuits)? (Please give answer to 
nearest 0.5 hours) (open answer limited to numeric) 
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19. How many TIMES per week do you typically participate in balance, rehabilitation 
or flexibility exercises? (open answer limited to numeric) 
20. How many HOURS a week do you typically participate in balance, rehabilitation 
or flexibility exercises? (Please give answer to nearest 0.5 hours) 
21. Does the information you have provided about training in the last 12 months reflect 
your typical training patterns? 
 Yes 
 No, I usually train more 
 No, I usually train less 
Bone injuries 
This section will ask you about injuries related to bone health  
Stress fractures 
22. Have you ever been diagnosed with a stress fracture  
 Yes 
 No 
 Don’t know 
23. How was the stress fracture diagnosed? 
 MRI 
 x-ray 
 Don’t know 
 Other (please specify) 
Fractures 
24. Have you ever had a fracture resulting from a fall from standing * height or less? 
 Yes 
 No 
 Don’t know 
25. How was the fracture diagnosed? (If "no" or "don't know" * to Q3 answer N/A) 
 MRI 
 X-ray 
 Don’t know 
 N/A 
 Other (please specify) 
Diagnosis of bone health  
This section aims to gather information on bone health diagnosed by imaging  






 Don’t know 
27. How was your bone health evaluated? 
 Dual x-ray absorptiometry (DXA) 
 Ultrasound  
 Don’t know 
 I have not had my bone health evaluated 
 Other (please specify) 
28. If your bone health was evaluated by DXA please provide Z-scores for all known 
sites if available. Enter NA if not available. If you have had multiple scans please 
provide most recent information. 
 Left femur 
 Right femur 
 Dual femur average 
 Lumbar spine 
 Forearm (33% radius) 
 Total body  
This survey is part of a project that assesses bone health and factors that influence 
bone including menstrual function, dietary intake and body composition in female 
distance runners. 
Would you like to be contacted with further information about this research? 
If you would like to be contacted for participation in this project please provide 
contact details. 
29. If bone health assessment is available at a later date would you like to be contacted 
for further testing at the University of Limerick? 
 No  




 Training and energy expenditure (FDR) 
Training  
Table C-1: Daily number of training sessions, EEE and training duration amongst FDR (n=7) 
Participant Variable Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 
F1271 Training sessions (n) 1 1 1 1 0 1 1 
EEE (kcal) 412 722 481 509 0 843 703 
Training duration (h) 0.8 2.0 1.0 1.0 0.0 0.7 1.5 
F1680 Training sessions (n) 2 1 3 1 0 2 1 
EEE (kcal) 613 529 668 546 0 1086 611 
Training duration (h) 1.4 1.0 2.0 1.5 0.0 2.1 1.2 
F1706 Training sessions (n) 3 3 0 2 2 2 2 
EEE (kcal) 556 691 0 608 522 519 684 
Training duration (h) 1.5 2.4 0.0 1.8 1.3 1.8 2.0 
F1983 Training sessions (n) 1 2 1 1 (strength) 1 1 1 
EEE (kcal) 604 582 435 113 398 590 576 
Training duration (h) 1.1 1.9 1.3 0.9 0.8 1.4 1.1 
F1985 Training sessions (n) 0 1 1 2 1 1 1 
EEE (kcal) 0 398 464 515 375 425 864 




F1986 Training sessions (n) 1 1 1 1 0 1 2 
EEE (kcal) 698 685 613 779 0 873 745 
Training duration (h) 1.0 1.4 1.1 1.7 0.0 1.5 1.7 
F416 Training sessions (n) 3 1 1 3 0 3 1 
EEE (kcal) 508 666 752 1077 0 798 617 
Training duration (h) 1.9 1.4 1.6 2.6 0.0 2.0 1.6 
 
F1706 and F416 both documented rehabilitation training sessions of short (<15 min) duration on multiple days they run. Although three FDR 
(F1680, F1985 and F416) reported two training sessions immediately after each other these were classified as separate sessions as the goals and 




Validity of energy expenditure – raw data 
Table C-1: Valid daily TEE assessed by DLW and SWP3 and the difference recorded for each day 
Participant Variable  Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 
F1271 TEE DLW (kcal) 3451 3468 3258 3176 2505 * * 
TEE SWP3 (kcal) 2490 2890 2757 2883 2016 * * 
Difference (kcal) -961 -578 -500 -294 -489 * * 
F1983 TEE DLW (kcal) * 2732 2591 1969 3033 3767 2586 
TEE SWP3 (kcal) * 2846 2419 1825 2705 2986 3127 
Difference (kcal) * 114 -171 -145 -328 -780 541 
F1985 TEE DLW (kcal) * * 3129 1922 3014 3542 3035 
TEE SWP3 (kcal) * * 2607 2488 2692 2938 2551 
Difference (kcal) * * -522 567 -321 -604 -484 
F1986 TEE DLW (kcal) * * 3609 2278 * * * 
TEE SWP3 (kcal) * * 2601 3069 * * * 
Difference (kcal) * * -1008 792 * * * 
F416 TEE DLW (kcal) $ $ 3021 * 2428 3683 3554 
TEE SWP3 (kcal) $ $ 3013 * 2325 2916 2942 
Difference (kcal) $ $ -8 * -104 -767 -612 
TEE assessed by SWP3 is reported as the TEE corrected for EEE that needed to be calculated based on the Compendium of Physical Activity.  




 Energy intake and carbohydrate data (FDR) 
Table D-1: Daily energy and carbohydrate intake for 7 FDR. Carbohydrate is expressed in g.kg-1 and as a percentage of total energy in the day 
Participant  Day 1 Day 2 Day 3 Day 4 Day 5 Day 5 Day 7 
F1271 Energy 2362 3311 2240 2569 3155 3903 2029 
CHO (g.kg-1) 5.5 7.6 4.3 5.5 6.0 7.4 5.3 
CHO (% energy) 50 49 41 46 41 40 56 
F1680 Energy 3461 3351 2608 2794 3171 3621 4370 
CHO (g.kg-1) 7.5 5.9 5.3 5.6 4.6 6.4 7.1 
CHO (% energy) 55 45 52 51 37 45 41 
F1706 Energy 2394 2552 1731 2955 2496 2535 2838 
CHO (g.kg-1) 6.3 5.4 3.7 6.4 5.1 5.6 6.3 
CHO (% energy) 54 44 45 45 42 46 46 
F1983 Energy 2470 2850 1618 2800 2654 2656 2917 
CHO (g.kg-1) 4.7 5.0 2.7 4.4 4.5 4.2 5.0 
CHO (% energy) 40 37 35 34 36 34 36 
F1985 Energy 3526 3078 4182 3695 3125 3527 2581 
CHO (g.kg-1) 7.2 4.7 8.8 6.9 4.8 4.4 4.3 
CHO (% energy) 49 36 50 45 36 30 40 
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F1986 Energy 2058 2015 2057 2406 2478 2070 2246 
CHO (g.kg-1) 3.3 3.8 3.9 3.3 4.6 3.3 3.4 
CHO (% energy) 44 51 52 37 51 44 42 
F416 Energy 2306 2423 2710 2305 2096 3017 3161 
CHO (g.kg-1) 5.5 6.7 5.6 5.7 4.9 7.0 6.5 





 Energy availability  
The following example details the calculation of energy availability included in Chapter 7. In order to report the mean data. F1271 is used as an 
example.  
FFM = 45.7 kg.  
Age = 29.6 y 
Height = 1.705 m 




Step 1:  Calculation of EEE. EEE refers to the energy expended as a result of being an athlete and must therefore be corrected for the BMR 
that would be expended during the during the duration of exercise. The calculation for this is outlined in column D of Table E-1 
Table E-1: Calculation of EEE 
Column A B C D 
Variable TEE during exercise Duration (min) BMR (kcal.min-1) EEE 
Calculation/ source Energy expenditure from 
SWP3 during specified 
exercise bout 






BMR (kcal.min-1)= 1323/1440 
(number of minutes in a day)  
= 0.92 
= 
Column A-(column B 
(min)*column C) 
Day 1 458 50 412 
Day 2 831 118 722 
Day 3 537 61 481 
Day 4 564 60 509 
Day 5 0 0 0 
Day 6 881 42 843 
Day 7 784 88 703 
 
Step 2: Calculation of average EA. As documented within the thesis EA was calculated using the following equation: 





To calculate average EA, both EI and EEE were averaged as per the bottom row of Table E-3 in columns A and B respectively. This value was 




45.7 = 50	2345. 26&&'
78 
Equation Appendix E-2 
Table E-2: EI, EEE and resultant EA calculated daily and using mean values 
 A B C 
 EI (kcal) EEE (kcal) EA (kcal.kgFFM-1) 
Day 1 2362 412 43 
Day 2 3311 722 57 
Day 3 2240 481 38 
Day 4 2569 509 45 
Day 5 3155 0 69 
Day 6 3903 843 67 
Day 7 2029 703 29 





Daily EA was also reported in graph format in Chapter 7. The numerical data is presented in Table E-3.  
Table E-3: Daily EA calculated from the individual EI and EEE. All data is presented as kcal.kgFFM-1 
Participant Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 
F1271 43 57 38 45 69 67 29 
F1680 54 53 37 42 60 48 71 
F1706 40 41 38 51 43 44 47 
F1983 40 49 25 58 48 44 50 
F1985 73 55 77 66 57 64 35 
F1986 25 25 27 30 46 22 28 
F416 39 38 43 27 46 48 56 
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